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Summary
The purpose of this study was to investigate the regulatory protein (protein B) and
component interactions of soluble methane monooxygenase (sMMO). sMMO is a
multi-component enzyme which catalyses the oxidation of methane to methanol. It
consists of three proteins, a hydroxylase, a reductase and protein B (Colby and
Dalton, 1978). Protein B contains no metals, cofactors or prosthetic groups and has a
molecular mass of 16 kDa. It has been shown that protein B is absolutely necessary
for the hydroxylase activity of the sMMO complex and is a powerful regulator of the
enzyme (Green and Dalton, 1985). It has also been found that 12 amino acids are
cleaved from the N-terminus of protein B from Me. eapsulatus (Bath) to form an
inactive truncate, known as protein B' and mutation of the Met12_Gly13 cleavage site
to Met12 -GIn I3 to give the single mutant protein G13Q, improved the stability of the
protein (Lloyd et al., 1997).
Much of this work has concentrated on the study of the catalytic and regulatory
significance of the 12 amino acids cleaved from protein B. Me. eapsulatus (Bath)
protein B appears to- cleave autocatalytically, generating the inactive protein B'
truncate. The secondary structures of proteins B and B' were seen to be the same,
although the overall structure was identified as differing slightly and protein B was
shown to be capable of existing in a monomer-dimer equilibrium, whereas protein B'
was identified as existing in a monomer form. An homologous protein B from Ms.
trichosporium OB3b, identified as being more a-helical in character, has been shown
to be more stable than Me. eapsulatus (Bath) protein B but still undergoes the
inactivating cleavage reaction to form truncates, although the cleavage sites differ
between the two proteins.
The construction, expression and purification of N-terminal truncates of Me.
eapsulatus (Bath) protein B identified that the presence of the first 7 amino acids was
essential for protein B activity within the sMMO system and a decrease in specific
activity was observed as each amino acid from 1 to 7 was lost. Upon loss of the 7th
amino acid, tyrosine, the truncate protein was observed to be totally inactive and also
much more prone to cleavage, but unchanged in terms of secondary structure.
Protein concentration was observed as having an effect on the stability of Me.
eapsulatus (Bath) protein B and, the single mutant G13Q, with increased
concentrations improving stability. This effect was not observed for the double
mutant MI2A:G13Q, although it was shown to be more stable than the other
proteins under more dilute conditions. The addition of a magnesium salt also
improved the stability of protein B.
Studies into the interactions of protein B with the other proteins within the sMMO
complex have also been performed. Evidence that the hydroxylase undergoes a large
conformational change upon the binding of the reductase and protein B has been
obtained and modelled to suggest that one trimer of the hydroxylase dimer rotates by
1800 relative to the other upon complex formation. It also showed the sMMO
complex to form in a stoichiometry of 1:2:2 hydroxylase:reductase:protein B. Other
data suggest that -sMMO component binding occurs on only one trimer of the
hydroxylase dimer under different conditions.
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Chapter 1
Introduction
1.1 Methane to Methanol Conversion
Methane is a colourless, odourless gas with a boiling point of -164°C and is the
most abundant organic gas in the atmosphere (Crutzen, 1991). Over the past 300
years, as a consequence of human activity, atmospheric methane levels have
increased. Terrestrial radiation in the infrared region is absorbed by atmospheric
methane, with the re-emission of the absorbed radiant energy causing global
warming. Because methane absorbs the radiation more efficiently than carbon
dioxide, it is estimated to contribute about 26 times that of carbon dioxide (mole for
mole) to climatic change (Lelieve1d et al., 1993). Therefore, a reduction in
atmospheric methane concentrations is important in reducing the global warming
effect (Hogan et al., 1991). Bacteria that can utilise methane provide a means of
removing it from the environment, although it is necessary to define the sources and
sinks of environmental methane in order to identify accurately which steps have
practical value in reducing the effects of global warming (Hanson and Hanson,
1996).
Methane is the chief constituent of natural gas. Chemically, it is fairly inert and thus
its activation has attracted increased attention in recent years because of its scientific
and industrial importance as a source of chemicals and fuels. In particular, the
conversion of methane to methanol is of great interest as an important energy source
for the 21st century to replace projected dwindling petroleum reserves (Yoshizawa et
al., 1998). Current chemical methods for the conversion of methane to methanol
involves indirect processes which are energy intensive and often result in other
oxidation products besides methanol being formed (Gesser et al., 1985). For,
example, most chemicals derived from methane, including methanol, are indirectly
converted via a syngas intermediate. Thus, methane and water are converted to
carbon monoxide and hydrogen based on high temperature (700-900 CC) energy
intensive processes. Several other catalytic steps are then required to convert the
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syngas intermediate, the carbon monoxide and hydrogen mixture, into methanol
(Dalton, 1991). The use of Hg(II) to catalyse the selective oxidation of methane to
methanol was described by Periana et al. (1993). The reaction was shown to occur at
180°C with reagents that could be used on a large scale. However, a yield of only 40
% was achieved and carbon dioxide was produced as the main side product.
Therefore, the methane monooxygenase (MMO) enzyme, for which is observed the
direct oxidation of methane at ambient temperature and pressure with 100 %
selectivity of methanol as the product, provides an ideal model for the development
of direct methane oxidation catalysts (Dalton, 1992).
The conversion of methane into more valuable chemical products has also been well
researched (Cover and Peterson, 1988; Green and Ramanathan, 1988). Methane can
be chemically converted to produce base, intermediate and fine chemicals. In some
cases the conversion process is direct, such as in the production of halomethane,
hydrogen cyanide and acetylene, in which methane is activated either at very high
temperatures or by the halogen radicals, but in many cases it is much more
complicated. Although much research has focused on developing a convenient
chemical method for converting methane into other useful organic chemicals, none
has been significantly successful. Methane is the end product of degradation of most
organic materials. Thus there is a need to be able to use this resource. The discovery
of the unique abilities of the MMOs of methane-utilising bacteria to catalyse
reactions of such commercial and environmental importance has opened up a whole
new field for scientific research.
1.2 Methane Utilising Bacteria
1.2.1 Methylotrophic Bacteria
The first methylotrophic bacterium was identified by Leow in 1892 (Quayle, 1987).
Since then, many methylotrophic bacteria have been isolated and characterised.
Methylotrophic bacteria are a diverse group of microorganisms that have the
common ability to generate energy by the utilisation of one-carbon (Cl) compounds
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for growth. The Cl primary substrate can take the form of methane, methanol, formic
acid, methylamines, carbon monoxide, cyanide or methylated sulphur species.
(Colby and Zatman, 1973). Sub-divisions of the major genera of methylotrophic
bacteria are as shown in Figure 1.1.
Figure 1.1: Sub-divisions of the major genera of methylotrophic bacteria.
Adapted fromGreen (1992).
Methylotrophic Bacteria
Facultative Methylotrophs ~~
Obligate Methylotrophs
Restricted Facultative
Methylotrophs
Obligate Methanol /
Methylated Amine Utilisers
Obligate Methane Utilizers
(Methanotrophs)
The facultative methylotrophs have the ability to be able to grow on multicarbon
substrates, whereas the restricted facultative methylotrophs can only utilise a narrow
range of these compounds. In contrast, however, obligate methylotrophs can only
grow on Cl compounds as their sole carbon and energy source (Colby et al., 1979).
These bacteria are rod shaped Gram-negative organisms and can be sub-divided into
the methanol/methylated amine utilisers and the methane utilisers, which can also
grow on limited amounts of methanol and are known as Methanotrophs.
1.2.2 Methanotrophic Bacteria
The first methanotrophic bacterium was isolated in 1906 by Sohngen (Quayle,
1972). Further isolation and characterisation studies were conducted by Whittenbury
et al. (1970) and led to over 100 different strains being identified. Analysis of their
morphology, resting structures, intracytoplasmic structures and physiological
characteristics formed the basis for the current classification schemes. The generic
groups identified included Methylomonas (Mm.), Methylobacter (Mb.),
Methylococcus (Mc.), Methylocystis (Mcy.), and Methylosinus (Ms.) (Whittenbury
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and Dalton, 1981) and the recent addition of the new genus Methylomicrobium
(Mm.) (Bowman et al., 1993, 1995). These organisms can be further subdivided into
Type I, Type II, and Type X organisms based on various characteristics including
DNA base composition, and the major carbon assimilation pathway. Type II
organisms, Ms. and Mcy., utilise the serine pathway to assimilate formaldehyde
(Lawrence and Quayle, 1970), whereas Type I, Mm. and Mb., and Type X, Mc.,
organisms assimilate formaldehyde via the ribulose monophosphate (RuMP)
pathway. Type X methanotrophs are distinguishable from the Type I organisms as
they possess, amongst other differences, DNA with a higher mol % G + C content
(Green, 1992;Hanson and Hanson, 1996).
A defining characteristic of methanotrophs is their use of enzymes known as
methane monooxygenases (MMOs) to catalyse the oxidation of methane to
methanol. The methanol is then further oxidised to formaldehyde, catalysed by a
second enzyme known as methanol dehydrogenase (MDH). The formaldehyde can
then either be assimilated into cellular biomass or further oxidised by the enzymes
formaldehyde dehydrogenase (FDH) and formate dehydrogenase to carbon dioxide
(C02). Figure 1.2 illustrates the methane oxidation pathway.
Figure 1.2: Pathway of methane oxidation.
The enzymes catalysing the reactions are: sMMO, soluble methane monooxygenase; pMMO,
particulate methane monooxygenase; MDH, methanol dehydrogenase; FADH, formaldehyde
dehydrogenase; and FDH, formate dehydrogenase. [Modified from Hanson and Hanson, (1996)].
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1.3 Methane Monooxygenase
The oxidation of methane to methanol occurs efficiently when catalysed
enzymatically by methane monooxygenase (MMO), the first enzyme in the methane
oxidation pathway ofmethanotrophs (Lipscomb, 1994;Wallar and Lipscomb, 1996).
Leadbetter and Foster (1959) first proposed the involvement of an oxygenase
enzyme in the initial attack on methane by methanotrophs, based on the
incorporation of 180 from 1802 into its cellular biomass. Observations of methane
oxidation catalysed by cell extracts of some methanotrophs suggested that a
monooxygenase, which catalysed the incorporation of one oxygen atom into the
substrate, was the form. of the oxygenase responsible for methane oxygenation
(Ribbons and Michalover, 1970; Ferenci, 1974). Colby et al. 1975, devised a
convenient and rapid method for assaying for MMO in which the disappearance of
bromomethane, a soluble derivative of methane and substrate analogue, was
monitored via gas chromatography. Further studies (Colby and Dalton, 1976)
confirmed that MMO activity could also be measured by monitoring for methanol
accumulation using the same technique and in 1977 it was reported that propylene
could also be oxidised by MMO, forming epoxypropane, which could be similarly
monitored by gas chromatography. Epoxypropane was not susceptible to further
oxidation by MMO and, therefore, monitoring epoxypropane formation has become
the standard method for the monitoring of MMO activity (Colby et al., 1977).
Studies of MMO from several methanotrophs during the 1970s revealed that the
enzyme existed in two forms differing in cellular location. Particulate MMO
(PMMO) is membrane-associated and thus enzyme activity is identified in the
cellular membrane fraction of the cell free extracts. Soluble MMO (sMMO) is
identified in the cytosolic fraction of the cell free extracts (Colby et al., 1975;
Ferenci et al., 1975;Tonge et al., 1975; 1977; Patel et al., 1979;Dalton et al., 1984).
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1.4 Regulation of MMO Expression
The determination of the form of MMO expressed is as a response to different
copper-to-biomass ratios achieved under different growth conditions (Stanley et al.,
1983). sMMO is expressed at low copper-to-biomass ratios, whereas pMMO is
expressed at higher ratios. The presence of a copper-regulated promoter was
subsequently proposed to be involved (Neilsen et aI., 1996). In both Me. capsulatus
(Bath) and Ms. trichosporium OB3b transcription of the sMMO gene cluster was
seen to be negatively regulated by copper ions and data suggested that transcription
was directed from a cr54_like and cr7o-like promoter, both regulated by copper ions.
The synthesis of polycistronic mRNA transcribed from the pMMO genes was
identified as being activated by copper ions and this was concomitant with repression
of sMMO gene transcription (Neilsen et al., 1997). A hypothetical model for the
transcriptional regulation ofMMO genes was therefore proposed (Figure 1.3).
The expression of sMMO genes was proposed to be subject to positive control, such
that copper ions would regulate sMMO expression by inactivation of an, as yet,
unidentified activator protein. In copper-free cells, transcription of pMMO genes
would be repressed by the binding of a regulator to the pMMO operator.
Transcription of sMMO genes would be brought about by the binding of the same
(or another) regulator to the activator sequence upstream of the sMMO promoter. In
copper-containing cells, copper ions would bind to the regulator, inducing a
conformational change preventing it from binding to the pMMO promoter, resulting
in transcription of the pMMO genes whilst transcription of the sMMO genes was
repressed.
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Figure 1.3: Model for the copper-dependent transcriptional regulation of pMMO and sMMO
genes.
pMMO and sMMO genes are indicated by the black boxes labelled pmo and smmo respectively. The
putative promoter regions are labelled P. In copper-free cells the regulator protein, labelled R, binds to
the pmo operator and represses its transcription. The same, or another regulator protein, also labelled
R, binds to an upstream activator site, labelled VAS, 5' of the smmo promoter and contacts the RNA
polymerase, labelled RNAPol, leading to the smmo genes being transcribed. In copper-containing
cells, copper-binding to the regulator protein induces a conformational change in the protein
preventing its binding to the pmo promoter or the smmo VAS. This leads to derepression and the
subsequent transcription of the pmo genes and the smmo genes become unactivated. [Reproduced
from Neilsen et al. (1997), with permission.].
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1.5 Particulate Methane Monooxygenase (pMMO)
The particulate membrane associated methane mono oxygenase (pMMO) is present
in all known methanotrophs. In methanotrophs capable of sMMO and pMMO
expression, pMMO appears to be produced at the same time as the extensive
formation of membranes is observed when cells are grown in copper containing
media. Under copper limitation the internal membranes are observed as being fewer
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in number and less well organised in nature and also the sMMO enzyme is produced.
However, it still remains unclear whether these two events are interrelated or not
(Prior and Dalton, 1985). The ability to switch from particulate to soluble MMO
during copper limitation conditions is advantageous to the organisms.
Methanotrophs that only express pMMO, such as Methylomonas album B08, are
incapable of avoiding copper stress and so these organisms experience copper
limited growth at a cell density dependent on the available copper concentration
(Dalton et al., 1984). Three new polypeptides are observed in membrane fractions of
Me. eapsulatus (Bath) cells switched from sMMO to pMMO expression. Their
apparent molecular masses are 45,35, and 26 kDa and, therefore, they are proposed
to be involved in pMMO activity (Stanley et al., 1983).
The purification of pMMO has proved to be particularly problematic. Tonge et al.
(1975) reported that pMMO from Ms. triehosporium OB3b could be resolved from
the membrane using a variety of techniques including detergent treatment and
sonication, although subsequent attempts to solubilise pMMO from the membranes
proved unsuccessful (Burrows et al., 1984). Work by Smith and Dalton (1989)
achieved pMMO activity after solubilisation of the enzyme from Me. eapsulatus
(Bath) using the non-ionic detergent dodecyl-I3-D-maltoside and treatment with
either egg or soybean lipids. Further purification of the protein into its component
polypeptides was unsuccessful and complete enzyme activity was lost. Recently
work by Zahn and DiSpirito (1996) and Nguyen et al. (1998) has provided
procedures for the solubilisation and isolation of pMMO from Me. eapsulatus (Bath)
and identified the active polypeptides as.having molecular masses of 47, 27, and 25
kDa. Acetylene has been identified as a suicide substrate of pMMO (Prior and
Dalton, 1985) and the 27 kDa polypeptide was identified as the acetylene-binding
protein. The active enzyme complex was shown to contain 2.5 iron atoms and 14.5
copper atoms per 99 kDa (Zahn and DiSpirito, 1996). However, Nguyen et al.
(1998) found pMMO to be a copper-containing protein only, which showed a
requirement for Cu(I) ions.
pMMO has been shown to be capable of functioning with several electron donors
including NADH, ethanol and succinate (Stanley et al., 1983). More recently, studies
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by Shiemke et al. (1995) have suggested that the enzyme obtains reducing
equivalents directly from quinol (probably plastoquinol) in vivo and Zahn and
DiSpirito (1996) identified pMMO as containing non-stoichiometric concentrations
of cytochrome b-559/569, which, it is suggested, could function as the initial
electron donor. The range of substrates that pMMO will oxidise is limited to a
number of alkanes and alkenes of up to 4 carbons only or less and suggests pMMO
has a rather restricted active site (Smith and Dalton, 1989).
The mixed reports about pMMO present conflicting information and have created
confusion concerning the nature of the complex, particularly the discrepancies
between the findings of Zahn and DiSpirito (1996) and Nugyen et al. (1998)
regarding the composition of the active site metal(s). Work by Semrau et al. (1995)
succeeded in cloning and sequencing genes from Me. eapsulatus (Bath) that encode
polypeptides proposed to be the 45 and 27 kDa subunits of pMMO, known as pmoA
and pmoB respectively, and have a high similarity to the subunits of ammonia
monooxygenase (AMO), implying that the enzymes are related. The work also
suggested that the two genes were present in duplicate copies and that the duplicate
genes were closely related in DNA sequence. Costello et al. (1995) identified a third
open reading frame, designated pmoC, which encodes the 25 kDa polypeptide of
pMMO, and was also present in duplicate copies. This raises the possibility that two
different copies of pMMO could be present in methanotrophs and might be
expressed differentially depending upon cellular needs (Lid strom and Semrau,
1995). Nevertheless, these genetic findings along with the biochemical information
available for the enzyme itself show pMMO and sMMO to be genetically and
structurally distinct.
1.6 Soluble Methane Monooxygenase (sMMO)
sMMO was first identified by Colby and Dalton in 1976. The work demonstrated
that that supernatant from a cell free extract of Me. eapsulatus (Bath) catalysed the
NADH and 02-dependent oxidation of methane. They further identified the multi-
component nature of the enzyme system by resolving the extract into two fractions
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by ion exchange chromatography, both of which were essential for reconstitution of
activity. sMMO was demonstrated to have a very broad substrate range and to be
capable of catalysing a number of different oxygen incorporation reactions (Colby et
al., 1977).
sMMO was first purified from Me. eapsulatus (Bath) by Colby and Dalton (1978).
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Since then sMMO has been purified from various methanotrophs including
Methylobaeterium sp. CRL-26 (Patel and Savas, 1987), Ms. sporium 5 (Pilkington
and Dalton, 1991), Methyloeystis sp. Strain M (Nakajima et al., 1992) and Ms.
triehosporium OB3b (Fox et al., 1989). sMMO has been shown to consist of three
distinct component proteins known as the hydroxylase (formally protein A), the
regulatory protein which is also known as protein B, and the reductase (formally
protein C) (Figure 1.4). Interestingly, the sMMO from Methylobaeterium sp. Strain
CRL-26 does not appear to contain the protein B component (Patel and Savas, 1987).
Figure 1.4: Schematic model of sMMO.
The hydroxylase is shown in blue, reductase in mauve and protein B in purple. a, ~ and y refer to the
subunits of the hydroxylase. Fe-OH-Fe represents the di-iron site at the active site of the hydroxylase.
The arrows indicate the direction of electron flow. [Modified from Rosenzweig and Lippard, (1994)].
CH4+02
NADH
The hydroxylase is a large non-haem iron containing protein comprising SIX
subunits, forming an a2~2Y2arrangement. The reductase is a single subunit protein
and contains one flavin adenine dinucleotide (FAD) and one Fe2S2 (iron-sulphur)
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centre per molecule. Protein B is similarly a single subunit protein but contains no
metals, cofactors or prosthetic groups.
The identification and cloning of the structural genes of sMMO have given complete
sequence information for the hydroxylase, reductase and protein B from Me.
eapsulatus (Bath), Ms. triehosporium OB3b and Methyloeystis sp. Strain M
(Stainthorpe et al., 1989, 1990; Cardy et al., 1991a, 1991b; McDonald et al., 1997).
DNA sequencing of the sMMO operon revealed that the genes encoding the c, ~and
'Y subunits of the hydroxylase (known as mmoX, mmoYand mmoZ respectively),
protein B (known as mmoB) and the reductase (known as mmoC) are all linked on
the chromosome (Figure 1.5).
Figure 1.5: Schematic arrangement of the sMMO operon.
Details are shown of the proteins encoded by the various genes. [Modified from Murrell (1992)].
(l
mmoZmmoX mmoY mmoC
Protein B y ? Reductase
Hydroxylase
The function of orjY remains unknown (Murrell, 1992, 1994). More recent studies to
elucidate its role involved purification and characterisation of the recombinant
protein (Lloyd, 1997). However, these studies failed to implicate the protein as being
involved in methane oxidation.
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1.6.1 The Hydroxylase Component
The purification and characterisation of the hydroxylase component of sMMO from
Me. eapsulatus (Bath) was first achieved by Woodland and Dalton (1984). It was
identified as having a molecular mass of approximately 210 kDa and being
comprised of three subunits a., ~, and y of 54, 42 and 17 kDa respectively. These
were present in stoichiometric amounts suggesting an a.2~2Y2 arrangement. The
studies also revealed the presence of 2 moles of non-haem iron per mole of protein.
Similarly, the hydroxylase component of Ms. triehosporium OB3b comprises three
subunits a., ~, and y of 54, 43 and 23 kDa respectively, arranged in an a.2~2Y2
configuration, forming a complex of about 245 kDa (Fox et al., 1989). However, the
protein was calculated as containing 4.3 moles of non-haem iron per mole protein.
The hydroxylase proteins of the sMMO systems of Methylobaeterium sp. CRL-26
(Patel and Savas, 1987), Methylosinus sporium 5 (Pilkington and Dalton, 1991),
Methylomonas GYJ3 (Liu et al., 1991) and Methyloeystis sp. M (Nakajima et al.,
1992) have been observed as exhibiting the same a.2~2Y2 subunit structure, and the
iron content in the first three was identified as being the same as that in Me.
eapsulatus (Bath) hydroxylase, whereas the latter gave an iron content similar to that
reported for Ms. triehosporium OB3b. Interestingly, a direct correlation between the
amount of iron in the protein and its specific activity was noted (Dalton, 1992). The
difference in iron content could therefore be a reflection of varying extents of iron
loss occurring during the purification procedure of the hydroxylase.
1.6.1.1 The Nature of the Iron Site
The requirement of iron for catalysis was illustrated by the reactivation of iron-
depleted hydroxylase upon the addition of iron-EDTA and DTT (Green and Dalton,
1988). Work by Atta et al. (1993) illustrated that Mn(II) could be incorporated into
the apo-hydroxylase of Me. eapsulatus (Bath), although this gave rise to inactive
hydroxylase. Nevertheless, it was concluded that two Mn(II) ions had been
incorporated and two Fe(II) ions lost per mole protein, suggesting that hydroxylase
contained a single di-iron site. Interestingly, only iron could re-introduce
functionality to the iron-depleted protein; neither Ni(II), Co(ll), Zn(II), Mo(VI), nor
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V(III) could give rise to active protein (Green and Dalton, 1988). This emphasised
the importance of the iron atoms being essential for the functioning of the
hydroxylase of sMMO. Furthermore, in vitro translation of total RNA isolated from
Me. eapsulatus (Bath) produced hydroxylase subunits with molecular masses equal
to the wild-type suggesting no post translational processing occurred, but they were
inactive within the sMMO system. Functionally-active protein was only obtained
upon the addition of iron to the translated hydroxylase. This suggested that the
subunits of the hydroxylase were synthesised in their native form and self-assembled
into an apo-protein into which iron was inserted (Green and Dalton, 1988).
Woodland and Dalton (1984) used electron paramagnetic resonance (EPR) to show
that the hydroxylase contained Fe(III) and that Fe(II) could be identified upon
reduction with DTT. This illustrated that sMMO contained a novel iron-containing
prosthetic group. EPR evidence by Woodland et al. (1986) provided the first
evidence that the two iron atoms within the proteins were coupled via a u-oxo
bridge. Extended x-ray absorption fine structure (EXAFS) confirmed the presence of
a u-oxo binuclear-type bridge structure in the hydroxylase of Me. eapsulatus (Bath)
(Ericsson et al., 1988). This was also confirmed to be the case for the hydroxylase of
Ms. triehosporium OB3b (Fox et al., 1988) for which the technique of Mossbauer
was also used. This remains an unusual finding for an oxygenase, as similar
structures have only been reported in hemerythrin (Wilkins and Wilkins, 1987),
purple acid phosphatase (Que and True, 1990) and ribonucleotide reductase (RNR)
(Nordlund et al., 1990), all of which have quite different functions (Wilkins, 1992).
In hemerythrin, the di-iron centre is involved in oxygen transport and storage
(Wilkins and Wilkins, 1987), whereas in ribonucleotide reductase (RNR) R2-protein
the di-iron centre and oxygen generate a tyrosyl radical that is involved in the
reduction of ribonucleoside diphosphate to deoxyribonucleoside disphosphate for
DNA synthesis (Stubbe, 1990). The di-iron site in purple acid phosphatase is thought
to be the catalytic site for phosphate ester hydrolysis (Doi et al., 1988). A proton
electron nuclear double resonance (ENDOR) study finally identified the nature of the
monoatomic bridge in the mixed valent di-iron centre of the hydroxylase of Me.
eapsulatus (Bath) as a hydroxo-bridge. It was suggested that this was probably also
present in the oxidised hydroxylase (DeRose et al., 1993). Similar experiments for
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the hydroxylase of Ms. triehosporium OB3b gave the same result (Thomonn et al.,
1993).
The iron atoms at the active site can exist in one of three states; oxidised
Fe(III)/Fe(III), half-reduced Fe(II)/Fe(lII) or fully reduced Fe(II)/Fe(II). The native
hydroxylase was EPR silent, whereas the mixed valent state was EPR active. Studies
indicated that the mixed valent state was unreactive towards oxygen, whereas the
fully reduced state interacts with oxygen, returning the enzyme to its oxidised state
(Woodland et al., 1986; Fox et al., 1988; Dalton, 1992). Single turnover experiments
have also been used to show that chemically reduced hydroxylase is able to effect the
oxidation of the MMO substrates propane and propene (Fox et al., 1988).
1.6.1.2 Sequence Studies
Comparisons of the deduced amino acid sequences for the sMMO proteins of the
hydroxylase from Me eapsulatus (Bath), Ms. triehosporium OB3b and Mey. sp.
Strain M showed the a-subunit to exhibit the highest sequence similarity (88.9 - 97.3
%) and identity (80.2 - 95.4 %) among the three methanotrophs (McDonald et al.,
1997). Amino acid sequence homologies further revealed that the active site
structures of the hydroxylases of the sMMO systems were similar to the R2 subunit
of ribonucleotide reductase. A sequence motif of Glu-X-X-His was shown to
coordinate the ions within the binuclear iron-binding site of the R2 subunit of the
protein by X-ray crystallography (Nordlund et al., 1990). The a-subunits of the
hydroxylase were identified as having the same sequence motif implying the
principle ligands of the di-iron centres to be similar and that the active site resides on
the a-subunit. This result was in agreement with the studies of Prior and Dalton
(1985) where it had been shown that the ketene product formed from radioactive
acetylene, a suicide substrate for sMMO, closely associated with the a-subunit of the
hydroxylase. The sequence homology work was further used to create a model of the
active site structure based on that of RNR, which was later verified by X-ray
structure analysis (Figure 1.13). It identified the principal ligands at the active site
and was consistent with the findings that two histidine ligands were present (DeWitt
et al., 1991; Smith and Dalton, 1992).
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Circular dichroism (CD) studies by Smith and Dalton (1992) suggested the
hydroxylase to have a high a-helical content, a result which supported the prediction
that the di-iron site was situated in a four helix bundle, based on the RNR structure.
A further model proposed the arrangement of the three subunits of the hydroxylase
based on chemical cross-linking studies. No cross-linking was observed for the y
subunits, only cross-linking products of the a and p subunits and a dimer of the p
subunits were identified (Fox et al., 1991).
1.6.1.3 Crystal Structure
The crystal structure of the hydroxylase of Me. eapsulatus (Bath) was determined in
1993 by Rosenzweig et al. (Figure 1.6) and a few years later the structure of the
hydroxylase from Ms. trichosporium OB3b was also elucidated (Elango et al., 1997).
The structures were found to be very similar and were in agreement with the
previous structural studies and models of the two proteins.
Figure 1.6: Structure of the hydroxylase from Me. capsulatus (Bath) at 2.2 A resolution
(Rosenzweig et aL, 1993).
,
The subunits are as follows: a are pale blue and green coloured, ~ are royal blue and mid-blue
coloured and y are yellow-green and yellow coloured.
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The two a~y protomers were found to be related by a two-fold symmetry axis with a
wide canyon running along the dimer interface and an opening in the centre of the
molecule. The structure illustrates there to be two di-iron sites, one on each of the a-
subunits. The three subunits were determined to be primarily a-helical in secondary
structure with a small region of ~-structure in the a-subunit. Interactions between the
two protomers involve helices from the a and ~ subunits with no participation from
the two y subunits. The structure also revealed the possible binding sites for the
regulatory protein B and the reductase as being in the extended canyon formed
between the a~ pairs of the dimer. Two of the iron-binding helices are exposed in
this canyon and could interact with the coupling protein resulting in a conformational
change near the active site. The structure also reveals a cavity at the iron centre
where the two iron atoms and the coordinating ligands are located on one internal
surface of the cavity and the rest is filled with the hydrophobic side chain residues;
Ile217, Ile239, Phe236, Leullo, Phe188, Alall7, Phe192, Leu204; and Glr08, with the
exception ofTW13. This is ideal for binding the non-polar substrate, methane, and is
close to the di-iron core where dioxygen is activated (Rosenzweig et al., 1993). This
proposal was verified by the findings of George et al. '(1996) where computational
investigation of the possible substrate binding sites identified methane as binding to
the hydrophobic residues described. However, no direct path to the active site exists
from the. surface of the protein, but hydrophobic pockets occur in the a-subunit
leading to the catalytic centre, which mayprovide a route for substrate access to the
di-iron site (Rosenzweig et al., 1993).
1.6.1.4 Activation by Hydrogen Peroxide
The catalysis of oxidation of methane and other sMMO substrates can occur via the
activation of the hydroxylase by hydrogen peroxide. In the normal sMMO reaction
protein B, the reductase, oxygen and NADH are required for catalytic activity, but
can' be replaced by hydrogen peroxide which serves as a source of both oxygen and
electrons for the reaction. The 'peroxide shunt' mechanism has been observed to
occur for the hydroxylases of both Me. eapsulatus (Bath) (Jiang et al., 1993) and Ms.
triehosporium OB3b (Andersson et al., 1991). Interestingly, protein B was found to
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affect the selectivity of C-hydroxylation for the hydroxylase functioning via the
peroxide shunt reaction. It was also observed to be an inhibitor of the
hydroxylase/hydrogen peroxide system (Jiang et al., 1993) (See also Section 1.6.3).
1.6.2 The Reductase Component
The isolation of the reductase component, previously named Protein C, was first
accomplished in 1978 by Colby and Dalton and identified as the protein responsible
for electron transport from NADH to the hydroxylase. It was found to be very
unstable unless kept in the presence of reducing agents such as thioglycollate or
dithiothreitol. The protein was identified as a single subunit protein of 38.5 kDa and
contained, per molecule, an FAD group identified from its absorption and
fluorescence spectra and by thin layer chromatography (Colby and Dalton, 1979) and
an Fe2S2 cluster confirmed by its absorbance and EPR spectra (Lund and Dalton,
1985) and Mossbauer spectroscopy (Solomon et al., 2000). Experiments involving
the removal and reconstitution of the redox centres of the reductase suggested a
correlation between the presence of the FAD and Fe2S2 redox centres and NADH
acceptor: reductase activity and MMO activity respectively. The FAD redox centre
was identified as interacting directly with NADH and the Fe2S2 centre was not
required for its oxidation. However, the Fe2S2 centre was shown to be required for
MMO activity, as it was observed as being necessary for electron transfer from the
reductase to the hydroxylase component (Lund et al., 1985). Therefore, the pathway
of electron flow between NADH and the two redox centres was identified, as shown
in Figure 1.7.
Figure 1.7: Order of electron flow from the reductase to the hydroxylase.
FAD and Fe2S2 are the redox centres of the reductase. The arrows indicate the order or electron flow.
[Modified from Lund et al. (1985)].
NADH -- •• FAD -- •• Fe2S2
I
---I." Hydroxylase
I
Acceptor:Reductase
Activity
MMO activity
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Work by Green and Dalton (1989) illustrated that the reductase undergoes a 3e--1e-
catalytic cycle. Initially, the FAD centre is fully reduced by the addition of 2
electrons from NADH. The electrons are then transferred singly to the Fe2S2centre,
which is only capable of carrying one electron at a time and provides single constant-
potential electrons to the acceptor, the hydroxylase component (Lund and Dalton
1985; Lund et al., 1985).
Copper, which plays a fundamental role in the regulation of MMO, has been shown
to inhibit the reductase by causing the loss of the Fe2S2, thus preventing transfer of
electrons from the reductase to the hydroxylase. At higher concentrations the FAD
centre was rendered inactive as observed by the loss of NADH : acceptor reductase
activity (Green et al., 1985). Increased copper levels induce expression of the
energetically more favourable pMMO and through interaction with the reductase
irreversibly inhibits the less efficient sMMO (Colby and Dalton, 1979; Green et aI.,
1985). This, therefore, provides the organism with a rapid method of switching to a
more efficient growth pattern in response to a change in environmental conditions
(Green et al., 1985).
The reductase has been shown to be present at only 10 % of the molar concentration
of the other sMMO components (Fox et al., 1989; Liu et al., 1997). It has been
shown to be capable of transferring electrons to several hydroxylase molecules in the
time it takes the hydroxylase to complete a single turnover. This has been suggested
to be the reason for the low levels of the reductase present as one molecule can
activate many hydroxylase molecules (Gassner and Lippard, 1999).
The reductase component has been purified from a number of sMMO systems,
including those of Ms. trichosporium OB3b (Fox et al., 1989), Methylobacterium sp.
CRL-26 (Patel and Savas, 1987), Methylosinus sporium strain 5 (Pilkington and
Dalton, 1991) and Methylocystis sp. M (Nakajima et al., 1992). They have all been
found to be very similar containing an FAD and Fe2S2 cluster and having molecular
weights between 38-40 kDa.
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The reductase from Ms. trichosporium OB3b has been shown to bind to the p
subunit of the hydroxylase (Fox et al., 1991). The reductase from Me. capsulatus
(Bath) has been identified as having a binding site on domain 2 of the a subunit of
the hydroxylase. Modelling studies proposed that binding to this region would result
in the reductase also contacting the p subunit of the hydroxylase (Rosenzweig et al.,
1997). Regulatory functions have also been proposed for the reductase in addition to
its role as an electron supplier (Liu et al., 1997). Work by Froland et al. (1992)
observed the reductase to cause a shift in the distribution of products. Studies by
Paulsen et al. (1994) identified the reductase as altering the redox potential of the
hydroxylase. Liu et al. (1997) expanded this finding to show that little change was
observed in the potential for the first electron transfer to the di-iron site, at the active
site of the hydroxylase, whereas the potential for the second electron transfer
increased. This provided a larger driving force for electron transfer from the
reductase to the hydroxylase, and favoured the transfer of 2 electrons rather than 1,
as required for catalysis.
1.6.3 The Regulatory Component, Protein B
The regulatory component is also known as protein B. It was first identified in 1978
by Colby and Dalton during the purification of sMMO from Me. capsulatus (Bath)
as the fraction capable of stimulating sMMO activity. Later, it was purified by Green
and Dalton (1985) and shown to be comprised ofa single 16 kDa subunit and devoid
of prosthetic groups or metal co-factors. Itwas also found to be a powerful regulator
of sMMO activity, converting it from an oxidase to an oxygenase or vice versa,
possibly in response to environmental conditions. In the absence of protein B,
uncoupling occurs, whereby NADH is oxidised and the hydroxylase and reductase
catalyse the 4 electron reduction of oxygen to water in both the presence and absence
of substrate. The enzyme is recoupled and switched from an oxidase to an oxygenase
upon addition of protein B, and oxygen is no longer reduced to water. In the absence
of substrate, electron transfer between the hydroxylase and reductase is shut down.
Substrate addition to the sMMO complex restores electron transfer between the
hydroxylase and reductase and the oxygenase reaction catalyses the oxidation of
substrate (Green and Dalton, 1985). Therefore, in the presence of protein B,
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electrons are readily transferred to the hydroxylase when substrate is present, but
shut down in its absence (Dalton, 1992) (Figure 1.8).
Figure 1.8: Regulation of the sMMO complex by protein B.
The hydroxylase is shown in blue, reductase in mauve and protein B in purple. Fe-OH-Fe represents
the di-iron site at the active site of the hydroxylase. The arrows indicate the direction of electron flow
and the widths of the arrows indicate the relative rates of reaction. [Modified from Green and Dalton,
( 1985)] .
• In the absence of protein B, the enzyme functions as an oxidase
• In the presence of protein B, the enzyme functions as an oxygenase
NADH+H+)
NAD+
Protein B from Ms. triehosporium OB3b was first purified by Fox et al. in 1989. it
existed as a dimer under certain conditions and was shown to be none essential for
activity. Therefore, in the Ms. triehosporium OB3b sMMO system the 4 electron
reduction of oxygen to water was not observed in the absence of protein B, as the
hydroxylase and reductase components were capable of directly catalysing oxygen
activation, unlike in the Me. eapsulatus (Bath) sMMO system. However, protein B
was seen to increase the reaction rate 150 fold, showing it to fulfil a necessary and
specific role in catalysis. Similarly, protein B purified from Methyloeystis sp. M was
observed as a dimer (Shinohara et al., 1998) and identified as being non-essential for
activity, but having only a stimulatory effect (Nakajima et al., 1992). During the
purification of the hydroxylase and reductase components of the sMMO from
20
Methylosinus sporium 5, a component was lost, thought to be equivalent to protein
B, which was identified as being essential for activity (Pilkington and Dalton, 1991).
In contrast, the sMMO of Methylobacterium sp. CRL-26 was shown to be lacking
the presence of a protein B component and such a component was not required for
sMMO activity. Although it has been proposed that the protein remains tightly
bound to the hydroxylase during purification and because of its small size and lack
of prosthetic groups, it remains undetected (Patel and Savas, 1987).
Surface plasmon resonance studies indicated that protein B bound to the hydroxylase
and reductase components of sMMO from Me. capsulatus (Bath) (Bhambra, 1996:
Lloyd et al., 1997). Furthermore, cross-linking studies showed Ms. trichosporium
oB3b protein B to bind to the a subunit of the hydroxylase (Fox et al., 1991) and
crystal structure data of the hydroxylase of Me. capsulatus (Bath) have proposed the
binding site of protein B to be in the canyon formed between the aJ3 pairs of the
protein (Rosenzweig et al., 1993). Crystals for the hydroxylase of Ms. trichosporium
OB3b grown in the presence of protein B exhibited slight structural differences to
the structure obtained for the hydroxylase alone. For example, a negatively charged
depression above helices of the a subunit, which has been identified as participating
in the active site and forming part of the active site pocket, was proposed to be the
binding site for protein B, as binding to this region could alter the iron ligand
geometry as well as the active site volume, thus modulating activity (Elango et al.,
1997).
Very recently the nuclear magnetic resonance (NMR) structures of protein B from
both Me. capsulatus (Bath) and Ms. trichosporium OB3b were published, as shown
in Figure 1.9 (Chang et al., 1999; Walters et al., 1999).
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Figure 1.9: NMR derived structures of protein B from (i) Me. eapsulatus (Bath) (Waiters et al.,
1999) and (ii) Ms. trichosporium OB3b (Chang et al., 1999).
(i) Shown is one of 14 structures derived for protein B from the NMR data. All residues are
displayed.
(ii) Shown is one of 15 structures derived for protein B from the NMR data. Only residues 35-128 are
shown which form the well-structured part of the protein. The N- and C-terminal segments are
omitted as their structures were ill-defined.
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In the case of the Me. capsulatus (Bath) protein B, the N-tenninal region contained
two partially folded helices, but their orientation relative to the protein core was
unidentified. Similarly, protein B from Ms. trichosporium OB3b consisted of an
aperiodic N-tenninus and in both cases the C-tenninal region was unstructured.
Protein B of Me. capsulatus (Bath) was considered to have a novel fold, as the DALI
server (Holm and Sander, 1993) failed to identify similar folds in other proteins. The
NMR studies indicated that substrates did not bind to or associate with protein B of
Ms. trichosporium OB3b, as no chemical shift changes were observed for the protein
in the presence of substrates (Chang et al., 1999). The NMR studies of Me.
capsulatus (Bath) protein B indicated that the reductase and protein B do not interact
in either the presence or absence of the hydroxylase. The studies identified the
'northern half' of protein B (Figure 1.10) as forming hydrophobic interactions with
the hydroxylase in contrast to the 'southern half' containing the terminal regions.
The residues, Leu96, Gly97, PhelOO, and ASpI08, identified as conserved within the
protein B and related hydroxylase cofactor proteins, were observed as being involved
in binding to the hydroxylase. Residues Trp78, ArgllS, and Tyrl17 were also identified
as being involved. The unstructured N-tenninus was observed to experience greater
flexibility than the core, a property apparently maintained in the presence of the
hydroxylase. Modelling studies, to dock protein B into its proposed binding site in
the hydroxylase cleft formed between the <l21h interface of the hydroxylase
(Rosenzweig et al., 1993), showed that the structure could be easily positioned into
the region and its mainly hydrophobic surface was ideally suited for binding in this
site (Walters et al., 1999) (Figure 1.10).
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Figure 1.10: Surface diagram model for the docking of protein B into the hydroxylase.
The hydroxylase and protein B are labelled. The exsubunits of the hydroxylase are shown in red, 13 in
blue and y in yellow. Protein B has been translated away from its proposed docking site on the surface
of the hydroxylase and rotated 90° clockwise about the j-axis to expose the residues most involved in
binding, identified as the 'northern half of the protein. The residues coloured blue are those most
affected by binding. [Reproduced from WaIters et al. (1999) with permission].
Protein B
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Protein B is not thought to participate directly in the electron transfer pathway as it
contains no metal ions or cofactors (Fox et al., 1989). However, the protein has been
shown to decrease the redox potentials for the oxidation of the di-iron site of the
hydroxylase in Ms. trichosporium OB3b (Paulsen et ai., 1994) and Me. capsuiatus
(Bath) (Liu and Lippard, 1991; Kazlauskaite et al., 1996) such that the di-ferrous
state is made more reactive to oxygen. It has been suggested that the negative shift in
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the redox potentials caused by protein B binding to the hydroxylase is due to a
change in the first coordination sphere of the iron(s) or a change in the protonation
state of the hydroxo bridge (Paulsen et al., 1994). Other effects which could account
for the changes in potentials involve a change in the solvent accessibility or the
structure of the active site environment as a result of a conformational change
occurring upon protein B binding (Kazlauskaite et al., 1996).
Further evidence that the binding of protein B results in an alteration of the iron
environment of the hydroxylase has been provided by EPR spectroscopy. For the
Ms. trichosporium OB3b system, protein B was also observed to cause a change in
the conformation of the di-ferric hydroxylase and it is hypothesised that the
structural changes observed may involve the conversion of the di-hydroxo-bridged
diamond core structure to one with more readily dissociable bridging oxygen ligands
to facilitate reaction with oxygen following di-iron site reduction (Oavydov et al.,
1997). However, for the Me capsulatus (Bath) system similar studies concluded that
protein B complex formation induced only minor alterations in ligand binding at the
di-iron centre of di-ferric hydroxylase, although in the presence of alcohols, major
perturbations were observed (Oavydov et al., 1999). This suggested protein B to play
a role in the catalytic cycle by providing favourable active site geometry for
substrate conversion and product release. Protein B binding to the mixed-valent or
fully-reduced hydroxylase caused a major alteration in the environment of the di-iron
cluster (Fox et al., 1991; Froland et al., 1992; OiWitt et al., 1995). The EPR
spectrum of the mixed valent hydroxylase was found to be progressively altered until
a stoichiometric complex was formed with protein B. Analogous changes in the EPR
spectrum of the reduced hydroxylase were maximised at 0.3 protein B per
hydroxylase di-iron cluster. Therefore, it was proposed that this observation results
from hysteresis in the relaxation of the altered hydroxylase structure in solution after
weakly bound protein B dissociated. Thus, a small amount of protein B was able to
affect a larger reduced hydroxylase population (Paulsen et al., 1994). On the basis of
these observations, proposals as to the regulatory effect of protein B from both Me
capsulatus (Bath) and .Ms. trichosporium OB3b systems were suggested. For
example the cyclic dissociation and reassociation at appropriate points in the
catalytic cycle could be involved in restricting substrate access to the di-iron site
25
until it is reduced or oxygen is activated and product release could be promoted by
protein B reassociation.
CD and magnetic circular dichroism (MCD) were used to provide insights into the
effect of protein B on the hydroxylase (Coates-Pulver et al., 1997). It was found that
the formation of the di-ferrous hydroxylase-protein B complex caused changes in the
conformation of the active site so that substrates interacted more strongly with the
di-iron metal centre than in uncomplexed hydroxylase. The CD and MCD spectral
changes arising from protein B binding suggested that the protein effects both Fe(II)
active site atoms, but one more directly while substrate binding perturbs the other.
Protein B has been shown to alter the product distribution for complex substrates that
can be hydroxylated in more than one position (Froland et al., 1992; Jiang et al.,
1993). It is proposed that this occurs as a result of changes in the hydroxylase
structure occurring upon complex formation with protein B causing substrates to be
presented differently to the activated oxygen species at the active site. Similarly,
protein B was shown to affect the selectivity of carbon hydroxylation when the
hydroxylase was activated via the peroxide shunt mechanism and was also able to
inhibit the hydrogen peroxide-driven oxidations. Protein B was, therefore, clearly
seen to be able to interact with the hydroxylase to significantly affect the
hydroxylaselhydrogen peroxide system (See also Section 1.6.1.4).
Protein B has also been shown to play a specific role in catalysis by exerting a
'gating' effect on oxygen reactivity by increasing the rate of Compound P (an MMO
reaction intermediate) by as much as 1000 fold and that the rate of conversion of
Compound P to Compound Q (another MMO reaction intermediate) (Section 1.6.4;
Figure 1.12) is also increased by at least 40 fold (Liu et al., 1995). The rate limiting
step in catalysis is, therefore, shifted to either the enzyme-bound product or product
release step. The method by which protein B enhances the reaction rate with oxygen
has.been proposed to be as a result of the protein lowering the. redox potential of the
hydroxylase-protein B complex or derived from an increase in oxygen accessibility
of the active site or the di-iron cluster by means of a conformational change,
proposals discussed previously.
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Protein B from Me. capsulatus (Bath) has been observed as being particularly
sensitive to proteases (Green and Dalton, 1985). Work by Pilkington et al. (1990)
purified two forms of the protein, the intact protein B and a truncated version, B'.
Later studies by Bhambra (1996) and Lloyd et al. (1997) identified a second
truncated protein, B". ESI-MS analysis indicated that the cleavage of protein B to
give B' occurs between Metl2 _Glyl3residues, resulting in 12 amino acids being lost
from the N-terminus, and Gln29-Vaeo cleaves to form B" with the loss of29 amino
acids from the N-terminus (Figure 1.11).
Figure 1.11: Cleavage sites of protein B from Me. capsulatus (Bath).
The N-terminal amino acids of protein B are shown with arrows indicating the sites of cleavage and
the truncate proteins produced. [Modified from Lloyd et al., 1997].
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Cleavage to form B" has also been observed in Methylocystis sp. M (Shinohara et
al., 1998). Studies have shown that the 12 amino acid fragment cleaved from protein
B to give B' had no effect on sMMO activity, in eith~r the presence or absence of
protein B' (Bhambra, 1996). B' was shown to have no effect on the redox behaviour
of the hydroxylase (Kazlauskaite et al., 1996). It has also been shown to form a
complex with the oxidised hydroxylase which is 3 times less stable than the
corresponding protein B complex and the strength of binding of protein B to the
hydroxylase becomes reduced in the presence of protein B'. This suggested that
protein B' bound at the same site as protein B, but the former did not affect the
hydroxylase in the manner protein B itself did to bring about activity (Kazlauskaite
et al., 1996).
Proteins B' and B" were seen to co-purify with protein B from Me. capsulatus
(Bath) and the addition of protease inhibitors failed in reducing the level of cleavage
observed (Bhambra, 1996; Lloyd et al., 1997). Expression of protein B has been
achieved in E. coli (West et al., 1992), although cleavage to form B' was still seen to
occur. Expression of protein B in protease deficient strains also failed to prevent
cleavage (Bhambra, 1996;Lloyd et al., 1997).
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Alteration of the Metl2_Glyl3 cleavage site to MetI2_GlnI3, equivalent to the site
found in Ms. trichosporium OB3b protein B and for which truncation had not been
reported, enhanced the stability of recombinant protein B preparations (Lloyd et al.,
1997). Similarly, a triple mutant protein B in which Gly'" and Glyl6 were mutated to
Ala residues and Glyl3 was mutated to GIn, was also resistant to truncation, but
exhibited only about half the activity of the native and single mutant proteins
(Brandstetter et al., 1999).
The existence of three forms of protein B has been proposed to be a mechanism to
control the amount of active protein B within the cell since the occurrence of the
cleavage reaction rapidly inactivates the protein, thus preventing sMMO activity. It
remains unclear whether cleavage occurs due to activation of an autocatalytic
process as a response to specific conditions, or due to proteolysis. Nevertheless, the
production of an inactive form of protein B is potentially useful to the cell. Substrate
oxidation does not occur in the presence of protein B' or B", so their formation may
be a mechanism of shutting down enzyme activity, possibly as a response to
substrate absence. This process would prevent the wast~ful oxidation ofNADH, and
so conserve the cell's energy (Kazlauskaite et aI., 1996; Lloyd et aI., 1997;
Shinohara et al., 1998).
1.6.4 sMMO Reaction Mechanism
The reaction mechanism of sMMO was identified in 1986 by Green and Dalton from
steady-state kinetic analysis studies. Methane was identified as binding to the
enzyme first, followed by NADH, which reacts to yield the reduced form of the
enzyme with the release of NAD+. The reduced form then binds oxygen to form a
second ternary complex, which breaks down to release the products water and
methanol. The enzyme was, therefore, seen to control the supply of electrons to the
active site to coincide with the arrival of methane.
Progress has subsequently been made towards improving understanding of the
mechanism of dioxygen and methane activation by MMO. In particular, current
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insights have been greatly advanced since the spectroscopic characterisation of
reactive sMMO intermediates has been possible. Figure 1.12 illustrates a current
proposal for the catalytic cycle of sMMO.
Figure 1.12: Proposed catalytic cycle ofsMMO.
Boxed letters 0- T refer to reaction intermediates, Hox and Hred refer to oxidised and reduced
hydroxylase respectively. MMOR refers to the reductase and MMOB refers to protein B. The states of
the di-iron site at the active site of the hydroxylase is illustrated at each stage of the reaction cycle
with the arrows indicating the reaction cycle flow. Oxygen atoms derived from O2 are filled.
[Reproduced from Wallar and Lipscomb, (1996), with permission].
The initial step in the catalytic cycle involves dioxygen activation by the di-ferrous
site in the presence of protein B but independent of substrate (Liu et al., 1995}.1t has
been proposed that oxygen binds in the active site prior to association with the di-
ferrous cluster, forming intermediate 0, an oxygen adduct (Froland et al., 1992}.
Compound 0 spontaneously converts to a peroxo-intermediate termed Compound P,
which has been characterised by Mossbauer spectroscopy (Liu et al., 1995}, which
showed both iron atoms to be in a high spin ferric state and to be similar to end-on
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peroxo-bridged biferric model complexes. Raman spectroscopy (Wallar and
Lipscomb, 1996) gave data consistent with peroxide-stretching frequencies and
suggested that both oxygens were bound symmetrically to the irons. Compound P
spontaneously converts to a high-valent ferryl species termed Compound Q.
Mossbauer spectroscopy has identified the intermediate as containing 2 antiferro-
magnetically coupled high spin Fe(IV) atoms and in combination with EXAFS, has
identified Compound Q as having a diamond core structure (Shu et al., 1997). Upon
formation of this intermediate, methane enters the reaction cycle and substrate
oxygenation occurs. It remains unclear whether cleavage of the 0-0 bond occurs via
homolytic or heterolytic cleavage (Lee and Lipscomb, 1999). The Compound R
intermediate is formed by reaction of Compound Q with substrate. This intermediate
does not live long enough to be trapped, so it has not been possible to characterise it
spectroscopically. Nevertheless, attempts to elucidate the possible steps within the
reaction pathway have been made, but it remains controversial whether methane C-H
bond activation occurs via a mechanism involving a radical step or a concerted
oxygen atom insertion process. Product analysis in the oxygenation of substrates that
include radical traps within their structures have provided experimental evidence
supporting both mechanisms (Wilkins et al., 1992; Liu et al., 1993; Wilkins et al.,
1994; Nesheim and Lipscomb, 1996; Frey, 1997; Valentine et al., 1997, 1999). Also
these studies give differing results for the sMMOs of Ms. trichosporium OB3b and
Me. capsulatus (Bath), despite their similar structures and reaction cycle
intermediates. Recent work by Jin and Lipscomb (1999) using methylcubane, the
reaction clock substrate, has provided data which supports a radical-based
mechanism for Ms. trichospoirum OB3b sMMO. They propose that subtle
differences in the accessibility to the reactive species in the active site of sMMOs
from Ms. trichosporium OB3b and Me. capsulatus (Bath) mask inherently similar
radical-based chemical mechanisms. Nevertheless, the terminal adduct, Compound
T, is the final product complex of the enzyme. The decay of Compound T yields di-
ferric hydroxylase, thus completing the reaction cycle.
Amino acids which have key roles in the MMO mechanism have been identified
from the crystal structure of the hydroxylase, particularly the comparison of the
crystal structures of Me. capsulatus (Bath) hydroxylase in the oxidised and reduced
states (Figure 1.13) (Rosenzweig et al., 1995).
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Figure 1.13: Representation of the active site structure of sMMO from Me. capsulatus (Bath) in
both the (i) oxidised and (ii) reduced states.
Illustration of the coordination of the two iron atoms, labelled Fe 1 and Fe2, at the active site of the
hydroxylase. [Reproduced from Solomon et al. (2000), with permission].
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~ "JOE")-
HI.147
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Glu243 was identified as undergoing a carboxylate shift, which is a structural
variation in the binding of Re02- fragments to polymetallic centres and maintains a
constant coordination level on the iron species. The flexible nature of the carboxylate
ligand is suggested to be important for the' formation of the di-iron(II) centre and
may facilitate the binding of dioxygen and the formation of the high valent iron-oxo
intermediates. T~13 is hydrogen-bonded through a water molecule in the reduced
hydroxylase to the proposed site of chemical reactivity and has been proposed to
function as a proton donor in the hydroxylation reaction. It may also cause changes
in the active site upon binding of protein B since it is positioned on the helix thought
to be the binding domain of protein B. Therefore, protein B would affect the di-iron
centre by perturbing the hydrogen-bonding network involving Thr213. Residues
Phel88 and Phel92 have been identified as 'clamping' the acetate ion into the active
site of the oxidised hydroxylase. These residues may, therefore, play a role in
facilitating methane and oxygen binding to the active site (Rosenzweig et al., 1995).
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The reduced hydroxylase structure identified an altered side chain conformation for
Leullo at the active site cavity. It has been suggested that this conformational shift in
Leu'!" served as a gate controlling access of substrates and products to and from the
active site. Furthermore, it was proposed that protein B may affect the hydroxylase
by means of the 'Leucine gate', thus controlling the reactivity of the MMO complex
(Rosenzweig et al., 1997).
1.7 Objectives of the present work
The sMMO of Me. capsulatus (Bath) is functionally inactive in the absence of the
regulatory protein, protein B, although protein B itself undergoes an inactivatory
cleavage reaction to form the inactive truncates, proteins B' and B", about which
knowledge is limited. Also, in the absence of a crystal structure of the sMMO
complex, the interactions of protein B with the other sMMO components is not well
defined. Gaining an insight into the reasons behind the cleavage reaction and
information on the component interactions of the complex are fundamental to
obtaining a full understanding of the sMMO system.
Therefore, the main aims of the work presented in this thesis were:
1) To investigate further the mechanism of protein B cleavage, the reason for its
occurrence and establish the individual roles of the truncate proteins B' and
B".
2) To devise methods which minimise or prevent truncate formation of protein
B, necessary for biochemical and structural studies to be possible.
3) To identify the reason(s) for the inactivity of the protein B' truncate and
determine specifically how many of the protein B amino acids are required
for its activity.
4) To study the component interactions of the sMMO system.
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Chapter 2
Materials and Methods
2.1 Organisms
The organisms used in this study were the obligate methanotrophs Methyloeoeeus
eapsulatus (Bath) (Mc. eapsulatus (Bath) (Whittenbury et al., 1970; Stanley et al.,
1983) and Methylosinus triehosporium OB3b (Ms. trichosporium OB3b)
(Whittenbury et al., 1970), obtained from the culture collection of the University of
Warwick, UK.
2.2 Growth of Me. capsulatus (Bath) and Ms. trichosporium OB3b
2.2.1 Media
Methanotrophs were routinely grown in sterile low copper Nitrate Minimal Salts
(NMS) media for the expression of sMMO. The constitution of the media was as
follows; 1 gil MgS04, 1 gil KN03, 0.2 gil CaCh.2H20, 0.5 mgll NaMo04.2H20, 3.8
mg/l FeNaEDTA, 1 ml/l Trace Element Solution containing 0.5 gil FeS04.5H20, 0.4
gil ZnS04.7H20, 0.015 gil H3B03, 0.05 gil CoCh.6H20, 0.25 gil Na2EDTA, 0.02 gil
MnCh.4H20, 0.001 gil NiCh.6H20 and 0.1 gil CuS04.5H20 and 15 ml 6.5 %
Na2HP041KH2P04 phosphate buffer pH 6.8. The phosphate buffer was sterilised
separately and mixed with the rest of the media once both were cool in order to
prevent precipitation. Solid media was prepared by the addition of 1.5 % (w/v)
Bacto-agar (Difco, Michigan, USA) to the NMS (minus the phosphate) prior to
sterilisation.
2.2.2 Plate cultures
Plate cultures were grown on NMS agar media in plastic Tupperware ™boxes in an
atmosphere of air supplemented with ~ 50 % (v/v) methane/Co- mix (95 % and 5 %
vlv respectively) and incubated at 30 QC in the case of Ms. triehosporium OB3b
plates and at 45 QCin the case of Me. eapsulatus (Bath) plates.
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2.2.3 Batch cultures
Growth of cells by batch culture was performed in 250 ml flasks containing 50 ml of
NMS media. Flasks were sealed with rubber Suba seals (W.H Freeman, Barnsley,
UK) and cultures were gassed by removal of 50 ml air from the flask and replacing it
with 60 ml of a methane/Co- mix (95 % and 5 % v/v respectively). Cultures were
incubated, with shaking at 200 rpm, at 30°C in the case of Ms. trichosporium OB3b
cultures and at 45°C in the case of Me. capsulatus (Bath) cultures.
2.2.4 Continuous cultures
Growth of cells in continuous culture was performed in 4.5 I fermenters (L.H.
Engineering Ltd., Stoke Poges, Bucks, UK) in NMS medium with an agitation speed
of 500 rpm and gas flow rates of 60-80 ml/min for methane and 80-100 ml/min for
air. The temperature was maintained at 30°C for the growth of Ms. trichosporium
OB3b and at 45°C for the growth of Me. capsulatus (Bath). The medium flow rate
was maintained at approximately 1.5 mllmin and the pH was maintained at 6.8 by
automatic titration with 1 M HCI and/or 1 M NaOH. The oxygen tension of the
cultures was maintained below 5 %. A 10 % (v/v) inoculum of culture that had.
grown to an ODs40 of 0.6 in 50 ml batch cultures was used and the chemostat
conditions were only initiated once the culture had grown to ODS40of 7-9 within the
fermenter.
2.2.5 Microscopy
Light microscopy was conducted using a Kyoga-Unilix II (Tokyo) phase contrast
microscope. Microbial cultures were examined using 1000 x magnification under oil
immersion to check for culture contamination.
2.2.6 Cell Harvesting
Harvesting of 20 I of cells from the chemostat overflow was conducted using a
Westfalia continuous centrifuge (Westfalia Separator Ltd., Wolverton, Bucks, UK).
The resulting cell paste was washed with 25 mM MOPS buffer pH 7 containing
ImM benzamidine and then re-suspended in the same buffer containing 5 mM DTT.
At this point the cell suspension could be frozen and stored at - 80°C.
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2.2.7 Whole cell assay
The method used was a modification of that of Brussean et al. (1990). 1 ml samples
of methanotroph cultures were incubated in the presence of a naphthalene crystal for
30 min, with agitation, at 30 °C in the case of Ms. trichosporium OB3b cultures and
at 45 °C in the case of Me. capsulatus (Bath) cultures. Oxidation of naphthalene to 1-
naphthol and 2-naphthol in the presence of sMMO was then detected by the addition
of 100 ul of a fresh solution of TOD (0.2 % w/v), which resulted in the formation of
a purple diazo dye. Lack of such a colour change indicated a lack of sMMO
expression within the cells; The naphthalene assay was not quantitative (Martin,
1994).
2.3 Purification of Me. capsulatus (Bath) sMMO components -
optimised protocols from this study
The purification of the sMMO components was performed by modification of the
published protocols (Colby and Dalton, 1978; Pilkington and Dalton, 1990;
Pilkington et al., 1990). Protein purification chromatography procedures were
conducted using Fast Protein Liquid Chromatography (FPLC) equipment
(Amersham Pharmacia Biotech, Bucks., UK). The 'FPLC Basic' system was used
which consists of two P-500 pumps, an LCC 500 programmable pump controller, a
monitor UV-M detector system and a FRAC~100 fraction collector.
2.3.1 Preparation of soluble extract
Thawed cell paste was diluted with 25 mM MOPS buffer pH 7 containing 1 mM
benzamidine, 5 mM dithiothreitol, 5 mM sodium thioglycolate and 0.01 mg/ml
deoxyribonuclease I. Cells were broken by 2 passages through a cell disrupter
(Constant Systems Ltd, Honiley, Warwickshire, UK) at 170 MPa and centrifuged at
48,000 x g for 1.5 hours to separate the extract into soluble and particulate fractions.
The supernatant was used as soluble extract or directly resolved into the three
constituent sMMO proteins.
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2.3.2 Resolution of sMMO into its three constituent proteins
To the soluble extract, NaCI was added to a final concentration of 50 mM and then
loaded onto a DEAE cellulose FPLC column (2.6 cm x 13.5 cm; 70 ml) (Amersham
Pharmacia Biotech, Bucks., UK) equilibrated in 25 mM MOPS buffer pH 7
containing 50 mM NaCI, 1 mM benzamidine, 5 mM DTT and 5 mM thioglycolate.
The hydroxylase was eluted at 50 mM NaCl. Protein was then eluted successively
with 500 ml batches of the same buffer containing 200 mM and 500 mM NaCI to
elute the protein B and reductase containing fractions respectively.
Further purifications of the separate fractions containing the sMMO components
were undertaken separately.
2.3.3 Purification of the hydroxylase component
Step 1: After the initial ion exchange step, the hydroxylase was applied to a pre-
packed Q-sepharose ion exchange FPLC column (2.6 cm x 14.5 cm; 77 ml)
(Amersham Pharmacia Biotech, Bucks., UK) equilibrated with 25 mM MOPS buffer
pH 7. Protein was eluted with a 100-400 mM linear gradient ofNaCI over 3 column
volumes. The hydroxylase was eluted from the column at 240 mM NaCl.
Step 2: The hydroxylase from step 1 was applied to a Superdex 200 gel filtration
FPLC column (2.6 cm x 68 cm; 360 ml) (Amersham Pharmacia Biotech, Bucks.,
UK). The hydroxylase was eluted with 25 mMMOPS buffer pH 7.
Step 3: Final purification of the hydroxylase was achieved be elution from a MONO
Q ion exchange FPLC column (HRI6/10; 20 ml) (Amersham Pharmacia Biotech,
Bucks., UK) using a NaCI gradient of 100-400 mM over 5 column volumes. The
hydroxylase eluted at 120 mM NaCl.
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2.3.4 Purification of the reductase component
Step 1: After the initial ion exchange step, the reductase was desalted and applied to
a Q-Sepharose high performance ion exchange FPLC column (2.6 cm x 14.5 cm; 77
ml) (Amersham Pharmacia Biotech, Bucks., UK). The reductase was eluted with a
300-700 mM linear gradient ofNaCI over 4 column volumes. The reductase eluted at
450mMNaCl.
Step 2: Fractions containing active reductase from step 1 were applied to a Superdex
75 gel filtration FPLC column (2.6 cm x 61 cm; 325 ml) (Amersham Pharmacia
Biotech, Bucks., UK). The reductase was eluted with 25 mM MOPS buffer pH 7
containing 5 mM OTT.
Step 3: Final purification was achieved by elution of the reductase from a MONO Q
ion exchange FPLC column (HRI OIl 0; 10 ml) (Amersham Pharmacia Biotech,
Bucks., UK) using a 300-700 mM NaCI gradient over 10 column volumes. The
reductase eluted at 500 mM NaCl.
2.3.5 Purification of the wild-type regulatory protein B'
Step 1: Ammonium sulphate was added directly to the DEAE fraction containing
regulatory protein BIB' to make a 50 % saturated solution. The mixture was stirred
at 4 °C for 30 mins. Centrifugation at 48,000 x g for 30 mins pelleted the
precipitated protein fraction, which was subsequently re-suspended in a minimum
volume of 25 mM MOPS buffer pH 7. The sample was concentrated in an ultra
filtration cell (Amicon, Danvers, MA, USA) using a membrane with a 3 kDa
molecular weight cut-off size (YM3, Amicon, Danvers, MA, USA) ready for the
next purification step.
Step 2: The ammonium sulphate precipitated regulatory protein from step 1 was
applied to a Superdex 75 gel filtration FPLC column (2.6 cm x 61 cm; 325 ml)
(Amersham Pharmacia Biotech, Bucks., UK). The regulatory protein was eluted with
25 mM.MOPS buffer pH 7.
Step 3: Final purification w~s achieved by elution of the regulatory protein from a
MONO Q ion exchange FPLC column (HRIO/IO; 10 ml) (Amersham Pharmacia
Biotech, Bucks., UK) using a 0-350 mM NaCI gradient over 10 column volumes.
The regulatory protein eluted at 220-250 mM NaCl.
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2.4 Purification of the GST-fused regulatory proteins, WTB, G13Q,
recombinant Ms. trichosporium OB3b protein Band M12A:G13Q
Plasmids containing the mmoB gene from Me. eapsulatus (Bath) and Ms.
triehosporium OB3b and the single mutant version of Me. eapsulatus (Bath) protein
B (G 13Q) were derived from pGEX-2T and the method of cloning (Lloyd, 1997)
was such that the genes were expressed as GST-fusion proteins under the control of
an inducible tae promoter. This strategy was also adopted for the MI2A:G 13Q
double mutant (Chapter 6). The plasmids also contained the bla, p-lactamase gene
encoding ampicillin resistance ...
The proteins encoded were purified with the following modifications to the
published protocol of Lloyd et al. (1997). After elution of the fusion protein from the
GST -affinity column, the GST affinity tag was cleaved from the recombinant protein
by addition of thrombin (2 ng thrombin/ug fusion protein). After 5-10 mins at room
temperature the mixture was applied to a Superdex 75 gel filtration FPLC column
(2.6 cm x 61 cm; 325 ml) (Amersham Pharmacia Biotech, Bucks., UK). The
recombinant protein of interest was eluted with 25 mM MOPS buffer pH 7.
2.5 Purification ofMs. trichosporium OB3b protein B - optimised
protocol from this study
The purification of the protein B was carried out by modification of the published
protocol (Fox et al., 1989).
Step 1: After ammonium sulphate precipitation of the regulatory protein (Fox et al.,
1989), the sample was concentrated and desalted into 25 mM MOPS buffer, pH 7 by
ultra-filtration using a membrane with a molecular cut-off size of 3 kDa (YM3,
Amicon, Danvers, MA, USA).
Step 2: The sample of protein B was applied to a MONO Q ion exchange FPLC
column (HRI 0/10; 10 ml) (Amersham Pharmacia Biotech, Bucks., UK). Protein B
was eluted over a linear gradient of 25 mM MOPS buffer, pH 7 containing 150 mM
to 350 mM NaCI over 8 column volumes. Protein B eluted at 260-270 mM NaCl.
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Step 3: Fractions containing active protein B from step 2 were concentrated and
applied to a Superdex 75 gel filtration FPLC column (2.6 cm x 61 cm; 325 ml)
(Amersham Pharmacia Biotech, Bucks., UK). Protein B was eluted with 25 mM
MOPS buffer pH 7 in a size dependent manner.
2.6 Purification of His-tagged protein B truncates
Various E. coli BL21(DE3) clones containing plasmids with genes encoding the
truncated forms of protein B fused to 6-His-tags, under the control of isopropyl ~-D-
thiogalactopyranoside (IPTG)-i!lducible promoters were constructed (as detailed in
Chapter 7). Each clone was grown in LB broth, induced and harvested and re-
suspended in 20 mM phosphate buffer containing 0.5 M NaCI and 10 mM imidazol,
pH 7.4-7.6. Purification was accomplished using the HisTrapTM kit for the
purification of histidine-tagged proteins (Amersham Pharmacia Biotech, Bucks.,
UK) according to the manufacturers instructions. After elution of the 6-His-tagged
truncate proteins using 500 mM imidazol, the samples were concentrated using an
ultra-filtration cell (Amicon, Danvers, MA, USA) and applied to a Superdex 75 gel
filtration FPLC column (2.6 cm x 61 cm; 325 ml) (Amersham Pharmacia Biotech,
Bucks., UK). Pure 6-His-tagged truncate proteins were eluted with 25 mM MOPS
buffer pH 7 in a size dependent manner.
2.7 Affinity chromatography
A HiTrap® affinity column (Amersham Pharmacia Biotech, Bucks., UK) was used
for affinity chromatography. The chelating sepharose media within the pre-packed 5
ml FPLC column was charged with copper. The column was equilibrated with 0.02
M Na2HP04 containing 1 M NaCl, pH 7 before loading the protein sample in the
same buffer and washing in the same buffer over 1 column volume. A linear gradient
from 0-100 % elution buffer ofO.02 M Na2HP04 containing 1 M NH4CI, pH7.2 was
used to elute the copper-bound proteins from the column over 3 column volumes.
Column regeneration was achieved by elution of the column-bound copper by
washing with 0.02 M Na2HP04 containing 1 M NaCI and 0.05 M EDTA, pH 7.2
over 1 to 2 column volumes.
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2.8 Chromatofocusing chromatography
Chromatofocusing chromatography was achieved using a MONO P FPLC column
(HR 5/20) (Amersham Pharmacia Biotech, Bucks., UK). The column was
equilibrated with Start Buffer A (25 mM methylpiperizine, either pH 5.64 or 5.7)
before loading the protein in the same buffer. Application of Buffer B (1 in 10
dilution of PolyBuffer 74™ (Amersham Pharmacia Biotech, Bucks., UK) either pH
3.5 or 4) at 0.3 ml/min to 1 ml/min over - 15 column volumes eluted the proteins in
a pH dependent manner.
2.9 Size exclusion chromatography
Size exclusion chromatography was achieved using a Superdex 75 gel filtration
FPLC column (2.6 cm x 61 cm; 325 ml) (Amersham Pharmacia Biotech, Bucks.,
UK). The column was equilibrated in 25 mM MOPS buffer, pH 7. The column was
calibrated using a Gel Filtration LMW Calibration Kit (Amersham Pharmacia
Biotech, Bucks., UK) containing ribonuclease A, chymotrypsinogen A, ovalbumin,
bovin serum albumin and blue dextran, of apparent molecular weights 13,700 kDa,
25,000 kDa, 43,000 kDa, 67,000 kDa and - 2,000,000 kDa respectively. The protein
sample for analysis was loaded onto the column in 25 mM MOPS buffer, pH 7.
Proteins were eluted in a size dependent manner.
2.10 Determination of total protein concentration
2.10.1 Colorimetric Bradford assay
Total protein concentrations were determined colourimetrically by the method of
Bradford (1976) using bovine serum albumin as standard and using commercially
available Bio-Rad reagent (BioRad Ltd., Watford, Herts, UK).
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2.10.2 Extinction-coefficient values
The concentrations of hydroxylase and protein B samples could also be determined
using the extinction-coefficient values calculated for each of the proteins by the
methods of Whittaker and Granum (1980) and Scopes (1974). The extinction-
coefficient value of the hydroxylase was identified as being 550,814 M-I cm-I at
280nm (C. Lesieur, personal communication). The extinction-coefficient values for
the protein B samples are detailed in Chapter 3, Section 3.7.
In order to identify the protein concentration the absorbance of the protein of interest
at 280 nm was elucidated and thus protein concentration determined using the
equation: A'=scl where A is the absorbance of the protein at 280nm, e is the
extinction-coefficient value of the protein, c is the concentration of the protein in
molar units, and Iis the pathlength in cm.
2.11 Production of anti-sera
Anti-sera to the regulatory protein of sMMO was raised in a New Zealand White
rabbit by subcutaneous injection of 1.5 mg/ml aliquots of regulatory protein
homogenised with Freund's adjuvant by V. Cooper (University of Warwick, UK). At
four weekly intervals, bleeds were taken and stored for 16 hours at 4°C. After this
time the clear supernatant was obtained and stored in 50 ul aliquots at -20°C.
2.12 sMMO assays by gas chromatography
Measurement of enzyme assay reaction products were performed by gas
chromatography analysis using a Pye Unicam Series 104 gas chromatograph (Pye
Unicam, Cambridge, UK). The machine was fitted with a flame ionisation detector
and a 'Porapack Q' column (1 m x 4 mm internal diameter; Waters Associates,
Milford, MA, USA) which was maintained at 190°C, with nitrogen as the carrier gas
at a flow rate of 30 mllmin. Peak areas were determined by a 3390A Integrator
(Hewlet Packard, Berkshire, UK) to which the system was linked. The gas
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chromatograph was calibrated by injection of 5 /-11aliquots of a freshly prepared 2
mM solution of propylene oxide in water.
2.12.1 Propylene oxide assay - Type 1
Assays were performed by modifications to the method of Pilkington and Dalton
(1990). 5 ml conical flasks sealed with Suba Seals (W. H. Freeman, Barnsley, UK)
were used. Each reaction contained 8 /-1Mof purified hydroxylase, reductase, and
protein B or 5 mg of soluble extract (concentrations determined by the colourimetric
Bradford assay) in a total volume of 475 /-11,made up with 25 mM MOPS buffer, pH
7. 3 ml of the gas phase of the reaction flask were removed and replaced with 3 ml of
propylene. The flask was incubated for 1 min at 45°C in a gyratory water bath.
Initiation of the reaction was by the addition of25 /-11of 100 mM ethanol-free NADH
(courtesy of S. Slade, Department of Biological Sciences, University of Warwick,
UK). The reaction mix was incubated for a further 3 min at 45°C in the gyratory
water bath before removal of 5 /-11of the liquid phase of the reaction mix for GC
analysis. MMO activities were expressed as nmol of propylene oxide produced per
min, per mg of protein. This method was used in the calculation of the activity
values quoted in Chapter 3.
2.12.2 Propylene oxide assay - Type 2 (C. Lesieur, personal communication)
Further modifications to the method of Pilkington and Dalton (1990) were performed
to reduce the quantity of proteins required for the assay procedure. 1.5 ml crimp top
vials were sealed with crimp tops (Sigma-Aldrich Chemical Company, Dorset, UK).
The reactions contained 8 /-1Mof each of the sMMO proteins (concentrations of
hydroxylase and protein B calculated using their extinction-coefficients) or 5 mg of
soluble extract protein in MOPS buffer pH 7 in a total volume of 100/-11.1 mlofthe
gas phase of the reaction vessel was removed and replaced with 1 ml of propylene.
The flask was incubated for 30 s at 45°C in a gyratory water bath and the reaction
initiated by addition of 5 /-11of 100 mM ethanol-free NADH. The reaction mix was
incubated for a further 3 min at 45°C in the gyratory water bath before removal of 5
/-11of the liquid phase of the reaction mix or 500 /-11of the gas phase for GC analysis.
MMO activities were expressed as nmol of propylene oxide produced per min, per
mg of protein. This method gave lower activity values (~ 60 % lower) than those
obtained by the Type 1 propylene oxide assay (Section 2.12.1), but the method
changes were justified as they incorporated an improved means of obtaining more
accurate and reproducible values for the protein concentrations of the hydroxylase
and protein B, and the reduction in assay size enabled the large number of
experiments reported in this thesis to be performed. The type 2 propylene oxide
assays were used in the calculation of the activity values quoted in Chapters 4-8, and
have not been compared to the results obtained by the Type 1 assays.
2.12.3 Peroxide shunt assay -
Assays were carried out by modifications to the method of Jiang et al. (1993).24 IlM
hydroxylase in 25 mM MOPS buffer, pH 7 with varying concentrations of WTB,
G13Q, recombinant Ms. trichosporium OB3b protein B, B' or MI2A:GI3Q from 0-
50 IlM in a total volume of 100 Ill, were sealed in 1.5 ml crimp topped vials. 1 ml of
the gas phase of the reaction vessel was removed and replaced with 1 ml of
propylene. The flask was incubated for 1 min at 45°C in a gyratory water bath and
the reaction initiated by addition of hydrogen peroxide to a concentration of 100
mM. The reaction mix was incubated for a further 10 mins at 45°C in the gyratory
water bath before removal of 500 III of the gas phase of the assay mix for GC
analysis to monitor for propylene oxide formation.
2.13 Assay for monitoring the conversion of p-nitrophenylacetate to
p-nitrophenol
The enzymatic conversion of p-nitrophenylacetate to p-nitrophenol was monitored
spectrophotometrically by modifications to the method of Balls and Wood (1956).
The reaction mixture (600 III total volume) contained 500 III of protein in 25 mM
MOPS buffer, pH 7, and 100 III of 10 mg/ml p-nitrophenylacetate dissolved in
ethanol. The reaction was started by addition of the p-nitrophenylacetate to the
protein. After 30 s incubation at 20°C, the solution was examined for p-nitrophenol
formation by monitoring absorbance changes at 400nm over time.
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2.14 Polyacrylamide gel electrophoresis (PAGE)
2.14.1 SDS-PAGE
The protein containing samples were boiled for 5 min in an equal volume of SOS
sample buffer (100 mM Tris-HCI, pH 6.8 supplemented with SOS (2 % w/v), OTT
(200 mM), glycerol (10 % (v/v)) and bromophenol blue (0.2 % (v/v)). A whole cell
extraction method was used for the rapid analysis of proteins from whole cells of
both methanotrophs and E. coli. Cultures were diluted in 25 mM MOPS buffer pH 7
to an 00540 of 1. Harvesting of 1 ml of the culture was then carried out and the cells
were re-suspended in 100 III SOS sample buffer and boiled for 5 min. 10 III of the
boiled samples were then analysed by SOS-PAGE.
A discontinuous system of SOS-PAGE was used, as described by Laemmli (1970). It
comprised a 4 % w/v stacking gel (1 ml 50 % (w/v)) acrylamide/N, N'-Methylene
bis-acrylamide (29:1 v/v), 4.2 ml stacking gel buffer (0.375 M Tris-HCI, pH 6.8),
125 III 10 % (w/v) SOS, 6.3 ml H20, 5 III TEMEO, I ml catalyst (5 % (w/v)
AMPS)), a 12% w/v separating gel (6 ml 50 % (w/v) acrylamide/N, N'-Methylene-
bis-acrylamide (29:1 w/v), 9.4 ml separating gel buffer (1 M Tris-HCI, pH 8.8), 250
III 10 % SOS (w/v), 4 ml 50 % (w/v) sucrose, 4.8 ml H20, 6.25 III TEMEO, 625 III
catalyst (5 % (w/v) AMPS), and a reservoir buffer (2.9 gil Tris-base, 14.4 gil
glycine, 1 gil SOS). Electrophoresis was carried out using the MINI protean system
(Amersham Pharmacia Biotech, Bucks., UK). Gels were stained using Coomassie
Brilliant Blue (0.5 g Coomassie Blue R-250, 225 ml methanol, 45 ml glacial acetic
acid, 225 ml water) and de-stained with a solution of methanol (40 % v/v) and
glacial acetic acid (10 % v/v) to visualise the protein. SOS-PAGE gels were
calibrated with Dalton Mark VII-L molecular mass markers which contained bovine
albumin, 66 kOa; egg albumin, 45 kOa; glyceraldehyde-3-P-dehydrogenase, 36 kOa;
bovine carbonic anhydrase, 29 kOa; bovine pancreas trypsinogen, 24 kOa; soybean
trypsin inhibitor, 20 kDa; and bovine milk a-lactalbumin, 14.2 kDa (Sigma-Aldrich
Chemical Company, Dorset, UK).
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2.14.2 Native-PAGE
For native-PAGE, the method of gel preparation and electrophoresis was the same as
that for SDS-PAGE except that SDS was omitted from all the solutions and replaced
with water. DTT was also omitted from the sample buffer and samples were not
boiled prior to loading on the gel. Native-PAGE gels were calibrated using
molecular weight markers for non-denaturing PAGE which contained bovine milk
a.-lactalbumin, 14.2 kDa; bovine carbonic anhydrase, 29 kDa; chicken egg albumin,
45 kDa; bovine serum albumin, 66 kDa (monomer) and 132 kDa (dimer); and jack
bean urease, 272 kDa (trimer) and 545 kDa (hexamer) (Sigma-Aldrich Chemical
Company, Dorset, UK).
2.15 Western blotting
Following electrophoresis, the polyacrylamide gel was soaked for 30 min in Western
Transfer Buffer (20 mM Tris-HCI pH 8, 150 mM glycine, 20 % v/v methanol)
Electroblotting of proteins onto Hybond-C nitrocellulose membrane (Amersham,
UK) was then performed in a X-Cell I blot module (Novex) at constant voltage (30
V) for 2 hours. The membrane was blocked by soaking at 4 -c overnight in 20 ml
TBST buffer (50 mM Tris-HCI pH 8, 150 mM NaCl, 0.1 % (v/v) Tween 20)
containing 2 % milk (Marvel skimmed milk powder) to block non-specific protein-
binding sites on the membrane. The membrane was then removed and a fresh 20 ml
ofTBST buffer containing 2 % milk was added.containing 50-100 J.lIof anti-serum.
After 2hours shaking the anti-serum was removed by washing three times in 20 ml
TBS buffer (TBST buffer without Tween 20). 20 ml of TBS buffer were then mixed
with 50 J.lIanti-rabbit IgG peroxidase conjugate (Sigma Immuno Chemicals, Dorset,
UK) and added to the membrane and shaken for a further 2 hours. The membrane
was subsequently washed twice in TBST buffer and twice in TBS buffer before
visualising the bound antibody-peroxide conjugate by soaking the membrane in
staining solution for 10 min. The staining solution comprised NaCI 1.5 g and 1 ml of
1 M Tris-HCI pH 7.5 dissolved in 50 ml distilled water, known as solution A, and 30
mg chloronaphthol tablet dissolved in 10 ml methanol and diluted to 50 ml with
distilled water, known as solution B. 50 J.lIof 8 M hydrogen peroxide were added to
45
solution B which was then mixed with solution A immediately prior to use. After the
blot had been developed to the desired extent, the membrane was rinsed in distilled
water and left to dry for 30 min at room temperature.
2.16 Mass spectrometry
Mass spectrometry was used to analyse various protein samples.
2.16.1 Electrospray ionisation mass spectrometry (ESI-MS)
ESI-MS was performed using a Quattro II QhQ tandem mass spectrometer
(Micromass, UK) equipped with an electro spray ionisation (ESI) source operated
with nitrogen as the nebulising gas in nebuliser assisted mode. Applied to the
capillary of the ESI source was a potential difference of 2.5 - 3.5 kV relative to the
counter elctrode. A voltage ramp was applied to the extraction cone such that the
voltage across the cone varied linearly from 30 V at 600 rn/z to 90 V at 2600 rn/z at a
source temperature of 60 °C.
For accurate determination of molecular masses, calibration 'was carried out using
horse heart myoglobin (Sigma-Aldrich Chemical Company, Dorset, UK) 20 pmol/ul,
The carrier solvent was water/acetonitrile (1: 1 v/v) containing 1 % formic acid, and
was applied at a flow rate of 5 Ill/min. Mass spectra were acquired over the range
m/z 600-1700 during a lOs scan and data were collected in multichannel analyser
mode. Processing of data was accomplished using the MassLynx (VG Biotech)
software. Deconvolution of the ESI-spectrum was carried out using the maximum
entropy 'MaxEnt' algorithm incorporated in the VG MassLynx software.
The ExPASy world wide web molecular biology server of the University of Geneva
was used for the calculation of theoretical molecular mass values
(http://www.expasy.ch/)
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2.16.2 Matrix assisted laser desorption ionisation time of flight mass
spectrometry (MALDI-ToF MS)
Matrix assisted laser desorption ionisation time of flight analysis was performed
using a linear Proflex II MALDI- ToF mass spectrometer (Bruker, Analytical
Systems Inc., Billerica, MA, USA) operated in a delayed ion extraction mode. A 333
nm nitrogen laser (VS-337I, Laser Science Inc., Newton, MA) with a 3 ns pulse
duration and a 3 Hz repetition rate was focused onto a stainless steel mulitPROBE
utilising a 10-spot circular sample plate.
The voltage applied to the sample was typically 20 kV. After a delaytime 17.7 kV
were applied to a pulseplate and the ions were extracted from the source and
accelerated into a 125 cm linear flight tube and subsequently detected by an electron
multiplier. Data was recorded by a 1 cm linear LeCroy digitiser and analysed by
Bruker Xtof 3.1.0 software.
The MALDI-spectrum was recorded by averaging data over.60 laser shots with a
laser power just above threshold for ion formation.
Sinapinic acid (Sigma-Aldrich Chemical Company, Dorset, UK) was used as the
matrix. 100 ,.d of a saturated solution of sinapinic acid in acetonitrile/water 2: 1 and
0.1 % TFA were mixed with 25 JlI of the protein solution (3 mg/ml) in ammonium
acetate buffer. 0.4 JlI of the mixture was applied to each sample spot and the sample
droplet was dried under a stream of cold air to give a uniform crystalline layer ready
for MALDI- ToF analysis.
2.17 Fluorescence studies
Protein samples in 25 mM phosphate buffer pH 7 were placed in a 3 ml quartz
cuvette with a 10 mm pathlength. Fluorescence measurements were made using a
Perkin Elmer LS-50 fluorimeter at room temperature with a scan speed of 500
nmlmin, excitation wavelength of 280 nm, and scanned over a range from 300-450
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nm. An accumulation of 8 scans were taken for each sample and scans were blanked
against buffer data collected under the same conditions.
2.18 Circular dichroism spectroscopy
Protein samples for CD analysis were buffer exchanged in 25 mM phosphate buffer.
CD measurements were collected on a Jasco 1715 spectropolarimeter. Samples for
far UV CD analysis were placed in a quartz cuvette with a pathlength of 1 mm and
scanned from 190 nm - 250 nm whereas for near UV CD analysis samples were
placed in a quartz cuvette with a 1 cm pathlength and scanned from 260 nm - 300
nm. In all cases the response time was 0.25 s, and the scan speed was 100 nmlmin
and 10 scans were accumulated. The scans were blanked against fresh buffer
recorded under the same conditions.
2.19 FTIR Spectroscopy
2.19.1 Sample preparation
Pure protein was buffer exchanged into 25 mM ammonium bicarbonate buffer pH 7.
The protein solutions were then frozen using liquid nitrogen and lyophilised under
reduced pressure (l mm Hg) before re-suspending in 50 mM deuterated phosphate
buffer pH 7.
2.19.2 Data collection and analysis
FTIR spectra were obtained at protein solution concentrations of ~ 8 mg/ml, Spectra
were recorded at room temperature using a Bruker IFS 66 FTIR spectrometer
equipped with a MCT detector (Graseby infrared) operated at liquid nitrogen
temperatures. Single beam spectra were collected which consisted of 256 scans,
equivalent to 40 s collection time and using a 180 MHz scanning mirror frequency.
The spectra collected were then converted to an absorbance spectrum by ratioing
against a single beam spectrum of the appropriate buffer collected under identical
conditions. Data were collected at 2 cm-! wavenumber resolution. Wavenumbers
collected were from 2000-1000. As water absorbs strongly in the amide I region of
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the spectrum, all experiments were performed in D20. Further reductions in solvent
absorbance were obtained by using a 50 urn path length cell fitted with calcium
fluoride windows. Band fitting to amide I absorbance was performed using the Opus
version 2.2 analysis program running under the OS2 operating system (Bruker).
2.20 Single particle analysis by electron microscopy
The proteins (hydroxylase 0.05 mglml; sMMO complex at 1:2:2, 1:5:5 molar ratios
at 0.1 mglml) were incubated with a glow-discharged (under air) electron
microscope grid coated with a continuous carbon film. Samples were negatively
stained in 4 % (w/v) uranyl-actetate. Micrographs were recorded under low-dose
conditions on Phillips CM 100 and EM 301 electron microscopes. Images were
scanned using a Zeiss SCAI scanner at 5.4 A scan step. Analysis of the single
particle data was undertaken using SPIDER (Frank, et al., 1996). Particles were
selected using Ximdisp (MRC Cambridge, UK) and aligned by a reference-free
alignment based algorithm (Penczek, et al., 1992) and finally classified into groups
and averaged.
2.21 Analytical ultracentrifugation
2.21.1 Samples used
WTB (2 mg/ml in MOPS + 150 mM NaCI), Protein B' (2 mg/ml in H20 + 150 mM
NaCl) and G13Q (2 mg/ml in MOPS + 150 mM NaCl).
Values calculated: partial specific volume from amino acid composition:
WTB vbar@4° C = 0.7256 mllg
G13Q vbar @ 4° C = 0.7253 mllg
Protein B' vbar @ 4° C = 0.7288 mllg
density of 150mM NaCl = 1.006 g/ml
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2.21.2 Experimental procedure
Solutions of 1 and 2 mg/ml of each peptide were run, with absorbance blanks, to
sedimentation equilibrium at 4 DC in 12 mm path length cells in the Beckman XL-A
analytical ultracentrifuge using an An-60- Ti rotor. The rotor speeds employed were
30,000 and 42,000 rpm. The concentration distribution of the peptides was
monitored using scanning absorption optics at 290 nm wavelength. The achievement
of sedimentation equilibrium was determined by subtraction of scans of at least 2
hours difference in time until no difference in distribution was observed. This was
done for both rotor speeds used: A baseline value of absorbance was not obtained, as
the upper limit for the epoxy resin centrepieces used is 42,000 rpm.
2.21.3 Data analysis
The data obtained were analysed using WinNONLIN3 program (David A. Yphantis,
Michael L. Johnson & Jeffrey W. Lary, available over the internet from
ftp://spin6.mcb.uconn.eduJpc/win95/winnonln/). The program fits multiple data sets
simultaneously accounting for speed and concentration differences. The program fits
2
M(I- V p)@
for sigma (the reduced molecular weight which is equal to ) knowing
RT
rotor speed, vbar, temperature and density, can then be converted to molecular
weight. The data for each peptide were fit firstly to a single ideal species model, and
then, if appropriate, a self-association model using sigma calculated from monomer
molecular weight. With self-association models the program fits for InKa in
absorbance units, which were converted to per molar units using the molar extinction
coefficient of the peptide, were then converted to Kj.
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2.22 Crystallisation of the regulatory protein
Crystallisation of the regulatory protein was performed using the hanging drop and
oil immersion methods. For the hanging drop method the protein (13-26 mg/ml) was
suspended in a droplet (2 J.11) on a glass cover slip mixed with 2 J.1lof the precipitant.
This was placed and sealed over a 2.5 ml well containing 1 ml of precipitant. In the
case of the oil immersion method the droplet of protein mixed with precipitant was
immersed under oil. The precipitant that resulted in the formation of quasi-crystals
was 25 mM Tris-HCl, pH 7 containing 25 mM lithium sulphate and 18 % PEG 8 K.
Seeding of the quasi-crystals into a fresh preparation of regulatory protein was
attempted to obtain large crystals.
2.23 Homology modelling studies
All sequence alignments were performed using the Blast alignment tool available on
the ExPASY server (http://www.expasy.ch/). Modelling of the N-terminal region of
the regulatory protein and mutants was performed using the Swissmodel program
available on the same server (Peitsch, 1995).
2.24 Secondary structure prediction
Secondary structure was predicted using the Jpred'' program available on the internet
at http://jura.ebi.ac.uk:8888/.Usingthesingleproteinsequenceofinterest,it
combines a number of modem, high quality prediction methods to form a consensus.
The accuracy of the method is approximately 72.9 % (Cuff and Barton, 1999).
2.25 Small angle X-ray scattering
2.25.1 Sample preparation
Prior to the collection of scattering measurements the sMMO proteins were dialysed
against 25 mM MOPS buffer pH 7. A sample of the dialysis buffer was retained and
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used as a blank to subtract the effect of the scattering contribution from the solvent.
Each protein (A, mB, B' and C) was analysed individually as well as various ratios
of components A:B:C ranging from 1:2:2 to 1:10: 1O. Protein samples were
centrifuged into a 1 mm glass capillary that was glued into the brass sample holder.
2.25.2 X-ray scattering data acquisition and analysis
X-ray data were collected using the small-angle X-ray scattering station at Los
Alamos, USA, using X-rays generated from a copper anode at a frequency of 1.54 A
over a Q range of 0.01-0.3 A, as described by Heidorn and Trewhella (1988).
Samples were maintained at 16. °C during data acquisition. Typical data collection
times were 10 min to 2 h, depending on protein concentration and molecular mass.
All scattering experiments were repeated at least twice using samples from
independent preparations.
Scattering data were reduced and analysed as detailed in Heidorn and Trewhella
(1988). Parameters used in the interpretation of the scattering data included radius of
gyration, Rg, forward (or zero-angle) scattering intensity, 10, and the pairwise length
distribution function, P(r). P(r) is the probable frequency of vector lengths
connecting small-volume elements within the scattering particle. P(r), therefore,
goes to zero at the maximum linear dimension of the particle, dmax• For a dilute
solution of monodisperse, identical particles the scattering intensity, I(Q), and P(r)
are related by a Fourier transformation:
Equation 2.1: P(r) = rl21t2 JI(Q)Q2(sin(Qr)/Qr) dQ
where Q = (47t sinB)/A. is the amplitude of the scattering vector, () is half the
scattering angle, and A.the wavelength of the scattered radiation (1.54 A). Per) is
calculated from the experimental scattering profile using an indirect Fourier
transform method (Moore, 1980). Rg and 1oare calculated as the second and zeroth
moments of Per), respectively.
1o, when normalized to molar· concentration, is proportional to the square of the
molecular weight for particles with the same mean scattering densities. By using a
standard protein of known molecular weight (lysozyme in this study), one can
determine the molecular weight of another monodisperse protein sample by taking
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ratios of the 10values. An 10analysis can thus be used to check the monodispersity in
samples of known protein concentration or to determine accurate protein
concentrations for solutions known to be monodisperse (Krueger et al., 1998). In
addition, 10 is highly sensitive to complex formation (Krueger et al., 1998). For a
three component system with component molecular weights Ma, Mb, and Me, 10 is
proportional to (Ma +Mb +Mei for the 1:1:1 complex but to the much smaller M/ +
Mb2 + M/ if the components do not form a complex. For a mixture of partially
complexed components, 10 is proportional to the concentration-weighted average of
the 10values for the complexed and uncomplexed components.
Molecular volumes were calculated from the scattering data using the equation:
Equation 2.2: V=21t2IJQ;
where Qi is the scattering invariant (Porod, 1982):
Equation 2.3: Q;= fQ2dQI(Q)
Because the scattering data are measured only over a finite Q-range, the scattering
invariant, and hence molecular volume, calculations are subject to systematic error.
These errors vary for different experiments and in our case are of the order of 10 %,
based on comparison of the expected volumes with those calculated from the
scattering data.
2.25.3 Modelling the scattering data
In the absence of high-resolution crystal structure data, the scattering from globular
proteins can be effectively modelled using uniform-density ellipsoid shapes
(Henderson et al., 1992; Zhao et al., 1998). Protein ,B and the reductase were each
modelled as uniform density ellipsoids, and model scattering profiles were calculated
using a Monte Carlo simulation program [SASMODEL (Zhao et al., 1998)].
SASMODEL generates models using one or more ellipsoid shapes with dimensions
constrained within a range given by the user. Large numbers of models are generated
by an algorithm that assigns random values (within the defined constraints) to the
lengths of each semi-axis. For- each model generated, a P(r) function is calculated
using a rapid Monte Carlo integration method (Heidorn and Trewhella, 1988) in
which the ellipsoids are filled with random points and all possible vector lengths
between the points are summed to give P(r). Model P(r) functions based on the
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hydroxylase crystal structure [Protein Data Bank (PDB) accession no. P22869], as
well as for the sMMO complex, were calculated using a program (PRPDB) that
utilizes a rapid Monte Carlo integration method similar to that used by SASMODEL.
The atomic co-ordinates from the crystal structure are placed in a box with a three-
dimensional grid. An option to include a hydration layer, in which the solvent layer
at the surface of the protein is assigned a different mean scattering density to the
bulk solvent, is included. The thickness and contrast of the hydration layer are
parameters that can be chosen by the user. The volume elements of the grid are
assigned scattering density values based on the number of electrons that fall within
the volume element (from either the protein or hydration layer components).
Alternatively, a uniform density can be assigned to grid elements occupied by the
structure. The model Per) is calculated by filling each volume element occupied by
the molecular shape with 4,000 random points and summing all vector-lengths
between pairwise combinations of the saved points. PRPDB can also use the output
from SASMODEL and calculate Per) profiles from uniform density ellipsoid shapes
as well as composite models made up from uniform density ellipsoids combined
with crystal structure coordinates. Typically, 4,000 points were used in our model
Per) calculations, which gave smooth well-determined profiles. Both SASMODEL
and PRPDB calculate model scattering profiles for comparison with experiment by
Fourier transformation of Per). Model fits are evaluated using least-squares methods
and saved in PDB format for ease of viewing.
2.26 Atomic force microscopy (AFM)'
The protein samples to be analysed were placed in a Nanoscope III fluid cell (Digital
Instruments, Santa Barbara, CA) and imaged under 50 mM Tris buffer pH 7 which
was flown over the cells to remove any non-adsorbed protein material. The samples
were imaged using tapping mode AFM in fluid, using a triangular cantilever of
nominal spring constant 0.3-0.6 N/m. The cantilever was oscillated at a resonance
frequency between 16 and 32 kHz. The imaging parameters were set to obtain a
high-resolution image with minimal tip-sample interactions. Particle volumes were
determined using custom built software (C. Goh Group, University of Toronto,
Canada).
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2.27 E. coli strains
E. coli strain Source
AD202 Nakano et al. (1994)
DH5a Hanahan (1983)
BL21 (DE3) Novagen, Abingdon, UK
2.27.1 Plasmids
Plasmid - Characteristics Source
pGEX-2T ApKtranslational fusion Amersham Pharmacia
expression vector Biotech, Bucks., UK
containing the Shistosoma
japonicum GST gene
under the control of the tae
promoter (5 kb)
pGEX-WTB pGEX-2T containing Lloyd et al., (1997)
mmoB from Me.
eapsulatus (Bath) as a
BamHII EeoRI fragment
(5.5 kb)
pGEX-G13Q pGEX- WTB containing a Lloyd et al., (1997)
Glyl3 to Glnl3 mutation in
mmoB
pGEX-MTB pGEX-2T containing S. Harris, unpublished
mmoB from Ms.
triehosporium OB3b as a
BamHII EeoRI fragment
(5.5 kb)
pGEX-M12AG13Q pGEX- WTB containing This study
Glyl3 to Glnl3 and Metl2 to
Ala12 mutations in mmoB
.pET-3a ApKexpression vector Novagen Inc., Madison,
containing the T7 RNA WI, USA
. polymerase promoter
(4.6kb)
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pET-G13Q pET -3a containing a Gly':' This study
to Glnl3 mutation in mmoB
and a 6-His-tag at the C-
terminal
pET -S4-His-tag pET-3a containing a Gly':' This study
to Gln13mutation in
mmoB, a deletion in the
first 12 bases ofmmoB and
a 6-His-tag at the C-
terminal
pET -N5-His-tag pET-3a containing a GlylJ This study
to Gln13mutation in
mmoB, a deletion in the
first 15 bases of mmoB and
a 6-His-tag at the C-
terminal
pET -A6-His-tag pET -3a containing a Gly':' This study
to Glnl3 mutation in
mmoB, a deletion in the
first 18 bases of mmoB and
a 6-His-tag at the C-
terminal
pET-Y7-His-tag pET -3a containing a GlyU This study
to GIn13mutation in
mmoB, a deletion in the
first 21 bases of mmoB and
a 6-His-tag at the C-
terminal
"
pET -D8-His-tag pET-3a containing a GlylJ This study
to Gln13mutation in
mmoB, a deletion in the
first 24 bases of mmoB and
a 6-His-tag at the C-
terminal
pET -A9-His-tag pET -3a containing a GlylJ This study
to GIn13mutation in
mmoB, a deletion in the
first 27 bases ofmmoB and
a 6-His-tag at the C-
terminal
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pET -G 10-His-tag pET-3a containing a GlylJ This study
to Gln13mutation in
mmoB, a deletion in the
first 30 bases of mmoB and
a 6-His-tag at the C-
terminal
pET-QI3-His-tag pET -3a containing a Glyl-' This study
to Glnl3 mutation in
mmoB, a deletion in the
first 39 bases ofmmoB and
a 6-His-tag at the C-
terminal
Ap, Ampicillin; GST, glutathione S-transferase; His-tag, 6 histidine residues.
2.27.2 Luria Bertani growth media for E. coli
Luria Bertani medium (LB) was used routinely for the culturing of E. coli, as
detailed in Sambrook et al. (1989) and Maniatis et al. (1982). Solid media was
prepared by the addition of 2 % (w/v) Bacto-agar (Difco, Michigan, USA) prior to
sterilisation. All media were made using distilled water and sterilised by autoclaving
at 120°C, 15 Ib/in2 for 15 min. Sterile disposable filter units with a pore size of 0.2
urn (Millipore, Watford, UK) were used to sterilise water soluble, heat labile
solutions.
2.27.3 Culture storage
For long-term storage, 500 ul of E. coli overnight cultures were mixed with 500 ul
of sterile glycerol (50 %) and frozen in liquid nitrogen for storage at - 70°C. To re-
culture the E. coli strain, 10ml LB, containing antibiotic as appropriate, was
inoculated with 50 ul of the glycerol stock.
2.27.4 Culturing conditions for E. coli
E. coli strains were routinely grown in batch cultures of 10 ml, 50 ml or 1 Ivolumes
at 37°C with shaking at 200 rpm. Antibiotics appropriate to the E. coli strain and
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plasmid were included in the growth medium. This ensured plasmid maintenance
and strain purity.
2.27.5 Antibiotics
Stock solution was prepared by dissolving ampicillin in water to a concentration of
100 mg/ml, sterilised by filtration using a sterile disposable filter unit with a pore
size of 0.2 urn (Millipore, Watford, UK) and stored in 1 ml aliquots at - 20°C.
Ampicillin was added to LB media to give a working concentration of 100 ug/ml.
2.28 Nucleic acids techniques
2.28.1 Plasmid extraction
Plasmid DNA was extracted using a QIAgen MINIPREP kit (QIAgen, Crawley,
West Sussex, UK) according to the instructions of the manufacturer.
2.28.2 Extraction of DNA with phenol and chloroform
DNA was extracted from solutions containing proteins by the addition of an equal
volume of a phenol chloroform mix (containing phenol and chloroform in a 1:1
ratio). After vigorous mixing by vortexing and subsequent centrifugation at 20800 x
g, 4°C, the DNA was recovered by ethanol precipitation (Section 2.28.3) of the
upper aqueous phase.
2.28.3 Precipitation of nucleic acids
To a specified volume of a solution containing nucleic acids was added 1/1Oth of the
original volume of 3 M sodium acetate (PH 5.2) and 2 times the original volume of
ethanol and incubated for 30 mins at - 20°C. Centrifugation at 20,800 x g, 4 °C for
20 min pelleted the nucleic acids, which were then washed in 70 % (v/v) ethanol and
air-dried before re-suspension in an appropriate volume of sterile water or TE buffer
pH 8 (Tris-HCIIO mM, di-sodium EDTA 1mM).
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2.28.4 Determination of the concentration of nucleic acids
The concentration of nucleic acids was determined from the absorbance at 260 nm,
measured using quartz cuvettes with a 1 cm path length in a Beckmann DU-70
spectrophotometer. Assuming an A260 of 1 for the following nucleic acid
concentrations: oligonucleotides, 20 ug ml"; RNA, 40 ug ml" and double stranded
DNA, 50 ug ml" (Sambrook et al., 1989), the concentration could be calculated.
2.28.5 Agarose gel electrophoresis
The Minigel apparatus (Flowgen Instruments Ltd., Sittingbourne, UK) was used for
agarose gel electrophoresis. Gels containing 1 % agarose (w/v) were prepared and
run in 1 x Tris-borate EDTA (TBE) buffer pH 8 (Tris-base 90 mM, Boric acid 90
mM, EDTA 2.S mM). O.S ug/ml ethidium bromide was added directly to the gel
before casting. DNA samples (10 Ill) were mixed with one-fifth volume marker dye
(2 Ill) (0.25 % (w/v) bromophenol blue, 0.25 % (w/v) xylene cyanol, 30 % glycerol).
Gels were run at a constant current of 50 rnA for 1-2 hours. DNA was visualised on a
UV transilluminator and photographed using an instant camera (CUS Land Camera,
loaded with Polaroid 665 positive/negative film). The agarose gels were calibrated
with a 1 kb ladder (Gibco BRL, Life Technologies Ltd., Paisley, UK).
2.29 Enzymatic modification of DNA
2.29.1 Restriction endonuclease digestion of DNA
Restriction endonucleases and buffer solutions were supplied by Gibco BRL (Life
Technologies Ltd., Paisley, UK) and New England Biolabs (Beverly, MA, USA).
DNA was digested according to the instructions of the manufacturer.
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2.29.2 Dephosphorylation of DNA
DNA was dephosphorylated using alkaline phosphatase obtained from Boehringer
Mannheim (East Sussex, UK) and used according to the instructions of the
manufacturer.
2.29.3 Ligation of DNA
T4 DNA ligase was used to ligate DNA. It was obtained from Gibco BRL (Life
Technologies Ltd., Paisley, UK) and used according to the instructions of the
manufacturer.
2.29.4 Agarose gel purification of DNA
Agarose gels were made and run as detailed in section 2.27.5, except that TAE
buffer pH 8 (0.04 M Tris-acetate, 0.001 M EDTA) was used instead ofTBE buffer.
The DNA fragments separated were removed from the gel by excision of the DNA
bands and purified using the GeneClean ™ Kit (Bio 101 Vista, California, USA)
according to the protocol of the manufacturer.
2.30PCR
2.30.1 Design of oligonucleotides
Oligonucleotides used for PCR and sequencing were synthesised and purified by
Gibco BRL (Life Technologies Ltd., Paisley, UK).
2.30.2 peR amplification
PCR amplification was performed in a total volume of 50 ul in 0.5 ml Eppendorf
tubes in a TouchDown Therm~ Cycling System (Hybaid, Tennington, Middlesex,
UK). Reaction mixtures were composed of 1.5 mM MgCh, SO mM KCI, 10 mM
Tris-HCI pH 9, 100 f.1Mof each dNTP, 50 pmol of each primer, 2.5 units of Taq
polymerase (Gibco BRL, Life Technologies Ltd., Paisley, UK) and approximately 1
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ng template DNA. The reaction conditions were as follows; 30 cycles consisting of
denaturation at 94°C for Imin, annealing at 50°C for lrnin, polymerisation at 72°C
for 1 min and then a final step of 72 °C for 10 min.
2.31 DNA sequencing
DNA sequencing reactions were performed by cycle sequencing with the Dye
Terminator Kit (PE Applied Biosystems, Warrington, Cheshire, UK). The primers
used are detailed in the relevant sections (Chapter 6, Table 6.1; Chapter 7, Table
7.1). The nucleotide sequences obtained were manually aligned with the expected
sequences to identify if the desired sequence had been cloned.
2.32 Transformation
A 10 ml overnight culture of the appropriate E. coli strain was grown and 200 III of it
was used to inoculate a second 10 ml culture which was left to grow for ~3 h or to an
OD of ~0.5-0.6. The second culture was then centrifuged at 2,000 x g for 5 min at 4
"C. The pellet was re-suspended in 0.1 M MgCh at 4 °C to half the original volume
(5 ml) and the centrifuged immediately at 2,000 x g for 10 min at 4°C. The pellet
formed was re-suspended in 0.1 M CaCh at 4 °C in half the original volume (5ml)
and centrifuged immediately at 2,000 x g for 10 min at 4°C. The resultant pellet was
then re-suspended in 0.1 M CaCh at 4 °C in V20th of the original volume (0.5 ml)
and incubated on ice for 90 min. After incubation, 100 III of the cells were added to
either ligated DNA or purified plasmid and left on ice for 30 min before a 1.5 min
heat shock at 42°C followed by a further 10 min incubation at 4°C. The resultant
suspension was added to 800 III SOC (2 % (w/v) bacto-tryptone, 0.5 % (w/v) yeast
extract, 10 mM NaCl, 2.5 mM KCI, 10 mM MgCh, 10 mM MgS04, 20 mM glucose)
and incubated at 37°C for 1 h with shaking. This time allowed for the plasmid-
encoded antibiotic resistance genes to be expressed. Cells were then plated onto LB
agar containing the appropriate antibiotic for plasmid selection and incubated
overnight at 37°C.
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2.33 Chemicals and gases
Gases, including methane, oxygen, propene, argon, oxygen free nitrogen and air
were obtained from either BOC (London, UK) or Linde Gas Ltd. (Stoke on Trent,
UK). All chemicals and biochemicals were of analytical grade and obtained from
Sigma-Aldrich Chemical Company (Dorset, UK) and BDH Chemicals Ltd. (Dorset,
UK). Restriction endonucleases and DNA modifying enzymes were obtained from
Gibco BRL (Life Technologies Ltd., Paisley, UK) and New England Biolabs
(Beverly, MA, USA)
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Chapter 3
Optimisation of Purification Protocols for Wild-Type,
Recombinant and Mutant Forms of Protein B and the
Reductase and Hydroxylase Components of sMMO
3.1 Introduction
The isolation of the pure form of a protein is a vital step in the advancement of
understanding biological structure and function. Isolation of the catalytic species is
essential for the understanding of an enzyme's mechanism of action and would be
impossible without techniques that allow its separation from other proteins and
cellular components.
The purification of protein B (the regulatory protein) from Me. eapsulatus (Bath) to
homogeneity was reported by Green and Dalton (1985) and was achieved by the use
of ion exchange- and gel filtration-chromatography followed by a final
hydroxylapatite step. Subsequent purification attempts proved unsuccessful and
resulted in the isolation of at least two forms of the protein (Pilkington et al., 1990;
Bhambra, 1996). Recently these forms of the protein have been identified as active,
full-length protein B and inactive N-terminally truncated cleavage products known
as B' and B" (Bhambra, 1996; Lloyd et al." 1997). Efforts to prevent truncate
formation focused on the addition of protease inhibitors at the time of cell lysis and
in the subsequent purification buffers. However, prevention of cleavage was not
achieved. Attempts to separate proteins B and B' in order to obtain pure, active
protein B for further studies involved the use of various combinations of reverse
phase-, hydrophobic interaction- and gel filtration- chromatography, all of which
proved unsuccessful (Bhambra, 1996).
In order for studies of protein B of sMMO to continue, it was essential that the full
length, active protein species could be purified to homogeneity. Similarly, if the
mechanism of cleavage to form the inactive truncates B' and B" was to be
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understood, and structural comparisons between the active and inactive species were
to be possible, then it was necessary to be able to purify the truncated forms.
It is not known whether the regulatory protein from other methanotrophs such as Ms.
triehosporium OB3b undergoes a similar cleavage reaction to that observed for
protein B from Me. eapsulatus (Bath). However, recent studies by Lloyd (1997) on
the recombinant form of Ms. triehosporium OB3b protein B, identified the
occurrence of truncate formation. Purification of wild-type protein B from Ms.
triehosporium OB3b to homogeneity was necessary to determine the possible
presence of truncate formation in protein B from the native host.
The work in this chapter concentrates on the optimisation of previously published
protocols for the purification of large quantities of > 90 % pure wild-type and
recombinant protein B from both Me. eapsulatus (Bath) and Ms. triehosporium
OB3b, and hydroxylase and reductase proteins from Me. eapsulatus (Bath). This was
conducted in order that further characterisation of the regulatory proteins and sMMO
components was possible, using techniques for which optimal purity was essential.
3.2 Purification of wild-type protein BIB' from Me. capsulatus
(Bath)
Protein B purified in this study using the protocol developed by Pilkington et al.
(1990) was analysed by SDS-PAGE (Chapter 2, Section 2.14.1) and shown to
consist of a mixture of intact and truncated versions of the protein (Figure 3.1). This
observation highlighted the need to optimise the purification protocol in order to
obtain pure protein B devoid of the cleavage products.
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Figure 3.1: SDS-PAGE of protein B purified using the purification procedure developed by
Pilkington et al. (1990).
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Protein B purified by the method of Pilkington et al. (1990) indicating the presence
of 2 protein bands at - 16 kDa and - 15 k Da, corresponding to protein B and protein B' respectively.
1 2
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20
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3.2.1 Optimisation of the published purification procedure
Protein B cleaves to form inactive protein B' and B" over time (Bhambra, 1996;
Lloyd et al., 1997). Therefore, efforts were made to increase the speed of
purification in an attempt to minimise the time available for this occurrence.
Ammonium sulphate precipitation was undertaken as a possible method of achieving
this (Chapter 2, Section 2.3.5, Step 1). Subsequent gel filtration chromatography of
the ammonium sulphate treated sample using a Superdex 75 FPLC column (2.6 em
by 61 cm; 325 ml) (Amersham Pharmacia Biotech, Bucks., UK) equilibrated with 25
mM MOPS buffer, pH 7 (Chapter 2, Section 2.3.5, Step 2) further purified the
protein. The protein was eluted in a size dependent manner (Figure 3.2).
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Figure 3.2 Purification profile of protein B from Me. capsulatus (Bath) on a Superdex 75 gel
filtration column.
The column was equilibrated in 25 mM MOPS buffer, pH 7. The elution rate was I ml/min. Peak 4
eluted after approximately 170 ml over 3 fractions of 4 ml each.
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Peak 4 (Figure 3.2) was proposed to correspond to protein B due to its position of
elution from the gel filtration column. However, the protein was found to be inactive,
which suggested that it had already undergone the cleavage reaction to form protein
B'. The final purification step of anion exchange chromatography was conducted
such that pure protein B' would be obtained for further analysis.
The peak 4 fraction from the gel filtration purification step was loaded onto a
MONO Q anion exchange FPLC column (HRI Oil 0; 10ml) (Amersham Pharmacia
Biotech, Bucks., UK) equilibrated with 25 mM MOPS, pH 7. The protein eluted
over a linear gradient of 150 to 350 mM NaCI over 10 column volumes (Chapter 2,
Section 2.3.5, Step 3), and the protein of interest at 275 mM NaCI (Figure 3.3).
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Figure 3.3 Purification profile of protein B' from Me. capsulatus (Bath) on a MONO Q column.
The column was equilibrated in 25 mM MOPS buffer, pH 7. Protein was eluted over a linear NaCI
gradient of 150-350 mM NaCI. The peak indicated corresponds to protein B', eluted at 275 mM NaCI.
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SDS-PAGE analysis indicated the protein to be ~ 95 % pure B' (Figure 3.4). Mass
spectrometry analysis identified the purified protein to have a mass of 14629.7 Da
(Figure 3.5). This confirmed the nature of the protein as that of protein B' and not
that of protein B, which wo~ld have given a mass value of ~ 15852 Da, or protein
B", which would have given a mass value of ~ 12717 Da, based on the known DNA
sequence of protein B.
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Figure 3.4: SDS-PAGE of MONO Q purified protein B'.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Protein B' after the final purification step identified as a single band at ~ 15 kDa so
showing it to be ~ 95 % pure and containing no protein B or protein Bit.
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Figure 3.5: ESI-MS of the pure protein.
The ESI-MS spectrum of the Me. eapsulatus (Bath) protein BIB' was recorded on a Quattro Il tandem
mass-spectrometer with an electrospray ion source and the data were processed using the MassLynx
program (VG Biotech) (Chapter 2, Section 2.16.1).
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The determination of molecular masses by mass spectrometry was reported as far
back as 1912. However, only more recently, in the 1960s-1970s has its use in bio-
molecular research been possible (Barber et al., 1981; Meng et al., 1988).
Electrospray ionisation mass spectrometry is a powerful analytical technique for the
analysis of proteins and peptides (Smith et al., 1990; Chait and Kent, 1992). ESI-MS
has been used successfully for the measurement of molecular masses up to 100,000
Da at resolutions of ~ 1unit (Covey et al., 1988). Thus ESI-MS was the ideal
technique for use in determining the exact molecular masses of the protein(s) within
the purified Me. eapsulatus (Bath) protein B sample.
Overall, a reproducible purification procedure for obtaining homogeneous protein B'
had been devised, although the initial objective of devising a method for isolating
protein B had not been accomplished. The observation that protein B degraded so
rapidly to protein B' during the purification procedure emphasised the highly
sensitive nature of the protein.
3.3 Preparation of anti-serum against proteins Band B'
Antibodies to protein B and B' were required for use as an assay for detection of
their production in cell samples. The purification of protein B by the method of
Pilkington et al. (1990) yielded a mixture of proteins B and B' (Figure 3.1), and was
identified as being free from contaminating proteins and was, therefore, suitable for
raising antibodies. Antiserum was raised (Chapter 2, Section 2.11) using the wild
type Me. eapsulatus (Bath) protein Band B' mixture as the immunogen. SDS-PAGE
of proteins B and B' from Me. eapsulatus (Bath) was performed followed by
Western blotting with ~ 100 III of the first bleed of antiserum against the proteins
(Chapter 2, Section 2.15). Binding was observed in each case (Figure 3.6). The
control reaction with pre-immune serum proved that the binding was not a non-
specific event (data not shown). The antiserum produced was found to bind to both
proteins B and B' .
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Figure 3.6: Western blot analysis of purified protein Band B' from Me. capsulatus (Bath)
probing with antibodies to proteins Band B' from the first bleed.
Specific binding of the antibodies to proteins Sand S' is illustrated.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Proteins Sand S'.
66
45
36
29
24
20
14.2
Non-specific binding
D
D'
3.4 Purification of recombinant Me. capsulatus (Bath) protein B
(WTB) and the single mutant G13Q
Plasmids containing the genes encoding wild-type protein B from Me. capsulatus
(Bath) [pGEX-WTB] and the mutant version [pGEX-G13Q] (Lloyd, 1997; Lloyd et
al., 1997) were available. These produced the proteins with GST affinity tags at the
N-terminus and provided an alternative method for the rapid purification of protein
B. The system had been engineered such that the removal of the tag with thrombin
protease was possible (Lloyd, 1997). However, subsequent purification of the protein
from the cleaved GST protein as well as any uncleaved protein and the thrombin
protease was important. Also, as the G13Q mutant had been shown to have increased
stability (Lloyd et aI., 1997), it provided a viable alternative active protein B for use
in experiments in place of the wild-type form which is sensitive to cleavage. Efforts,
therefore, were concentrated on optimising a purification method for both proteins in
order to obtain highly pure protein samples of each for characterisation studies.
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3.4.1 Transformation of constructs into protease negative cells for expression
pGEX-WTB and pGEX-G13Q were provided as glycerol stocks in E. coli InvaF'
cells (Chapter 2, Section 2.27.1). Cultures of them were grown and the plasmids
purified. The protease-negative E. coli AD202 strain (Nakano et al., 1994) was
chosen for improving protein expression levels. Thus, transformation of [pGEX-
WTB] and [pGEX-G 13Q] into competent E. coli AD202 cells was conducted and
cells containing the plasmids selected by the ampicillin resistance conveyed.
3.4.2 Protein induction
Protein induction was controlled by an isopropyl I3-D-thiogalactopyranoside (IPTG)
promoter. Protein expression was induced for both pGEX-WTB and pGEX-G13Q at
an ODs4o of - 0.5 by addition of 1 mM IPTG at 37°C. Samples were taken for SDS-
PAGE and Western blot analysis, probing with antibodies to protein BIB', before
IPTG induction and at I, 2, 3 and 4 hours after induction. Figures 3.7 and 3.8 show
the results obtained for WTB, which were the same as those observed for the G13Q
samples.
Figure 3.7: SDS-PAGE analysis of samples of E. coli AD202 [pGEX-WTBJ before and after
IPTG induction.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: AD202 [pGEX-WTB] before induction with IPTG.
Lane 3: AD202 [pGEX-WTB] 1 h after induction with IPTG.
Lane 4: AD202 [pGEX-WTB] 2 h after induction with IPTG.
Lane 5: AD202 [pGEX-WTB] 3 h after induction with IPTG.
Lane 6: AD202 [pGEX-WTB] 4 h after induction with IPTG.
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Figure 3.8: Western blot analysis of E. coli AD202 [pGEX-WTB) 4 h after induction with IPTG,
probing with antibodies to protein BIB'.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: AD202 [pGEX-WTB] 4h after induction with IPTG.
Lane 3: Protein B/8' control.
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The gel (Figure 3.7) identified an increase with time in the expression level of a
protein at ~ 43 kDa corresponding to GST-WTB induction. The blot (Figure 3.8)
confirmed that the protein induced was probably GST -WTB by its cross-reaction
with the Me. eapsulatus (Bath) protein BIB' antibodies.
3.4.3 Protein purification
The GST fusion proteins were rapidly purified from the soluble extract of E. coli
"
AD202 cells using the GST affinity purification system (Amersham Pharmacia
Biotech, Bucks., UK) (Chapter 2, Section 2.4). GST-WTB or GST-G13Q was eluted
from the Glutathione Sepharose 4B affinity column using Tris-HCI buffer pH 8
containing 10 mM glutathione. Cleavage of the GST tag from the protein of interest
was achieved by incubation of the protein for 10 min at room temperature with
thrombin protease at a concentration of 10 unitslmg of fusion protein. The sample
was loaded directly onto a Superdex 75 FPLC gel filtration column equilibrated with
25 mM MOPS buffer, pH7. This procedure successfully separated all the proteins
contained within the mixture, and eluted uncleaved GST fusion protein, thrombin
protease, GST, and the protein of interest, respectively (Figure 3.9). SDS-PAGE
analysis (Figure 3.10) verified the clean separation ofuncleaved GST-fusion protein,
11.
GST and the protein of interest, and indicated that the protein of interest was
obtained at a purity of - 95 %. The figures are shown for WTB but the same results
were obtained for G l3Q. The protein samples were tested for propylene oxidation
activity (Chapter 2, Section 2.12.1) and found to be active, indicating that the protein
had not completely degraded to protein B' .
Figure 3.9: Purification profile of WTB on a Superdex 75 gel filtration column.
The column was equilibrated in 25 mM MOPS buffer, pH 7. Protein was eluted in a size dependent
manner. Peak 4 corresponds to WTB.
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Figure 3.10: SDS-PAGE of the purification ofWTB.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: GST-WTB eluted from Glutathione Sepharose 4B affinity column.
Lane 3: GST-WTB after incubation with thrombin for 10 mins at room temperature.
Lane 4: Blank.
Lane 5: GST protein after S75 step, under loaded.
Lane 6: GST protein after S75 step, overloaded.
Lane 7: WTB after S75 step, overloaded.
Lane 8: WTB after S75 step, under loaded.
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WTB and G13Q purified by the protocol outlined were of a pure enough quality for
further studies to be conducted on the samples. Also, as the purification procedure
was faster than that undertaken for wild-type protein from Me. capsula/us (Bath),
only minimal cleavage was observed for WTB (Figure 3.10, Lanes 7 and 8).
Therefore, this method of purification was successful in isolating uncleaved and
minimally cleaved recombinant wild-type Me. capsulatus (Bath) protein B (WTB)
and the single mutant version, G13Q.
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3.5 Purification of wild-type protein B from Ms. trichosporium OB3b
It was important to undertake studies to confirm the sequence of Ms. trichosporium
OB3b protein B by accurately determining the molecular mass of the protein and
also to elucidate whether the protein underwent a similar cleavage reaction to that
observed for Me. eapsulatus (Bath) protein B. It was, therefore, necessary to purify
protein B from Ms. trichosporium OB3b to a high enough purity for mass
spectrometry analysis. Thus, the purification procedure developed by Fox et al.
(1989) was modified to achieve this.
3.5.1 Optimisation of current protocols for Ms. trichosporium OB3b protein B
purification
The modified protocol (Chapter 2, Section 2.5) involved the separation of the sMMO
components from the soluble extract by ion exchange chromatography on a
Sepharose CL-6B (Amersham Pharmacia Biotech, Bucks., UK) FPLC column
followed by ammonium sulphate precipitation of the protein B fractions. Subsequent
anion exchange chromatography on a MONO Q FPLC column was then carried out,
after a buffer exchange procedure had transferred the protein into 25 mM MOPS
buffer, pH 7. The protein was eluted over a linear gradient of ISO mM to 350 mM
NaCl over 8 column volumes. Protein B eluted at 260-270 mM NaCI (Figure 3.11),
as determined by activity assays of each fraction.
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Figure 3.11: Purification profile of protein B from Ms. trichosporium OB3b on a MONO Q
column.
The column was equilibrated in 25 mM MOPS buffer, pH 7. The protein was eluted with a 150-350
mM NaCI gradient. The protein eluted at 260-270 mM NaCl.
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SDS-PAGE analysis of the protein B fraction (Figure 3.13, Lane 2) identified an
additional band of ~ 30 kDa. Therefore, a gel filtration step was included to separate
protein B from this contaminating protein. Protein from the anion exchange step was
concentrated before loading onto a Superdex 75 gel filtration FPLC column
equilibrated with 25 mM MOPS buffer, pH 7. Protein was eluted in a size dependent
manner (Figure 3.12).
76
Figure 3.12: Purification profile of protein B from Ms. trichosporium OB3b on a Superdex 75
column.
The column was equilibrated in 25 mM MOPS buffer, pH 7. Peak 3 corresponds to protein B.
0.2
0.1
o 1I
60 120
I
14080 100
Elution Volume (ml)
Peak 3 was found to be active, indicating it.to be the protein B fraction. SDS-PAGE
analysis (Figure 3.13, Lane 3) indicated that the ~ 30 kDa band remained after the
gel filtration step and was, therefore, presumed to correspond to a dimer of the
protein. This is in agreement with the findings of Fox et al. (1991) and Chang et al.
(1999) where Ms. trichosporium OB3b protein B was also observed as existing as a
dimer under certain conditions. However, the dimer band was observed as being
slightly weaker for the protein B eluted from the S75 column (Figure 3.13, Lane 3)
compared to the protein prior to this purification step (Figure 3.13, Lane 2).
Therefore, it is possible that some contaminating proteins visible at ~ 30 kDa were
separated from the protein of interest. This is clearly indicated on the purification
profile (Figure 3.12) where the protein B peak was observed to be separated from
some higher molecular weight contaminating proteins, which eluted prior to the
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protein B fractions. Truncates of Ms. triehosporium OB3b protein B were also
observed. Nevertheless, the protein was identified as being of sufficient purity for
subsequent analysis by mass spectrometry.
Figure 3.13: SDS-PAGE analysis of wild type Ms. trichosporium OB3b protein B at different
stages of purification.
Lane I: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Protein B after MONO Q step.
Lane 3: Protein B after S75 step.
Each lane contained - 5 ug protein.
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3.5.2 ESI-MS analysis of Ms. trichosporium OB3b protein B
Purification of wild-type Ms. triehosporium OB3b protein B, like that of Me.
eapsulatus (Bath) protein B, resulted in a mixture of intact full length protein B as
well as truncated forms. Therefore, it was necessary to confirm that the co-purifying
proteins were indeed truncates and to elucidate whether the cleavage sites were the
same as those observed for Me. eapsulatus (Bath) protein B. Determining the
molecular mass of the intact protein was also essential in elucidating whether or not
it agreed with the published sequence data for the protein.
Electrospray ionisation mass spectrometry (ESI-MS) was used to analyse desalted
samples of Ms. trichosporium OB3b protein B, after the final purification step. The
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mass spectrum obtained is shown in Figure 3.14 and the peak data detailing the
corresponding cleavage sites are in Table 3.1.
Figure 3.t4: ESI-MS of purified protein B from Ms. trichosporium OB3b.
The ESI-MS of the Ms. trichosporium OB3b protein B was recorded on a Quattro II tandem mass-
spectrometer with an electrospray ion source and the data was processed using the MassLynx program
(VG Biotech) (Chapter 2, Section 2.16.1).
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Table 3.t: ESI-MS data for purified protein B from Ms. trichosporium OB3b indicating the
corresponding cleavage sites.
Cleavage sites were identified using the Proteins function of the BioLynx software, part of the
MassLynx Program (VG Biotech) (Chapter 2, Section 2.16.1).
Observed molecular Cleavage site, numbered with respect to the wild-
mass (Da) type Ms. trichosporium OB3b protein B seg_uence
14750.2 OB3b protein B intact
14021.4 Y -N°
13176.6 T"_G'o
12774.0 F'~_ALU
11965.9 E"O-E"
ESI-MS of wild-type Ms. trichosporium OB3b protein B indicated that it contained a
mixture of intact protein B and various N-terminally truncated forms of the protein.
The molecular mass of the intact protein was determined to be 14750.2 Da, which is
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approximately 133 Da lower than the value of 14882.9 Da predicted from the
available sequence information (Protparam Tool on the ExPASy Website;
http://www.expasy.ch/).This is because the sequence data begin with the ATG start
codon, and ATG also codes for methionine (13l.2 Da). Methionine is often post
translationally removed, which explains the discrepancy in molecular mass.
The N-terminally truncated proteins were not cleaved at the same positions as
observed in Me. capsulatus (Bath) protein B, a result considered and analysed further
in Chapter 4.
3.6 Purification of recombinant Ms. trichosporium OB3b protein B
As a result of the truncates observed in purifying wild-type Ms. trichosporium OB3b
protein B (Section 3.5), purification of the wild-type recombinant protein was
undertaken. A construct, similar to those available for Me. capsulatus (Bath) protein
B, was available for Ms. trichosporium OB3b protein B for expression of the protein
as a GST fusion (Lloyd, 1997). The plasmid [pGEX-MTB] (Chapter 2, Section
2.27.1) was used in the same way as [pGEX-WTB] and [pGEX-GI3Q], as detailed
in Section 3.4, to improve protein expression levels. The same purification protocol
was used (Chapter 2, Section 2.4) and gave the same results as those identified for
WTB and G13Q. This provided an efficient method of purifying highly pure, active,
uncleaved recombinant Ms. trichosporium OB3b protein B for further studies.
3.7 Determination of the extinction-coefficients of the regulatory
proteins
For protein structure studies, it was necessary to determine the concentration of the
proteins accurately. Therefore, it was important to elucidate the extinction-
coefficients of the proteins (Chapter 2, Section 2.10.2).
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Fluorescence was used to monitor the time taken for guanidine hydrochloride to
denature the protein. This involved monitoring the change in fluorescence over time
for samples of recombinant Ms. trichosporium OB3b protein B, G13Q and protein
B' incubated in the denaturant (Chapter 2, Section 2.17). As the proteins became
denatured the expected shift in dmax to ~ 350 nm after ~ 2.5 hours incubation was
observed. Thus, the difference in absorbance at 280nm was determined for the native
and denatured samples. This information, together with the theoretical extinction-
coefficient values calculated using Equation 3.1, enabled the native extinction-
coefficient values to be determined using Equation 3.2.
Equation 3.1:
Theoretical Eunfolded= (X W X EW) + (X Y X EY) + (XF X EF)
where x=number of residues
E =extinction coefficient
W = tryptophan
Y = tryosine
F = phenylalanine
Equation 3.2:
Enative= (AnativeX Eunfolded)/ Aunfolded
where A=Absorbance at 280nm
The extinction-coefficients calculated for recombinant Ms. trichosporium OB3b
protein B, G13Q and protein B' (Table 3.2) were found to be fairly similar to the
expected values determined by Equation 3.1.
Table 3.2: Extinction-coefficient data
Protein Theoretical E unfolded Experimental E native
G13Q 17780 16839
Protein B' 16500 16032
Rec. Ms. trichosporium OB3b 15220 16837
protein B
The experimental E nativevalues were used for determining the protein concentrations
for all the subsequent experiments conducted.
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3.8 Separation of protein Band truncate(s) by chromatofocusing
chromatography
Protein B from Me. eapsulatus (Bath) purified by the method of Pilkington et at.
(1990) has been identified as consisting of a mixture of intact protein B and
truncated protein B' (Section 3.2). Extended incubation of this purified protein B/B'
leads to further truncate formation, notably that of B" (Bhambra, 1996; Lloyd et al.,
1997). Truncation has also been observed to occur for Me. eapsulatus (Bath) protein
B from recombinant sources as well as wild-type and recombinant Ms.
trichosporium OB3b protein B. Therefore, it was considered necessary to develop a
means of separating protein B and its truncate(s) from one another. Thus further
studies involving pure, homogeneous protein B and/or truncate protein(s) would be
possible.
Chromatofocusing is an ion exchange chromatography technique that separates
proteins on the basis of their isoelectric points. The technique takes advantage of the
buffering action of the charged group of the MONO P ion exchanger. It achieves this
by creating a pH gradient using two buffers of different pH values, the first (Buffer
A) is used to adjust the pH of the chromatofocusing column and the second (Buffer
B) is then run through the column, thereby creating a pH gradient along the column
itself. This causes proteins to migrate along the column according to their pI values
(Pharmacia LBK Biotechnology Division: Bucks, UK). For samples of wild-type
Me. eapsulatus (Bath) protein B and its truncates, it was anticipated that their
sequence of elution from the column would be Btl (pI= 4.64), B' (pI= 4.55) and
finally intact protein B (pI = 4.49), since the protein with the highest pI value elutes
first. The theoretical pI value of each of the proteins was determined by analysis of
their amino acid sequences using the ProtParam tool on the ExPASy website
(http://www.expasy.ch/). Chromatofocusing resolves proteins with pI units differing
by as little as 0.02, making it ideal for separating the different forms of protein B.
Two samples of protein B purified from Me. eapsulatus (Bath) by the method of
Pilkington et at. (1990) were subjected to chromatofocusing chromatography on a
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MONO P FPLC column (Amersham Pharmacia Biotech, Bucks., UK) (Chapter 2,
Section 2.8). Sample 1 had been incubated at 20°C for - 4 hours to induce cleavage
and exhibited an activity level of approximately 2000 nmol/minlmg, compared to
that of Sample 2 which was fresh from purification and exhibited a higher level of
activity of approximately 3500 nmol/minlmg. The activity levels of the samples
correlate with the proportions of inactive proteins B' and B" present, compared to
active protein B. Mass spectrometry (Figure 3.15) and SDS-PAGE (Sample 1,
Figure 3.18, Lane 2; Sample 2, Figure 3.16, Lane 2) analysis of the two samples
more accurately confirmed the nature and relative proportions of the proteins within
the two samples. It was, therefore, concluded that Sample 1 contained proteins
B:B':B" at an approximate ratio of 4:10:2.5, whereas Sample 2 contained the
proteins at an approximate ratio of 10:6: 1. This information was used in the
assigning of the chromatofocusing peaks.
Figure 3.15: (i) MALDI- ToF MS of Sample 1 and (ii) ESI-MS of Sample 2.
(i) The MALDI- ToF MS of Sample I was recorded on a Protlex III mass spectrometer. Data were
recorded by a I GHz Le Croy digitiser and analysed by Bruker Xtof 3.1.0 software (Chapter 2.
Section 2.16.2). Data displayed as mass to charge ratio (m/z) against arbitary intensity (a.i.). 12715
peak corresponds to protein B", 14626 peak to protein B' and 15848 to protein B.
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(ii) The ESI-MS of Sample 2 was recorded on a Quattro II tandem mass-spectrometer with an
electrospray ion source and the data were processed using the MassLynx program (VG Biotech)
(Chapter 2, Section 2.16.1). Peak 15852 corresponds to protein B, peak 14629 to protein S' and
12718 to protein B".
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Figure 3.16: SDS-P AGE of Sample 2.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Sample 2 of proteins S, S' and B" at an ~ ratio of 10:6: 1.
66
45
36
29
24
20
14.2
..--- Protein B
4 Protein B'.. - Protein B"
84
The MONO P chromatofocusing column was equilibrated with Start Buffer A (25
mM methylpiperazine, pH 5.64). The protein samples for analysis were buffer
exchanged into the Start Buffer A and then loaded onto the column. The B", B' and
B proteins eluted over a linear pH gradient created on the column by the application
of Buffer B (1 in 10 dilution of Polybuffer 74™ (Amersham Pharmacia Biotech,
Bucks., UK), pH 3.5 at 1 ml/min). The fractions corresponding to the different
protein peaks were separately pooled for further analysis of the isolated protein
forms. The elution profiles obtained for the two samples of wild-type protein B from
Me. eapsulatus (Bath) are shown in Figure 3.17.
Figure 3.17: Chromatofocusing elution profiles for wild type protein B from Me. eapsuJatus
(Bath).
Start Buffer A, 25 mM methylpiperazine, pH 5.64; ButTer B 1 in 10 dilution Polybuffer 74™, pH 3.5
at 1 mllmin on a MONO P HR 5/20 chromatofocusing chromatography column. The separation of the
proteins B, B' and B" is identified on the traces.
Sample 1
t
Sample 2
t
The three major chromatofocusing peaks for sample 1 were in similar proportions to
the concentrations of B, B' and B" identified by the mass spectrometry and SDS-
PAGE data. The peaks were, therefore, presumed to correspond to the three forms of
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the protein, as indicated in Figure 3.17, Sample 1. The chromatofocusing elution
profile for Sample 2, which had been identified as containing more of the active
protein B, further supported the assignment ofB, B' and B" peaks to be as indicated
in Figure 3.17.
SDS-PAGE analysis of the protein B fraction obtained from chromatofocusing
chromatography indicated the protein to be pure, as observed by the single band at
16 kDa and as compared to the impure starting material (Sample 1) of protein B
from Me. capsulatus (Bath) which contained proteins B, B' and B" (Figure 3.18).
Figure 3.18: SDS-PAGE of -the protein B fraction obtained from chromatofocusing
chromatography.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kOa).
Lane 2: Sample 1 of proteins B, B' and B" at an - ratio of 4: 10:2, prior to chromatofocusing
chromatography.
Lane 3: Protein B fraction from chromatofocusing chromatography.
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Propylene oxidation activity assays (Chapter 2, Section 2.12.1) of the fractions
assigned to B' gave no sMMO activity, whereas those for the putative B fractions
showed the presence of active protein B. Assays were conducted containing 8 f.lMof
each protein hydroxylase and reductase in 25 mM MOPS buffer pH 7, and purified
protein B in the Polybuffer 74™ in which it was eluted from the chromatofocusing
column. It proved impossible to remove the Polybuffer 74™ from the protein B or
highly concentrate the protein without further degradation of the protein occurring,
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as extended time scales were involved in the concentration and dialysis processes.
Control reactions of sMMO activity containing the hydroxylase, reductase and
protein B in 25 mM MOPS buffer pH 7 were compared to the activity levels
obtained upon addition of Polybuffer 74™ to the system, in the quantity in which it
had to be added in the test study to give 8 J.lMprotein B. Itwas found that a decrease
in specific activity of approximately 60 % resulted. Taking this into account, an
estimated specific activity value of 6380 nmlminlmg was obtained for the protein B
purified by chromatofocusing and verifies the protein to be active protein B in a
highly pure form.
WTB and G13Q, produced from the pGEX-2T expression system (Section 3.4), were
also subjected to chromatofocusing chromatography. Optimum separation of the
intact protein from the truncated form was achieved using Start Buffer A, at pH 5.7,
and Buffer B at pH 4, applied at a flow rate of 0.3 ml/min (Figure 3.19).
The traces in Figure 3.19 give further evidence that chromatofocusing is capable of
separating proteins B and B'. Both the samples of recombinant protein had been
cleaved from their precursor GST -fusion proteins with thrombin, directly before
being applied to the column. Therefore, these results can be interpreted as comparing
B' formation within the two samples, as the intact fusion protein does not undergo
significant cleavage to give truncated proteins over such a short period of time
(Lloyd et al., 1997).
G13Q has been shown previously to be more stable than WTB, with B' formation
occurring at a much reduced rate in the mutant form (Lloyd et al., 1997). This is
reflected in the chromatofocusing elution profiles (Figure 3.19) by the very small
presumptive B' peak for G 13Q compared to the larger B' peak for WTB.
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Figure 3.19: Chromatofocusing elution profiles for WTB and G13Q.
Start Buffer A, 25 mM methylpiperazine, pH 5.7; Buffer B I in 10 dilution Polybuffer 74™, pH 4 at
0.3 mllmin on a MONO P HR 5120 chromatofocusing chromatography column. The separation of the
proteins is as identified on the elution profiles.
WTB
t
G13Q
t
Mass spectrometry analysis of the peaks from chromatofocusing chromatography
proved unsuccessful as the Polybuffer 74™ in which the proteins were eluted
appeared to distort the signal, and attempts at its removal proved problematic.
Thus, separation of protein Band B' was shown to be possible by the use of the
purification procedure described. This proved vital in enabling studies into the
mechanism ofB to B' cleavage, detailed in Chapter 4.
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3.9 Determination of the purity of hydroxylase and reductase, as
purified by the current published protocols
Previous methods of purification of the hydroxylase and reductase (Pilkington and
Dalton, 1990) were analysed to determine the levels of purity achieved. Optimisation
of these methods was undertaken as it was deemed necessary to develop an efficient
system for obtaining proteins of optimal purity.
3.9.1Purification of the hydroxylase and reductase proteins from Me.
capsulatus (Bath)
The published protocol for the purification of the hydroxylase and reductase
involved the use of ion exchange- and gel filtration- chromatography (Pilkington and
Dalton, 1990). These techniques, which separate proteins by the exploitation of a
different protein property, would be expected to clearly separate the proteins from
one another. For example, the hydroxylase, reductase and protein B all differ greatly
in size and would be expected to be easily separated by the gel filtration
chromatography step. The purity of the proteins obtained by these methods was
analysed by SDS-PAGE (Figure 3.20).
Figure 3.20: SOS-PAGE of the sMMO proteins purified by the method of Pilkington and
Dalton, (1990).
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Hydroxylase, consisting of a, 13 and y subunits.
Lane 3: Reductase. .,
Lane 4: Blank.
Lane 5: Protein B and truncates.
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SDS-PAGE analysis indicated the samples of hydroxylase and reductase to be
approximately 75 % and 90 % pure, respectively (Figure 3.20). However, activity
assays containing 8 f.!Mof each of the purified hydroxylase and reductase proteins,
in the absence of any protein B, gave a low level of activity, indicating
contamination to be present. Western blot analysis of the hydroxylase and reductase
proteins, probing with antibodies to Me. eapsulatus (Bath) protein BIB', was
performed to determine whether any protein B remained bound to either of the
proteins (Figure 3.21).
Figure 3.21: Western blot analysis of the sMMO proteins as purified by the method of
Pilkington and Dalton, (1990), probing with antibodies to Me. capsulatus (Bath) protein BIB'.
Lane I: Molecular weight markers (bovine albumin, 66 kOa; egg albumin, 45 kOa;
glyceraldehyde-3-P-dehydrogenase, 36 kOa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kOa; soybean trypsin inhibitor, 20 kOa; bovine milk a-lactalbumin, 14.2 kOa).
Lane 2: Hydroxylase.
Lane 3: Reductase.
Lane 4: Protein B and truncates.
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Western blot analysis identified protein B to have remained bound to the
hydroxylase protein after purification (Figure 3.21). To confirm this result activity
assays containing 8 f.!Mof each of the purified hydroxylase and reductase proteins
were conducted in the presence of protein B antibodies, in order to determine
whether activity would be lost. This would confirm if residual protein B, bound to
the purified hydroxylase protein, was responsible for the minimal activity observed
(Figure 3.22).
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Figure 3.22: sMMO activity assays of the hydroxylase and reductase purified by the method of
Pilkington and Dalton (1990) and the effect of adding Me. eapsulatus (Bath) protein BIB'
antibodies.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.1) were performed by mixing ~8 f..lM
aliquots of hydroxylase and reductase with various quantities of undiluted Me. capsulatus (Bath)
protein BIB' antibodies or pre-immune serum. 100% antibodies or pre-immune serum represents 400
ul in a total assay volume of 500 ul. Enzyme activity is shown as a percentage of the activity of
hydroxylase and reductase alone. The hydoxylase is denoted by H and the reductase by R. The
activities presented are the mean of 3-4 separate experiments. Standard error bars are shown.
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The activity lost upon addition of protein B antibodies confirmed that the activity
possessed . by the hydroxylase and reductase alone was due to protein B
contamination and proved that in the absence of protein B, hydroxylase and
reductase are definitely inactive. This is unlike the sMMO of Ms. trichosporium
OB3b where the hydroxylase and reductase retain minimal activity in the absence of
protein B (Liu et al., 1995). The serum itself appeared to interfere with the activity of
the complex when added at 100 %, but at 50 % had no effect on the activity, unlike
the protein B antibody-containing serum which inhibited the activity by ~ 70 %. The
inhibition observed by the pre-immune serum was probably due to the high
concentration. of proteins contained within the serum interfering with the binding
within the assay mix, therefore, preventing the small amounts of impure hydroxylase
and reductase from complexing to give activity. However, at 50 % concentration this
problem was overcome, indicating that the lack of protein B antibodies in this
sample prevented activity from being inhibited.
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Further purification of the hydroxylase and reductase proteins was performed by the
addition of an extra ion exchange chromatography procedure (Chapter 2, Section
2.3.3, Step 3; Section 2.3.4, Step 3). The hydroxylase and reductase protein purified
by this method gave no residual activity when assayed in the absence of protein B,
thus confirming them to be pure and free of contaminating protein(s). SDS-PAGE
analysis indicated the proteins to be > 95 % pure (Figure 3.23). They were, therefore,
used for subsequent structural studies.
Figure 3.23: SDS-PAGE of purified hydroxylase and reductase proteins
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Hydroxylase after final MONO Q step, consisting of a, ~ and y subunits.
Lane 3: Reductase after fmal MONO Q step.
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3.10 Conclusion
Optimisation of protocols for the purification of Me. eapsulatus (Bath) protein B',
Ms. triehosporium OB3b protein B, WTB and G13Q were developed for the
isolation of protein of> 95 % purity required for further characterisation studies. A
separation procedure by chromatofocusing was also developed to separate protein B
and its truncates from each other. The purification of the hydroxylase and reductase
from Me. eapsulatus (Bath) were also optimised resulting in higher purity of these
sMMO components. The studies using protein B antibodies to inhibit the residual
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activity of the hydroxylase and reductase present in semi-pure preparations also
confirmed that the hydroxylase and reductase alone are inactive and that protein B is
essential for activity. This highlights the difference between the sMMO of Me.
eapsulatus (Bath) and the homologous system from Ms. triehosporium OB3b, as, in
the latter case, the sMMO enzyme appears to function in the absence of protein B
(Liu et al., 1995). The reason for this difference between the two systems remains
unclear, as in most other respects they are similar. The fact that low levels of activity
obtained from sMMO assays of the hydroxylase and reductase proteins from Me.
eapsulatus (Bath) purified by the method of Pilkington et al. (1990) indicates the
difficulty in obtaining highly pure, homogeneous hydroxylase protein and
emphasises its strength of binding with protein B. This therefore suggests the
possibility that the low level of activity observed for the hydroxylase and reductase
proteins alone from Ms. triehosporium OB3b could be the result of a purity problem.
Protein B purified from Me. eapsulatus (Bath) and Ms. triehosporium OB3b were
illustrated as undergoing cleavage to form N-terminally truncated versions of the
proteins. Mass spectrometry indicated the cleavage sites of Ms. triehosporium OB3b
protein B truncation to be different from those observed for protein B of Me.
eapsulatus (Bath), a result further considered and expanded upon in Chapter 4.
The ability to separate proteins B and B', a process previously unachievable, by the
use of chromatofocusing chromatography has also been vital in providing a means to
study protein B to B' formation, as describedin Chapter 4.
93
Chapter 4
The Cleavage of Protein B
4.1 Introduction
Protein cleavage usually occurs by chemical or enzymatic means. Many enzymes are
activated by specific proteolytic cleavage reactions as a mechanism of activity
regulation. For example, some enzymes, such as chymotrypsin which is involved in
digestion, are synthesised as inactive precursors known as zymogens or proenzymes,
and in the case of chymotrypsin, chymotrypsinogen. Activation is mediated by
cleavage of the zymogen, such as chymotrypsinogen, due to the action of a specific
enzyme, in this instance trypsin. Thus, the zymogen is kept in a form that can be
readily activated, when needed, as the proteolytic reaction serves to give rise to an
active species very rapidly, rather than waiting for an active form to be synthesised
de novo (Stryer, 1988).
Within the last decade, proteins have also been identified that can undergo self-
catalysed modification reactions, which do not require the intervention of other
enzymes. These reactions include protein splicing and autoproteolysis. Protein
splicing was first observed for the protein product of the Saccharomyces cerevisiae
TFPl gene (Hirata et al., 1990; Kane et al., 1990). The 69 kDa subunit of vacuolor
ATPase of the yeast Candida tropicalis (Gu et al., 1993) and the DNA polymerases
of the extreme thermophilic archaebacterium Thermococcus litoralis (Hodges et al.,
1992) are further examples of proteins which undergo protein splicing (Shao and
Kent, 1997). Similarly, autoproteolysis has been observed for glycosylasparaginases
and pyruvoyl enzyme precursors. The initial formation of an ester bond by the acyl
rearrangement of a peptide bond, are common features of these autoprocessing
reactions. Although such acyl rearrangements are thermodynamically unfavourable,
their coupling to diverse types of self-catalysed irreversible steps drives the protein
rearrangements to completion (Perler et al., 1997).
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It has been proposed that the mechanism of cleavage of protein B to form inactive
truncates could be autocatalytic. The suggestion was made in view of the fact that
the addition of protease inhibitors and the expression of recombinant protein B in
protease deficient strains of E. coli, failed in preventing the occurrence of the
cleavage reaction (Bhambra, 1996; Lloyd et al., 1997). However, in contrast to
protein B being inactivated due to cleavage, the other proteins mentioned are
activated by the process. Nevertheless, the ability to rapidly shut down sMMO
activity, possibly in response to lack of substrate, has been proposed as a mechanism
of preventing the wasteful oxidation of NADH, thus conserving the cell's energy
(Green and Dalton, 1989; Kazlauskaite et al., 1996). This effect could be mediated
by cleavage of protein B to form inactive protein B' (Lloyd et al., 1997). However,
the possibility that the cleavage product, protein B', may have some as-yet undefined
activatory role within a system other than that of sMMO, cannot be ruled out.
Conserved motifs, have been identified in proteins which undergo these
autoprocessing reactions and they have been identified as being essential for the
splicing reaction. Although protein B, by sequence analysis, has been shown not to
contain any of these conserved sequence motifs (Section 4:4.1), it is possible that it
may cleave by a similar chemical mechanism.
A combination of N-terminal sequencing and ESI-MS has been used to identify the
cleavage site in wild type protein B from Me. capsulatus (Bath) which results in the
formation of the inactive truncate, protein B"(Bhambra, 1996; Lloyd et al., 1997). It
was found that the protein was cleaved between Metl2_Gly13, such that 12 amino
acids were lost from the N-terminus. This processing of protein B was also observed
for the recombinant protein expressed in E. coli (Bhambra, 1996; Lloyd et al., 1997).
Protein B from Me. capsulatus (Bath) and Ms. trichosporium OB3b have a 89.4 %
similarity between their protein sequences (Cardy et al., 1991a) and yet protein B'
formation had not been reported in Ms. trichosporium OB3b. However, this could be
attributed to the lack of a Metl2_Glyl3 site within the protein. This observation
provided the strategy for the work of Lloyd et al. (1997) in which a more stable
protein B was produced by mutation of the Glyl3 residue to a glutamine. However,
the work did not specifically identify the level to which cleavage still occurred
within the N-terminal region of the mutant G13Q, or whether the cleavage site
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remained the same as that observed for the wild-type protein. Subsequent work to
produce highly purified wild type Ms. triehosporium OB3b protein B (Chapter 3,
Section 3.5) enabled analysis of its cleavage to be possible and identified that the
Met)2-Gln)3 site was not the site of cleavage in this case (Chapter 3).
This Chapter details a comparison of the cleavage sites within the recombinant, wild-
type and mutant protein B proteins in order to determine whether any trend was
present which could identify whether the mechanism of cleavage is site specific.
Studies into the mechanism of cleavage and the effect of losing certain amino acids
from the N-terminus of protein B on its structure are also described. These studies
were undertaken to further the understanding of the production of protein B' and to
attempt to identify the reason for its occurrence and inactivity within the sMMO
system.
4.2 Is the mechanism of cleavage of protein B autocatalytic?
Various approaches were undertaken in an attempt to elucidate the nature of
cleavage of protein B and to identify whether its mechanism of occurrence was
autocatalytic.
4.2.1 Studying the mechanism of cleavage
The technique of chromatofocusing was used to determine whether protein B, when
separated from its truncated forms (Chapter 3, Section 3.8), could be detected as
undergoing further cleavage to form truncates. Active wild-type protein B from Me.
eapsulatus (Bath) was separated into its truncated forms by chromatofocusing
(Chapter 3, Section 3.8, Figure 3.17, Sample 2). The pooled protein B fractions were
then subjected to chromatofocusing (Chapter 2, Section 2.8) again after incubation at
20°C for - 3 hours. Once the active protein B fractions had been separated, the
fractions were pooled and· subjected to a repetition of this procedure a further two
times (Figure 4.1, Elutions 1-3).
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The chromatofocusing elution profile (Figure 4.1, Elution 1) indicated the presence
of presumptive protein B, B' and B" peaks, suggesting that protein B cleaved with
the formation of its truncates during the time it was incubated at 20 "C. Elution 2
indicates that protein B to protein B' cleavage occurred during the incubation stage.
Elution 3 gives further evidence for the cleavage of protein B.
Figure 4.1: Chromatofocusing elution profiles monitoring for the presence of protein B and its
truncates.
Conditions of MONO P run included Start buffer as 25 mM N-Methylpiperazine pH 5.7, Protein
eluted from the column with 10 times diluted Polybuffer 74™ pH 3.5.
Elution I) Sample of highly pure protein B after ~ 3 h incubation at 20 QC.
Elution 2) Sample of purified protein B from run I after a further ~ 3 h incubation at 20 QC.
Elution 3) Sample of purified protein B from run 2 after a further ~ 3 h incubation at 20 QC.
Elution 1 Elution 2 Elution 3
Thus, a highly purified sample of protein B from chromatofocusing was observed to
partially degrade to protein B' over the ~ 3 hours incubation at 20 "C. The mixture
formed could then be repeatedly resolved and repurified (Figure 4.1). Each sample of
repurified protein B underwent cleavage to protein B', indicating that the truncates
were likely to be generated autocatalytically. This proposal was supported by the fact
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that prior to chromatofocusing chromatography, the protein had been extensively
purified and identified by SOS-PAGE (Figure 3.16, Lane 2) and mass spectrometry
analysis (Figure 3.15 (ii)) to be free of contaminating proteins, such as proteases. It
is also supported by the work of Bhambra (1996) and Lloyd et al. (1997), where the
addition of a wide variety of protease inhibitors and expression of recombinant Me.
capsulatus (Bath) protein B in protease deficient E. coli strains, both failed to
prevent the protein B truncation reaction.
4.2.2 How does protein B cleave?
Recent research has identified that autoprocessing pathways rely on the formation
and resolution of internal (thio) esters (Perler, 1998; Stoddard and Pietrokovski,
1998). It has been shown that the nucleophilic amino acids Cys, Ser and Thr can
rearrange in proteins, replacing the amide peptide bond between itself and the
preceding amino acid with a more reactive thioester or ester bond. Such bonds can
then be broken by hydrolysis, to bring about the cleavage reaction. Aminohydrolase
and aspartate decarboxylase processing are examples of proteins which undergo this
type of reaction (Ouggleby et al., 1995; Lowe et al., 1995; Guan et al., 1996; Ramjee
et al., 1997). Sequence analysis of protein B failed to identify any level of homology
with autoprocessing proteins. Nevertheless, it is possible that cleavage of protein B
may occur via a similar chemical mechanism, involving attack by a specifically
nucleophilic residue on a certain amino acid(s), as dictated by the protein's structure.
Subsequent ester formation would allow rapid hydrolysis to occur leading to truncate
formation.
One possible mechanism to explain autocatalytic cleavage could be that of
intramolecular cyclisation via nuceophilic attack from the N-terminal serine residue
of protein B on its other amino acids. It was believed that the N-terminal region of
protein B must be flexible in order to undergo cleavage so readily, an idea which has
been verified by the recent structural determination of the protein by NMR (Chang et
al., 1999; Walters et al., 1999). The flexible N-terminal region of protein B could
allow the N-terminal amino acid to attack amino acids within a certain region, as
dictated by its structure. Upon the cyclisation reaction (Mechanism 4.1) water would
be lost, such that the N-terminal region would be detected by mass spectrometry as
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being the correct molecular weight, but lacking a mass of 18 Da attributable to the
water molecule lost during the process. This strategy was adopted to investigate the
possibility of this mechanism being responsible for protein B cleavage.
Mechanism 4.1: Cyclisation reaction mechanism resulting in the loss of the first 12 amino acids
from the N-terminal of protein B.
The NH2 group of the N-terminal amino acid attacks the carbonyl group of the amino acid residue at
the site of cleavage to form a cyclic intermediate. N-protonation of the cyclic intermediate leads to
protein B' formation and the loss of the first 12 amino acids of protein B as a cyclic peptide with the
loss of a water molecule.
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Mass spectrometry (Chapter 2, Section 2.16.1) was conducted on samples of WTB,
which had been left to cleave at room temperature overnight. However, the technique
was unable to identify the 12 amino acid fragment cleaved from the N-terminus of
the protein. It was possible that this problem arose due to the fact that the first 12
amino acids contain no basic amino acid residues, and, therefore, the fragment would
not attract protons efficiently to facilitate its identification by mass spectrometry.
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A second possible mechanism to explain the observations was that a specifically
nucleophilic side chain group, present on the surface of the core region of the protein
B, could interact with the mobile N-terminal region, initiating the cleavage reaction
(Mechanism 4.2).
Mechanism 4.2: Possible mechanism for the cleavage of the first 12 amino acids from the N-
terminus of protein B.
Nucleophilic side chain group of a residue on the core region of protein B, such as a side chain
hydroxyl or thiol group of a serine, threonine or cystine, attacks the carbonyl group of the amino acid
residue at the cleavage site to form a cyclic intermediate. N-protonation subsequently results in ester
formation and an intermediate, which is identified as having two N-terminals. Hydrolysis rapidly
breaks the ester bond forming the protein B' truncate and a peptide of first 12 N-terminal amino acids
of protein B.
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Identification of whether a specifically nucleophilic side chain group was present in
an accessible region of protein B involved the use of p-nitrophenylacetate, which
reacts with nucleophilic groups to form p-nitrophenol (Balls and Wood, 1956), as
shown by Mechanism 4.3.
Mechanism 4.3: Reaction of p-nitrophenylacetate with a nucleophilic group to form p-
nitrophenol.
Nucleophilic side chain group of a residue on the core region of protein B, such as a side chain
hydroxyl or thiol group of a serine, threonine or cystine, attacks the carbonyl group of the acetate
moiety of p-nitrophenylacetate. This results in the formation of the p-nitrophenol ion.
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The formation of p-nitrophenol was monitored spectrophotometrically at 400nm
over time in the presence of different conce?trations of WTB (Chapter 2, Section
2.13). Controls included the background rate of p-nitrophenylacetate conversion to
p-nitrophenol, as well as the rate of conversion of p-nitrophenylacetate to p-
nitrophenol in the presence of a control protein known to be stable (hydroxylase) and
boiled WTB, which also does not undergo cleavage. The results are displayed in
Figure 4.2.
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Figure 4.2: Monitoring the formation ofp-nitrophenol.
The formation of p-nitrophenol from p-nitrophenylacetate was monitored at 400nm over time in the
presence of different concentrations of WTB. Control reactions were conducted in the absence of
protein, in the presence of hydroxylase protein and boiled WTB (Chapter 2, Section 2.13).
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These data indicate that a specific nucleophilic amino acid side group is present to
initiate the reaction of p-nitrophenylacetate to p-nitrophenoL, as an increased reaction
rate is observed for p-nitrophenylacetate in the presence of increasing concentrations
of WTB. Also the reaction is slow, as is observed for the cleavage of protein B over
time. The control reactions indicated that a background level of conversion was
present and that minimal conversion was observed for the hydroxylase protein,
which is known to be stable, and for the control sample of boiled protein B which
does not undergo cleavage. This also suggests that the nucleophilicity of the specific
side group is dependent upon the structure of the protein, as denatured protein loses
its activity within the p-nitrophenylacetate assay. It is clear from this evidence that
an autocatalytic mechanism of cleavage is most likely responsible for protein B
truncate formation.
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4.3 ESI-MS analysis of the cleavage of protein B from various
sources
Wild-type recombinant Ms. trichosporium OB3b protein B, WTB and G13Q can be
purified to levels sufficient to enable sequence analysis to be possible by ESI-MS
(Chapter 3).
The technique was used to determine the cleavage sites of wild type and recombinant
protein B from Ms. trichosporium OB3b, WTB and G13Q. Samples of each protein
(- 1 mg/ml) were incubated at room temperature for - 24 hours prior to ESI-MS
analysis to determine accurately the molecular masses of the truncated proteins
contained within the samples, and thus identify the sites of cleavage (Table 4.1).
Table 4.1: ESI-MS of the cleavage products of (i) wild type protein B from Ms. trlchosporium
OB3b, (ii) recombinant protein B from Ms. trichosporlum OB3b, (iii) G13Q and (iv) WTB
The ESI-MS of the proteins was recorded on a Quattro II tandem mass-spectrometer equipped with an
electrospray ion source. Data were processed using the MassLynx program (VG Biotech) (Chapter 2,
Section 2.16.1).
(i) Wild-type Ms. trichosporium OB3b protein B
Observed molecular mass Cleavage site, numbered with respect to the
(Da) wild-type Ms. trichosporium OB3bB protein B
sequence
14749.9 OB3b protein B intact
14017.2 y7_NK
13178.2 " T15_G1b
13118.0 G1b_KI7
12772.7 Fl~_A~u
11965.1 E~b_E~
(ii) Recombinant Ms. trichosporium OB3b protein B
Observed molecular mass Cleavage site numbered with respect to the
(Da) wild-type Ms. trichosporium OB3bB protein B
sequence
15027 Rec. OB3b protein B intact
13279 K14_T15
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(iii) G13Q
Observed molecular mass Cleavage site numbered with respect to the
(Da) wild-type Mc. capsulatus (8ath) protein 8
sequence
16300 G13Q intact
14700 Ml~_QlJ
(iv) WTB
Observed molecular mass Cleavage site numbered with respect to the
(Da) wild-type Mc. capsulatus (8ath) protein 8
sequence
16230 WTB intact
14630 Ml~_GlJ
The cleavage sites identified for WTB and G13Q, MI2_GI3 and MI2_QI3respectively,
are equivalent to the main cleavage site observed within the wild-type Me.
capsu/atus (Bath) protein B, which results in protein B' formation (Bhambra, 1996).
Therefore, it would appear that the extra N-terminal amino acids, resulting from the
cloning system used for the expression of the recombinant proteins, do not affect the
cleavage site, as they are observed to be the same.
The greater molecular mass of recombinant Ms. trichosporium OB3b protein B
compared to that of the wild-type protein reflects the fact that the recombinant
protein contains an extra two N-terminal amino acids, as a result of the cloning
system used ..This difference seems to have affected the cleavage sites, as they differ
for the wild-type and recombinant proteins." Nevertheless, the cleavage occurs in
roughly the same area of the N-terminal region of the proteins, as in the recombinant
protein it occurs on the N-terminal side of the TIS residue, whereas in the native
protein it occurs on the C-terminal side of the same amino acid. Therefore, it may be
possible that sterlc effects are responsible for the cleavage as it occurs at
approximately the same place, but is not amino acid specific. These data could
suggest that the site could be a certain distance away from a particularly nucleophilic
amino acid side chain group on the surface of the protein core. This could react with
the flexible N-terminus of protein B specifically at this point, irrespective of the
amino acids present at this position. Interestingly, the main cleavage site for
recombinant Ms. trichosporium OB3b protein B (KI4_TIS)is two amino acid residues
further from the N-terminal than the cleavage sites of WTB and G13Q. This could be
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because the core regions of the two proteins differ slightly, so it is possible that a
specifically reactive side chain group may be in a slightly different position in the
two proteins. Alternatively, the flexibility of the N-terminal region of the two
proteins may differ to some extent as a result of their slightly different amino acid
compositions.
4.4 The role of protein B' within the sMMO system
It has been proposed that protein B' formation could occur as a general regulatory
mechanism, possibly in response to certain conditions, such as those of copper
excess, in order to control the amount of active protein B within the cell. Thus, the
inactivation of the sMMO system by the formation of protein B' would allow the
conservation of energy within the cell, as it would prevent the wasteful oxidation of
NADH in the absence of, for example, substrate (Kazlauskaite et al., 1996; Lloyd et
al., 1997). However, other proteins, which are known to undergo cleavage reactions
either by autocatalytic mechanisms or specific proteolysis reactions, do so as a
means of enzyme activation (Perler et al., 1997). Thus it cannot be ruled out that the.
formation of protein B' may have an activatory role within an alternative system yet
to be elucidated.
It has been shown that protein B' binds weakly to the hydroxylase of sMMO but has
no effect on the redox potential value of the hydroxylase, unlike protein B which
lowered the redox potential value, thus enabling oxygen activation to occur
(Bhambra 1996; Kaslauskaite et al., 1996). Therefore, it is seen to be important to
identify any functions of protein B' to determine if it has any role within the sMMO
system.
4.4.1 Sequence similarity searching
The approach was taken to elucidate if protein B' had any other function than that of
inhibiting sMMO activity. Comparison of sequence similarity searches for protein B'
to the results obtained for protein B was conducted. This was in order to elucidate
whether the loss of the 12 amino acids from the N-terminus of protein B would
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identify a protein with a more significant sequence similarity to protein B' than
protein B, for which activity could then be determined.
for Information
The BLAST (Basic Local Alignment Search Tool) program available from the
wasNational BiotechnologyCentre (NCBI) used
(http://www.ncbi.nlm.nhi.govIBLASTI) to reveal sequence similarity for proteins B
and protein B' from Me. capsulatus (Bath) to other known protein sequences. This
program was used to search for similarity between the query sequences and
sequences in the peptide database (using BLASTP). The results obtained are shown
in Figure 4.3.
Figure 4.3: Hit list from BLASTP report showing sequences producing significant alignments to
(i) protein B' and (ii) protein B.
Sequences producing significant alignments are detailed with their accession numbers. Score and E
values are indicated.
(i) Me. eapsulatus (Bath) protein B'
Sequences producing significant alignments:
splP187971MMOB METCA METHANE MONOOXYGENASE REGULATORY PROTE .
pdbl1CKVI Structure Of The Soluble Methane Monooxygenase .
dbj1BAA84753.11 (AB025021) soluble methane monooxygenase re •..
splP273561MMOB METTR METHANE MONOOXYGENASE REGULATORY PROTE .
gbIAAC45291.11- (U81594) soluble methane monooxygenase prote .
9bIAAF01270.1IAF153282_3 (AF153282) MmoB [Methylocystis sp .
gb1AAB58743.11 (AF001356) TbhD [Burkholderia cepacia]
dbj1BAA07113.11 (D37875) coupling protein [Nocardia corallina]
splQ004591TMOD PSEME TOLUENE-4-MONOOXYGENASE SYSTEM PROTEIN ...
gbIAAB09621.11- (U04052) toluene-3-monooxygenase ferredoxin .'.
pirllS44305 phenol hydroxylase - Pseudomonas putida >giI483 ...
splP197311DMPM PSESP PHENOL HYDROXYLASE P2 PROTEIN (PHENOL
pirllS47416 phenolhydroxylase chain C - Pseudomonas put ida ...
(ii)Me. eapsulatus (Bath) protein B
Sequences producing significant alignments:
splP187971MMOB METCA METHANE MONOOXYGENASE REGULATORY PROTE .
pdbl1CKVI Structure Of The Soluble Methane Monooxygenase .
dbj1BAA84753.11 (AB025021) soluble methane monooxygenase re .
splP273561MMOB METTR METHANE MONOOXYGENASE REGULATORY PROTE .
9bIAAC45291.11- (U81594) soluble methane monooxygenase prote .
9b1AAF01270.11AF1532823 (AF153282) MmoB [Methylocystis sp .
9b1AAB58743.11 (AF001356) TbhD [Burkholderia cepacia]
dbj1BAA07113.11 (D37875) coupling protein [Nocardia corallina]
SplQ004591TMOD PSEME TOLUENE-4-MONOOXYGENASE SYSTEM PROTEIN .
9bIAAB09621.11- (U04052) toluene-3-monooxygenase ferredoxin .
pirllS44305 phenol hydroxylase - Pseudomonas put ida >giI483 .
sp1P19731!DMPM PSESP PHENOL HYDROXYLASE p2 PROTEIN (PHENOL
pirllS47416 phenolhydroxyla&e chain C - Pseudomonas put ida ...
Score E
(bits) Value
263 3e-70
263 3e-70
182 1e-45
169 8e-42
169 1e-41
168 2e-41
40 0.007
37 0.060
37 0.078
32 2.0
32 2.6
32 2.6
31 4.5
Score E
(bits) Value
289 5e-78
287 3e-77
198 3e-50
182 2e-45
181 2e-45
179 8e-45
40 0.008
37 0.069
37 0.090
32 2.3
32 3.0
32 3.0
31 5.2
No differences were observed for the sequences identified as having similarity to
proteins B and B'. However, the (Expect) E-values, which provide an estimate of the
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statistical significance, indicated that protein B' was more similar to, for example,
the regulatory proteins of toluene monooxygenase and phenol hydroxylase than
protein B itself, as indicated by the lower E-values. sMMO has a wide substrate
range, although previous work on protein B' has only shown it to be inactive when
oxidising propylene (Bhambra, 1996). Therefore, it is possible that the formation of
protein B' changes the substrate specificity of sMMO enabling it to oxidise only
larger substrate molecules, such as toluene or benzene, as suggested by the increase
in similarity to the regulatory proteins of these larger substrate molecule oxidising
enzymes.
4.4.2 Can sMMO oxidise large substrate molecules when protein B' is used as
the regulatory protein?
sMMO can oxidise benzene to phenol (Green and Dalton, 1989; Jiang, 1993). GC
analysis (Chapter 2, Section 2.12) indicated that the product of benzene oxidation,
phenol, had a retention time of ~2.24 minutes. Assays were conducted using 8 J.lMof
each hydroxylase, reductase and either protein B or protein B' and 10 mM benzene.
Samples were incubated at 45°C for 30 seconds before a~dition of 5 mM NADH.
Samples were analysed by GC after 3 and 30 minutes incubation at 45°C.
Phenol, produced from benzene oxidation, was observed by the peak at retention
time ~ 2.24 minutes for the assay samples containing sMMO. However, no peak
corresponding to phenol was observed for "the sMMO assay samples containing
protein B' in place of protein B. This suggested that protein B' was definitely
inactive within the sMMO system and thus did not function in permitting the enzyme
to oxidise only larger substrate molecules, for which benzene is typical.
4.4.3 Does protein B' bind to the hydroxylase?
As protein B' is known to be inactive within the sMMO system, it was necessary to
accurately confirm if proteirt B' bound to any significant degree to the hydroxylase.
This would, therefore, identify whether the reason for the inactivity of protein B'
was due to an inability to bind effectively to the hydroxylase or whether it related
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more specifically to the actual absence of the first 12 N-terminal ammo acids.
Previous studies have used surface plasmon resonance to indicate that protein B'
bound much more weakly than protein B to the hydroxylase (Bhambra 1996; Lloyd
et ai., 1997). Similarly the binding of protein B' to the hydroxylase was also
determined using direct electrochemistry (Kazlauskaite et ai., 1996). Work by Jiang
et ai. (1993), indicated that protein B inhibited the hydroxylase when functioning via
the peroxide shunt mechanism. Therefore, studies were undertaken to determine if
protein B' could inhibit the hydroxylase when functioning via the peroxide shunt
reaction, as this would indicate whether B' could bind effectively to the hydroxylase.
Assays of propylene oxidation by the H202-coupled reaction with hydroxylase were
effected in the presence of proteins B and B'. Product formation was monitored by
GC (Chapter 2, Section 2.12) after 10 minutes incubation (Figure 4.4).
Figure 4.4: The effect of proteins Band B' on the oxidation of propylene in the hydroxylase
IH202 system.
HzOrcoupled propylene oxidation assays (Chapter 2, Section 2.12.3) contained 24 ~M hydroxylase,
100 mM HzOz and proteins Band 8' at 0, 25, and 50 ~M concentrations. Reactions were incubated
for 10 min before injecting 500 ul of the gas phase of the reaction onto a calibrated Porapak Q GC
column for product quantification. Enzyme activity is shown as a percentage of the activity of the
hydroxylase activated via the peroxide shunt mechanism which represents 550.3 nmol propylene
oxide produced (9.2 nmol/min/mg). The activities presented are the mean of 3-4 separate experiments.
Standard error bars are shown.
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A slight inhibition of activity was observed for the hydroxylase functioning via the
H202 system in the presence of protein B' compared to the effect observed for
protein B itself. This suggested that protein B' binds to the hydroxylase but not as
strongly as protein B as it is insufficient to cause the dramatic effect observed by
protein B. This is consistent with the conclusion of previous workers (Bhambra,
1996; Kazlauskaite et al., 1996; Lloyd et al., 1997).
4.5 Does protein B' exist within sMMO-expressing cells?
Protein B' has been purified from sMMO-expressing Me. eapsulatus (Bath) and Ms.
triehosporium (OB3b) cells. Previous work by Lloyd et al. (1997) indicated that
protein B' formation only occurred upon cell breakage, as analysis of whole cell
lysates and soluble extracts of sMMO-expressing Me. eapsulatus (Bath) cells
indicated only the latter to contain protein B'. However, the method of capturing the
proteins contained within the sMMO-expressing methanotroph cells was modified to
,
answer this question. Samples of the sMMO-expressing cells were removed from
chemostat cultures in which they were growing under oxygen-limiting conditions
(Chapter 2, Section 2.2.4). The cells were boiled immediately in SDS-PAGE sample
loading buffer, thus capturing the proteins released upon cell lysis but without
allowing time for degradation to occur before addition of the denaturant. The
samples were centrifuged for 10 minutes at 10.000 x g before analysis by SDS-
PAGE and subsequent Western blotting, probing with antibodies to proteins B and
B' from Me. eapsulatus (Bath) (Figure 4.5). Cells were verified to be sMMO-
expressing by means of the naphthalene assay (Chapter 2, Section 2.2.7) and controls
containing purified Me. eapsulatus (Bath) protein B and Ms. trichosporium OB3b
protein B confirmed the binding and cross-reactivity of the antibodies (data not
shown).
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Figure 4.5:Western blot of proteins Band B' in sMMO-expressing Me. capsulasus (Bath) and
Ms. trichosporlum OB3b whole cells.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Me. capsulatus (Bath) cells expressing sMMO.
Lane 3: Ms. trichosporium OB3b cells expressing sMMO.
Lane 4: Me. capsulatus (Bath) cells expressing pMMO.
1 2
66
45
36
29
24
3 4
l
JJ(" Protein BMc. eapsulatus (Bath)
._ Protein BMs. triehosporium (OB3b)
..___Protein B' Mc. eapsulatus (Bath)
The Western blot (Figure 4.5) clearly identified protein, B' as being present in
sMMO-expressing cells of Me. eapsulatus (Bath) but not present in those of Ms.
triehosporium OB3b. The control samples of pMMO-expressing Me. eapsulatus
(Bath) cells confirmed the absence of sMMOwithin pMMO-expressing cells.
It is unclear why protein B' should be present' in sMMO-expressing cells of one type
of methanotroph and not the other. Experiments were conducted to determine
whether the addition of copper to Me. eapsulatus (Bath) cells altered the level of
protein B or protein B' during the conversion of the cells to pMMO expression.
However, the levels of proteins B and B' remained constant throughout the time
course until the cells expressed pMMO.
llO
4.6 Structural analysis of proteins Band B'
Until very recently, when the NMR structures of protein B from both Me. eapsulatus
(Bath) and Ms. triehosporium OB3b were published (Chang et al., 1999; Walters et
al., 1999), no information was available on the structural characteristics of protein B.
Studies were undertaken to determine the structural features of protein B and protein
B' and hence by comparison of the two, it was hoped that information on the
possible reason(s) for the inactivity of protein B' could be determined.
4.6.1 Secondary structure analysis of protein Band B'
Techniques sensitive to the secondary structure content of proteins, which could be
interpreted to give information on the differences between proteins B and B', were
pursued. The techniques of circular dichroism (CD), fluorescence, and Fourier
Transform Infrared Spectroscopy (FTIR) were used. '
4.6.1.1 Circular dichroism analysis
CD can be used to give secondary structure information. CD measurements made in
the far UV region (170-250 nm) report on the backbone structure of the protein, as at
these wavelengths contributions made to the spectra are dominated by the
contributions of peptide bonds. CD bands 'in the near UV region (250-300 nm)
originate from the aromatic amino acids and are very small in the absence of ordered
structure and represent a highly sensitive criterion for the native state of a protein,
and thus can be used as a fingerprint of the correctly folded conformation.
Near and far UV CD analyses were conducted on samples of WTB, G13Q and
recombinant Ms. triehosporium OB3b protein B, and their equivalent protein B'
proteins (WTB', G13Q protein B' and recombinant Ms. triehosporium OB3b protein
B') produced after incubation of the intact protein samples at 20°C for 24 hours.
Figures 4.6 and 4.7 show the CD spectra obtained.
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Figure 4.6: Far UV CD spectra of (i) WTB and WTB', (ii) G13Q and G13Q B' and (iii)
recombinant Ms. trichosporium OB3b protein B and recombinant Ms. trichosporium OB3b
protein B'.
The CD spectra were recorded on a Jasco 1715 spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each protein (0.12 mg/ml in 50 mM
phosphate buffer, pH 7) in a 1 mm pathlength quartz cuvette.
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Figure 4.7: Near UV CD spectra of (i) WTB and WTB', (ii) G13Q and G13Q B' and (iii)
recombinant Ms. trichosporium OB3b protein B and recombinant Ms. trichosporium OB3b
protein B'.
The CD spectra were recorded on a Jasco 17IS spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each protein (O.S mg/ml in SOmM
phosphate buffer, pH 7) in a 1 em pathJength quartz cuvette.
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These spectra indicate that no significant secondary structure change accompanied
protein B' formation for WTB, G13Q and recombinant Ms. trichosporium OB3b
protein B. In all cases far UV CD gives evidence of a-helix and p-sheet character;
the minima at 208 nm, 222 nm and maximum at 192 nm, indicate a moderate
proportion of a-helical character and the minimum at 215 nm indicates p-sheet
character to also be present. However, recombinant Ms. trichosporium OB3b protein
B is seen to be more a-helical than WTB and G13Q, as it has a more pronounced
minimum at 208 nm.
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The near UV CD data for the intact and truncated proteins for WTB and G 13Q
indicated that a slight change in the environments of the aromatic amino acids was
present. Upon truncation a weak increase in molar ellipticity was observed, which
indicated a minor change to occur in the packing and tertiary structure of the
proteins. This effect is not so pronounced for recombinant Ms. trichosporium OB3b
protein B where both the recombinant Ms. trichosporium OB3b protein B and
recombinant Ms. trichosporium OB3b protein B' spectra have approximately the
same molar ellipticity values at each wavelength. In this case the lack of change in
the near UV CD spectra suggests that the aromatic amino acids and their
environments remain unchanged, and, thus, packing and tertiary structure of the
protein remain the same upon truncation.
4.6.1.2 Fluorescence analysis
Studies of the structures of protein B and protein B' also involved a comparison of
the fluorescence spectra obtained for proteins WTB and WTB', G13Q and G13Q B',
and recombinant Ms. trichosporium OB3b protein B and recombinant Ms.
trichosporium OB3b protein B'. Fluorescence spectra provide a sensitive means of
characterising proteins and their conformations and are determined principally by the
polarity of the environment of the tryptophan and tyrosine residues and their specific
interactions. Figure 4.8 shows the fluorescence spectra obtained for samples of
WTB, G13Q and recombinant Ms. trichosporium OB3b protein B, and their
equivalent protein B' proteins (WTB', G13Q protein B' and recombinant Ms.
trichosporium OB3b protein B') produced after incubation of the intact protein
samples at 20°C for 24 hours.
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Figure 4.8: Fluorescence spectra of (i) WTB and WTB', (ii) G13Q and Gl3Q B' and (iii)
recombinant Ms. trichosporium OB3b protein B and recombinant Ms. trichosporium OB3b
protein B'.
The fluorescence spectra were recorded on a Perkin-Elmer LF-50 fluorimeter at room temperature
with excitation at 280 nm (Chapter 2, Section 2.17). The spectra shown are sum of 8 scans of each
protein (0.5 mg/ml in 50 mM phosphate buffer, pH 7)in a 3 ml quartz cuvette with a 10 mm
pathlength.
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The fluorescence spectra obtained for each protein show that a slight decrease in
fluorescence intensity correlates with protein B' formation. However, the Amax value
for the intact and truncated proteins remains the same at 338 nm in each case. These
data suggest that a quenching effect is occurring upon truncation. This indicates that
there is a change in the interactions of the tyrosine and tryptophan amino acids of the
proteins with their neighbouring groups.
Overall these data indicate that truncation has a slight effect on protein B structure.
They suggest that truncation alters the packing of the intact active protein B, as
determined by fluorescence analysis. However, the effect did not cause a significant
change in the secondary structural characteristics of the protein, as determined by far
DV CD, although a minor change in the tertiary structure was also visualised, as
determined by near UV CD.
4.6.1.3 Fourier transform infrared spectroscopy (FTIR)
Fourier transform infrared spectroscopy (FTIR) was also pursued to gain information
on any secondary structural changes that occur to protein B upon truncation to
protein B'. IR spectra give details on molecular vibrations, which can be interpreted
to give molecular conformation information. Unlike CD, which, in general, can only
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give details on the proportion of a-helix content of a protein reliably, FTIR provides
better estimates of the content of ~-structure and, therefore, the techniques
complement each other effectively.
FTIR experiments were carried out in collaboration with Dr. Alan Wilkinson
(University of Birmingham, UK) to analyse the secondary structure changes that
occurred upon truncation of the intact protein WTB, G13Q and recombinant Ms.
trichosporium OB3b protein B to their truncated protein B' proteins. The proteins
(0.5 mg/ml, MOPS buffer pH 7) were incubated at 20 QCand samples were removed
at 0, 24 and 48 hours for analysis by FTIR. Details of sample preparation and
analysis by FTIR spectroscopy are given in Chapter 2, Section 2.19. Figure 4.9
illustrates the change in secondary structure observed for the various samples.
Figure 4.9: Amide I band fitting results for the FTIR spectroscopy data for (i) WTB, (ii) G13Q
and (iii) recombinant Ms. trichosporium OB3b protein B giving the secondary structure content
for each protein after incubation at 20°C at 0 h, 24 hand 48 h.
FTJR spectra of each of the protein (8 mg/ml in 50 mM deuterated sodium phosphate buffer) were
recorded at room temperature using a Bruker IFS 66 FTIR spectrometer equipped with an MCT
detector. Single beam spectra were collected which consisted of 256 scans. Data was collected at 2
cm" wavenumber resolution (Chapter 2, Section 2.19).
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These FTIR data show there to be a decrease in p-character for both proteins WTB
and G13Q as the proteins become truncated to their protein B' equivalents over 24
hours incubation at 20°C. After truncation the structure remains roughly the same
after a further 24 hours incubation. Little structural change is observed for
recombinant Ms. trichosporium OB3b protein B upon truncation.
4.6.2 Crystallography studies
Attempts have been made to crystallise the Hydroxylase - Protein B complex from
sMMO of Ms. trichosporium OB3b (Elango et al., 1997). Although crystals were
obtained, no density for protein B in the crystal structure was shown in the electron
density map. However, the crystals of the hydroxylase grown under these conditions
were of a different crystal form from those grown in the absence of protein B,
although the conformations of the hydroxylase in the two forms were essentially
identical. Previous studies have indicated that the interaction of protein B and the
hydroxylase alters the structure of the hydroxylase and that these alterations reverse
slowly upon protein B dissociation (Liu et al., 1995). In the crystal structure of the
hydroxylase grown in the presence of protein B, one dimer is rotated slightly relative
to the other. It is unclear whether this observation has any relevance to the
physiological role of protein B (Elango et al., 1997).
Until very recently, little was known ab<?ut the tertiary structure of protein B.
Obtaining crystal structures of proteins B and B' would provide invaluable
information, which could help explain the precise role and function of protein B
within the sMMO complex, and the effect on its structure of the loss of the 12 N-
terminal amino acids to form protein B' .
In collaboration with Dr. R. McKenna, (University of Warwick, UK) screening for
crystals of protein BIB' by both the hanging drop and microbatch methods was
carried out to test over 1200 conditions (Chapter 2, Section 2.22). Weakly diffracting
crystals with an average geometry of approximately 0.1 mm x 0.25 mm x 0.25 mm
were obtained by the micro batch method under conditions of 18 % PEG 8 K, 25 mM
lithium sulphate, 25 mM Tris-HCl pH 7 (Figure 4.10).
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Figure 4.10: Photograph showing the crystalline entities of protein BIB'.
Weakly diffracting 'quasi' crystals obtained by the microbatch method under conditions of 18 % PEG
8 K, 25 mM lithium sulphate, 25 mM Tris-Hel pH 7.
The crystallisation trial shown (Figure 4.10) contains needle-like structures radiating
from a central nucleation point. Crystalline entities are visible towards the edges and
can be seen by the light polarization effects. Seeding of. these crystals failed to
produce crystals of improved quality. Even though this work did not produce any
well diffracting stable crystals for structural studies, the production of even the small
'quasi-crystals' is, nonetheless, a major step towards this goal.
4.6.3 Dimer studies of proteins Band B'
Protein B 'from Methyloeystis sp. strain M has been shown to exist as a dimer
(Shinohara et al., 1998). Protein B from Ms. trichosporium OB3b has been observed
as having a molecular weight of 31 kDa, suggesting that it too may be capable of
existing as a dimer (Fox et al., 1989; Chapter 3). Similar observations have also been
made for Me. eapsulatus (Bath) protein B (Bhambra, 1996). Since the hydroxylase is
a dimer it is logical that protein B may exist as a dimer, so that each hydroxylase
monomer can interact with a protein B monomer for activity. Thus, the extra dimer
interactions of protein B may serve to provide extra stabilisation of the Hydroxylase
- Protein B complex. Therefore, it is important to determine accurately whether
protein B exists, as a dimer as this can aid in furthering the understanding of the
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component interactions of sMMO necessary for activity. Alternatively, it is possible
that protein B' forms dimers and it is these that have been observed, mistakenly as
protein B dimers. It is possible that it is this occurrence that results in the inactivity
of protein B within the sMMO system. Therefore, various techniques have been used
to determine whether proteins B or B' exist as dimers in solution.
4.6.3.1 PAGE analysis of protein B
Analysis of wild-type Me. capsulatus (Bath) protein B', WTB and recombinant Ms.
trichosporium OB3b protein B by SDS-PAGE indicated them to run at their
expected molecular weight values, although a band at 30 kDa was often observed for
the proteins run on SDS-PAGE. This band was indicated to be that of protein BIB'
by Western blot analysis, probing with antibodies to protein BIB' (data not shown).
Therefore, it appeared that the proteins could exist as 'dimers' even after
denaturation for SDS-PAGE analysis, whilst some of the protein was observed as
running in the correct position. Native-PAGE analysis proved difficult in actually
assigning weights for the proteins, although they were observed as running at values
higher than ~ 16 kDa, and often 2 bands were observed. This data suggested that the
proteins were possibly capable of existing as dimers, but ~ould exist as monomers at
the same time.
To determine whether dimer formation was as a result of a disulphide bond between
to monomers of the proteins, SDS-PAGE was carried out on samples treated with
and without ~-mercapto-ethanol, a reducing agent which breaks such bonds. SDS-
PAGE analysis indicated the treated and untreated samples to be the same, both with
a weak band at ~ 30 kDa.Native PAGE analysis gave the same results. Overall,
PAGE analysis proved inconclusive in identifying accurately the presence of protein
B or protein B' dimers, but did provide evidence of their transient existence.
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4.6.3.2 Molecular size determination
Size exclusion chromatography can be used to indicate the molecular size of proteins
by a comparison of their relative mobilities on the column compared to that of the
protein standards used in the calibration of the column. It would indicate whether the
proteins existed as monomers or dimers, or a mixture of the two. It was noted that
anomalous running of proteins on the column can also occur.
Samples of the proteins GI3Q, WTB, wild-type Me. eapsulatus (Bath) protein Band
B', recombinant and wild-type Ms. trichosporium protein B were subjected to size
exclusion chromatography on a Superdex 75 FPLC column (Chapter 2, Section 2.9)
and the elution volume for each was recorded and the molecular size inferred from
the calibration curve. The results obtained for the molecular size of each of the
proteins are shown in Figure 4.11.
Figure 4.11: Size exclusion chromatography of G13Q, WTB, wild-type Me. capsulatus (Bath)
protein Band B', recombinant and wild-type Ms. trichosporlum OB3b protein B.
Data displayed are the means of 3 separate experiments. Error bars are displayed.
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The molecular sizes inferred from the data show that the proteins do not elute at the
expected molecular size of ~ 16 kDa. However, G13Q, WTB and wild-type Me.
capsulatus (Bath) protein B all eluted at approximately the same retention time,
indicating them to be very similar or the same in shape and size, as would be
expected. This was also the case for recombinant Ms. trichosporium OB3b protein B
and wild-type Ms. trichosporium OB3b protein B. Protein B', known to be smaller
than its intact predecessors, eluted to give a correspondingly smaller molecular size,
but one which was still greater than that expected for its molecular weight. Also, the
smaller wild-type and recombinant Ms. trichosporium OB3b proteins eluted to give
higher molecular sizes than the recombinant Me. capsulatus (Bath) based proteins,
WTB and the single mutant G13Q. The values do not correspond to 'dimers' of the
proteins, so this would imply that the proteins are eluting as a reflection of their
different shapes, and do not infer their weights. Also, only one elution peak was
observed for each protein, so the proteins are not identified as existing as mixtures of
monomers and dimers under these conditions. This work is in agreement with recent
work by Brandstetter et al. (1999), where it was also found that protein B from Me.
capsulatus (Bath) eluted at an anomalously high molecular size value.
4.6.3.3 MALDI- ToF MS analysis of protein B
The use of mass spectrometry in the analysis of native protein conformation has
proved difficult, particularly because of the denaturing conditions required for
ionising molecules for mass measurements. However, recently matrix assisted laser
desorption ionisation time of flight mass spectrometry (MALDI- ToF MS) has been
used in the determination of native protein molecular weights by modification of the
sample preparation procedures to provide non-denaturing conditions required for the
stability of the protein (Karas et al., 1989, 1990; Glocker et al., 1996). Thus in this
study, in collaboration with Dr. Anne-Mette Hoberg (Department of Biological
Sciences, University of Warwick, UK), sample preparation procedures were
modified to create non-denaturing, 'softer' conditions to see if the protein could be
observed in the dimer conformation.
A Proflex III MALDI- ToF mass spectrometer was used for the analysis of
recombinant Ms. trichosporium OB3b protein B (Chapter 2, Section 2.16.1). The
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MALDI- ToF 'dried-droplet' sample preparation method resulted in a distinct peak at
15008.9 Da and a very low intensity peak at 29956.2 Da, possibly the dimer.
Similarly, analysis of Me. eapsulatus (Bath) protein B' by the same method gave
distinct peaks at 14635.4 Da (B') and 13277.6 Da (another cleavage product) and
very low intensity peaks at 29214.9 Da and 25006.3 Da, which could correspond to
the respective dimers (Figure 4.12).
Figure 4.12: Analysis of (i) recombinant Ms. trichosporium OB3b protein Band (ii) wild-type
Me. capsulatus (Bath) protein B by MALDI-ToF mass spectrometry.
The MALDI-ToF MS of the proteins were recorded on a Bruker Proflex III MALDI-ToF mass
spectrometer. Data were recorded by a 1GHz Le Croy digitiser and analysed by Bruker Xtof 3.1.0.
software. Data displayed as mass to charge ratio (mlz) against arbitary intensity (a.i.) (Chapter 2,
Section 2.16.1).
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This study provided evidence for the protein existing predominantly in the monomer
form but that dimer formation was identifiable' under certain conditions.
4.6.3.4 Sedimentation equilibrium analysis
Analytical ultracentrifugation experiments on proteins WTB, protein B' and G13Q
were conducted in collaboration with Dr. N. Errington (National Centre for
Molecular Hydrodynamics, University of Leicester, UK) in order to determine
Whether the proteins existed as dimers in solution.
By means of sedimentation equilibrium experiments in the analytical ultracentrifuge,
changes in molecular weight, when molecules associate to form more complex
structures such as dimers, can be studied. The technique provides a method of
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determining the molecular weight of the complex as it exists in solution, and
estimating the binding constants of the interactions between the components.
Sedimentation equilibrium experiments were conducted on samples of WTB, protein
B' and G13Q (Chapter 2, Section 2.21). The association of the proteins in solution is
a function of their behaviour during sedimentation and can be distinguished from
non-specific aggregation by analysis of residual plots after fitting the data to
particular models of association. The data for WTB, G13Q and protein B' fitted
poorly to the single ideal species model with WTB and G13Q indicating self-
association behaviour. The deviation to the model encountered for protein B' (Figure
4.13) was proposed to be due to either protein degradation occurring, possibly by
means of the truncation reaction, or due to the non-ideality phenomena, which has
the effect of reducing the apparent molecular weight obtained by sedimentation
equilibrium analysis. The data for WTB and G13Q were fitted to self-association
models from which a K<t for each was deduced. Good data fits were obtained for the
self-association models for WTB and G13Q based upon the residuals to the fit
(Figures 4.14 and 4.15). Nevertheless, it was possible that non-ideality effects were
present for WTB and G13Q due to their high level of similarity to protein B'.
However, as non-ideality and self-association have opposing affects upon the
molecular weight obtained, it was impossible to extricate one from the other. For this
reason, the K, and K, values have to be quoted as estimates based on the data
analysis conducted here, and in the light of the results obtained for protein B', cannot
be stated as being precise values.
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Figure 4.13: Sedimentation equilibrium profiles for protein B' at (i) 1 mg/ml and (ii) 2 mg/ml.
Graphs display the fit of the sedimentation equilibrium data (coloured circles) to the single ideal
species model (black line) at the given speeds,
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Figure 4.14: Sedimentation equilibrium profiles for WTB at (i) 1 mg/ml and (ii) 2 mg/ml.
Graphs display the fit of the sedimentation equilibrium data (coloured circles) to the monomer-dimer
self-association model (black line) at the given speeds,
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Figure 4.15 Sedimentation equilibrium profiles for G13Q at (i) 1 mg/mt and (ii) 2 mg/mt.
Graphs display the fit of the sedimentation equilibrium data (coloured circles) to the monomer-dimer
self-association model (black line) at the given speeds.
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These data obtained from the sedimentation experiments are summarised in Table
4.2 and are conclusive in the findings that protein B' does not self-associate to any
significant degree, whereas WTB and the G13Q mutant show an equilibrium
between monomeric and dimeric forms. From the dissociation constants it can be
seen that the interaction between the G13Q peptides i~ approximately 10 times
weaker than that observed with WTB.
Table 4.2: Sedimentation equilibrium analysis data summary.
Protein Molecular mass from K. (rom monomer- K, from monomer-
single ideal species fit dimer fit (M-I) dimer fit (11M)
(Da)
WTB 21365 25100 40
B' 10540 NA NA
GI3Q 20307 3019 330
Although, the experiments failed in accurately identifying dimers of proteins B or
B', they did provided evidence for their transient existence under certain non-
specific conditions. Nevertheless, proteins B and B' have been identified as fairly
similar in that they cause the proteins to give anomalously high values by Size
exclusion chromatography. However, the overall structures of wild-type Me.
capsulatus (Bath) proteins B and B' are suggested to differ, as a difference of ~ 8
kDa is observed between their experimental molecular size values when the loss of
the first 12 N-terminal amino acids corresponds to only 1.2 kDa. Therefore, the first
12 N-terminal amino acid residues are inferred to contribute to the particularly
anomalous migration of protein B on the size exclusion column, possibly implying
that these few amino acids are responsible for a structural difference. Studies by
sedimentation equilibrium analysis have also identified that the loss of 12 amino
acids from the N-terminus of protein B has reduced its level of self-association to be
insignificant, when compared to the level obtained for the intact protein. In this
respect the difference between the intact and truncated proteins is highlighted.
4.6.4 Biophysical characterisation of proteins Band B'
The techniques of small angle X-ray scattering (SAXS) and atomic force microscopy
(AFM) were used to further compare the structures of proteins B and B'. SAXS can
be used to determine the solution structure of proteins at relatively low resolution
and can, therefore, provide valuable information on the overall shape of a protein
molecule. Similarly, AFM was used to probe for differences in the conformation of
the two proteins.
4.6.4.1 Small angle X-ray scattering (SAXS)
SAXS studies were carried out in collaboration with Drs. Jill Trewhella and Steve
Gallagher (Los Alamos National Laboratory, USA) (Chapter 2, Section 2.25). The
solution scattering profiles for each were measured (Figure 4.16). Scattering data
were collected for proteins G13Q and protein B' over a range of concentrations from
2-15 mg/ml, in 25 mM MOPS, pH 7, 13 QC. For each component there was no
concentration dependence of scattering data, indicating that interparticle interference
effects .were negligible and hence no correction was required. The vector length
distribution functions for each component, calculated as the inverse Fourier
transform of the scattering profiles, are shown in Figure 4.17. A significant increase
in dmax was observed for protein B' compared to G13Q. The best-fit ellipsoid models
for G13Q and protein B' have approximate dimensions 50, 34, 30 A and 66, 28, 27
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A respectively. These models give reduced 'X: values of 1.01 and 1.02 respectively,
indicating a near perfect fit (which would have "I: = 1.0) to the scattering data. As a
measure of the discrimination between these fits to the data, the scattering data for
G13Q can be compared to the best fit ellipsoid determined for protein B' which
gives an X2 = 12.5. Vice versa, the experimental data for protein B' compared to the
best fit model for G13Q gives X2 = 13.0. The measure of the 10 values and molecular
volumes show that both protein G13Q and protein B' are monodisperse in solution,
indicating that the observed changes in structural parameters cannot be attributed to
aggregation (Table 4.3). Thus, protein B' is identified as being structurally longer
and thinner than protein G13Q.
Figure 4.16: Solution scattering profiles (/(Q) versus Q data) for G13Q (.) and protein D' (0).
The solid lines represent the model I(Q) profiles calculated using uniform ellipsoids for G 13Q and B'.
The error bars are based on counting statistics only.
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Figure 4.17: Vector length distribution functions (p(r) functions) for G13Q (.) and protein B'
(0).
The experimentally derived values are indicated by (.) G 13Q and (0) B'. The solid lines are the P(r)
functions calculated for the models indicated in Figure 4.16.
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Table 4.3: Kg, dm... and molecular volumes for proteins G13Q and protein B'.
Protein Kg (A) c: (A) Measured 10 (arbitrary Measured Expected
units) volume (A3) volume (A3)
Gl3Q 17.5±0.9 50 3950±150 19200±3100 19400
B' 19.8±0.9 70 3650+160 20300±1700 17900
The observed extension of the structure upon removal of the N-terminal segment of
protein B, therefore, must be due to a partial unfolding or to some sort of opening of
the structure triggered by the loss of interactions with the N-terminal residues.
4.6.4.2 Atomic force microscopy (AFM)
Atomic force microscopy, otherwise known as scanning force microscopy, was
invented in 1986 (Binnig et al., 1986). It is a powerful tool for the investigation of
biological structures, yielding a three dimensional image at low resolution. The
technique is based on the movement of a sharp tip at the free end of a soft cantilever
which scans over a samples keeping the tip at almost touching distance from the
sample surface. The tip and cantilever movement is coupled to an optical readout
system for monitoring the bending of the cantilever induced by the surface
topography, and digitally reproduces the topography of the sample surface.
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In collaboration with Mr. Bernie Sattin (Department of Chemistry, University of
Toronto, Canada) samples of proteins G13Q and protein B' were immobilised on
mica and air dried. The samples were imaged by tapping mode AFM in air, using a
TESP (diving board cantilever) oscillated at its resonance frequency to a free
amplitude of approximately 30 nm. Once the AFM was engaged in imaging,
parameters were controlled to achieve a high resolution image with minimal tip-
samples interaction (Chapter 2, Section 2.26). The images obtained for proteins
G13Q and protein B' are shown in Figure 4.18.
Figure 4.18: Tapping mode AFM images of (i) G13Q and (ii) protein B'.
Labelled are samples of each protein and their aggregates.
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The images indicate that under the conditions of the experiment protein B' tended to
aggregate more than protein G13Q. The volumes corresponding to the immobilised
protein molecules were calculated for each protein to determine the observed
volumes for each, as displayed in Figure 4.19.
Figure 4.19: Distribution of the observed volumes of (i) protein G13Q and (ii) protein B'.
Observed volumes data analysed using Origin™ 4.10 software (Microcal Software Inc., USA).
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The data distribution was identified as being bimodal for protein B', whereas this
was not the case for G13Q, confirming the observations that protein B' was
aggregating under the conditions of the experiment. The first peak was considered to
be that of protein B' alone and the second peak, the aggregates formed. Gl3Q was
shown to have a volume of ~ 30 nnr', whereas protein B' was observed to have a
volume of ~ 40 nnr'. This is in agreement with the SAXS data which indicated
protein B' to be larger than G13Q, although due to the differences in the two
techniques (SAXS which studies the protein in solution whereas AFM analysis was
conducted on dried protein samples), the volumes obtained in each case could not be
compared. Nevertheless, the AFM results similarly support the idea of an opening of
the protein B molecule upon protein B' formation due to the fact that a larger volume
is observed for protein B' .
4.7 Conclusion
The ability to separate proteins B and protein B' by chromatofocusing lead to
analysis which suggested that autocatalysis was the most likely cause of the cleavage
of Me. eapsulatus (Bath) protein B. This was supported by the evidence for a
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nucleophilic amino acid side chain group being present as a means of mediating the
cleavage reaction. These results, together with previous studies in which the addition
of protease inhibitors and expression of recombinant protein B in protease-deficient
strains of E. coli failed to prevent the cleavage reaction (Bhambra, 1996; Lloyd et
al., 1997), further support the autocatalysis mechanism as being responsible for the
cleavages observed.
The identification of the various truncates of protein B, recombinant and wild-type,
from both Me. capsulatus (Bath) and Ms. trichosporium OB3b suggests the N-
terminal region of the protein to be flexible. This has recently been verified by the
.,
elucidation of the NMR structures of the two methanotrophic proteins (Chang et al.,
1999; Walters et al., 1999). Studies into the possible mechanism of cleavage
identified a hydrolytic mechanism as being involved and that the initiation of the
reaction could occur via a nucleophilic side chain group coming into contact with the
flexible N-terminal region. Thus, the slight differences in the structures of these two
proteins could be responsible for the slight differences in the sites of cleavage
observed. These would suggest steric effects, caused by the different amino acid
sequences giving the proteins slightly different structures, to be involved in
determining the site(s) of cleavage. Nevertheless, the proteins both become N-
terminally truncated, presumably by the same mechanism, and in this respect remain
similar.
Protein B' has not been identified as having a functional role within the sMMO
system, although binding studies suggest it to bind weakly to the hydroxylase. The
presence of protein B' within the sMMO-expressing Me capsulatus (Bath) cells,
would suggest it has a function, although it is possible that this may not relate to the
sMMO system.
Structurally proteins B and B' are similar. Evidence from CD, fluorescence, SAXS,
and AFM suggests an 'unpacking' occurs upon truncation, which changes the shape
of the protein, but does not alter the secondary structure content significantly. This
'unpacking' could be the reason for protein B' binding less strongly, if at all, under
certain conditions to the hydroxylase. The data also do not give information on the
structure of the N-terminal region of protein B, as upon its loss no significant change
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in secondary structure is observed. Therefore, the N-terminal region can be identified
as being relatively unstructured.
The techniques of PAGE, SIze exclusion chromatography, MALDI- ToF mass
spectrometry and sedimentation equilibrium analysis all provided weak evidence for
dimer formation for wild-type Me. capsuatus (Bath), wild-type and recombinant Ms.
trichosporium OB3b protein B, GI3Q, WTB and protein B', suggesting that self-
association was possible. SAXS, however, provided no evidence for this.
Nevertheless, the extent of dimer formation, as monitored by the different
techniques, varies, and all suggested the monomer form to be the dominant species.
Therefore, association of monomers to form dimers appeared to be possible under
certain conditions, but was not necessarily the native form of the protein. These data
were in agreement with the work of Chang et al. (1999) and Fox et al. (1991), where
limited dimer formation was observed for Ms. trichosporium OB3b protein B in
solution under various conditions. The studies however, failed to identify dimer
formation as a major difference between the intact and truncated forms of protein B
and it, therefore, does not represent the means by which protein B' is inactive within
the sMMO system.
Very recently the structures of protein B from Me. capsulatus (Bath) and Ms.
trichosporium OB3b have been determined by NMR analysis (Chang et al., 1999;
Walters et al., 1999). Nevertheless, the progress achieved with regard to the
crystallisation of Me. capsulatus (Bath) protein BIB' is important as the NMR
structures failed to give definitive structure to the whole of the N-terminal region of
the protein: The resolution of a crystal structure of intact protein B is still vital in
elucidating the nature of the important N-terminal region and its orientation with
respect to the core of the protein. Even the production of the small quasi-crystals
identified here is a major step towards achieving this aim. The crystallisation trials
may, however, have been hindered by the low level of stability of the protein,
possibly due to the 'flexible' N-terminal region of the protein enabling cleavage
reactions to occur. Thus, the need to stabilise the protein against such cleavage
reactions is highlighted, not only for improving the possibility of obtaining larger,
stable, well diffracting crystals, but also for other experiments on protein B to be
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conducted without interference from the cleavage reaction. This issue is considered
in Chapter 5.
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Chapter 5
Stabilisation of Protein B by Biochemical Methods
5.1 Introduction
The stabilisation of protein B against irreversible inactivation via truncation to
protein B' is of major importance, if further studies of the protein are to be possible.
The truncation process constantly poses immense difficulties when conducting
biochemical and structural analyses, as the protein readily degrades. The problem
has partly been overcome for Me. eapsulatus (Bath) protein B by the mutation of the
Glyl3 residue to a glutamine (Lloyd et al., 1997), which has reduced the rate of the
cleavage reaction enabling analysis of the protein to be possible. However, the G13Q
mutant still degrades to form its protein B' equivalent, known as G13QB', at the
Metl2-Glnl3 site (numbered with respect to the wild-type protein B sequence), which
corresponds to the site of cleavage within the wild-type protein (Chapter 4).
Therefore, minimising inactivation is crucial for the successful study of the protein
itself and with respect to the sMMO system.
Since the first observations of the truncation of Me. eapsulatus (Bath) protein B
(Pilkington et al., 1990), various attempts have been made to stabilise the protein
against this occurrence. The addition of protease inhibitors during the purification
procedure of native wild-type protein B failed to prevent truncation occurring (Lloyd
et al., 1997), as did purification under methane saturating conditions, anaerobic
conditions and in the absence of freeze-thaw cycles (Bhambra, 1996). Such
conditions have been shown in the past to prevent the inactivation of other enzymes.
Surveying a range of conditions under which the stability of the enzyme may be
improved was, therefore, considered worthwhile. The aim of the work presented in
this Chapter was to determine whether any conditions could be found that would
suppress protein B' formation.
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5.2 Effect of protein concentration and temperature on stability
Increasing protein concentration can affect the stability of a protein, as it makes the
environment around the protein similar to that of the cell. Within cells, proteins are
subject to the influence of high concentrations of various macromolecules, often
amounting to concentrations of hundreds of mg/ml. Thus, although biochemical
experiments try to reproduce quasi physiological conditions of temperature, pH and
salt concentrations, rarely are proteins observed experiencing the effects of the
typically high concentrations of various macromolecular species found in
physiological media. Such physiological media are referred to as 'crowded'.
Crowding favours the formation of compact structures and macromolecular
complexes and decreases the diffusional mobility of macromolecules (Ralston, 1990;
Minton, 1997). In some circumstances these factors can aid in increasing protein
stability. Therefore, optimising levels of protein concentration can be important. A
decrease in protein concentration, although lowering the possible rate and degree of
aggregation, increases the exposure of the protein to the solvent environment, which
may ultimately promote the autocatalytic degradation observed. A delicate balance
of non-covalent forces including, hydrophobic, ionic and van der Waals interactions
as well as hydrogen bonds, holds the native catalytic form of protein B together.
Upon exposure to adverse environmental conditions, such as low protein
concentrations, these forces can be weakened or broken, resulting in partial or total
unfolding of the protein (Creighton, 1989). "This in turn may enhance the possibility
of the cleavage reaction occurring, leading to inactivation.
Similarly, inactivation can occur due to heat, as thermal unfolding of the enzyme can
take place. This exposes reactive groups and hydrophobic areas that can
subsequently react, possibly causing the cleavage reaction observed for protein B.
Although sMMO is most active at 45°C, at this temperature the protein interactions
of the components may be stabilising one another, particularly when present within
the cell environment where more protective agents may be present. However, the
purified protein alone within only a buffer environment, would be expected to
experience the destabilising effects previously described (Creighton, 1989).
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5.2.1 Analysis by SDS-PAGE
The technique of SDS-P AGE is useful in clearly identifying the presence of intact
and truncated versions of protein B within a given sample. Studies into the effect of
temperature on samples of G13Q and recombinant Ms. trichosporium OB3b protein
B were monitored over a 6 hour time period at 20, 45 and 60°C (Figure 5.1).
Figure 5.1: SDS-PAGE analysis of G13Q and recombinant Ms. trichosporium OB3b protein B
after incubation at (i) 20°C, (ii) 45°C and (iii) 60 °C for 0 h, 2 h, 4 hand 6 h.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, }6 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lanes 2-5: Gl3Q (-1.5 mg/ml) at 0 h, 2 h, 4 h, 6 h respectively after incubation.
Lanes 6-9: recombinant Ms. trichosporium OB3b protein B (- 1.5 mg/ml) at 0 h, 2 h, 4 h, 6 h
respectively after incubation.
Each lane contained - 5 ug protein.
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SDS-PAGE analysis indicated that temperature does not affect the cleavage rate of
G13Q or recombinant Ms. trichosporium OB3b protein B, as the level of truncation
"
remained approximately the same over time in each case (Figure 5.1).
Similarly, SDS-PAGE was used to monitor the effect of concentration on the
stability of proteins G13Q, recombinant Ms. trichosporium OB3b protein B, and
WTB over time at 6 mg/ml and 0.25 mg/ml for 24 hours at 20°C (Figure 5.2).
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Figure 5.2: SDS-PAGE analysis of (i) G13Q and recombinant Ms. trichosporium OB3b protein
Band (ii) WTB after incubation at 6 mg/ml and 0.25 mg/ml for 24 h at 20 DC.
(i) Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: G 13Q 6 mg/ml, 0 h incubation at 20°C.
Lane 3: G I3Q 6 mg/ml, 24 h incubation at 20°C.
Lane 4: G 13Q 0.25 mg/ml, 0 h incubation at 20°C.
Lane 5: G 13Q 0.25 mg/ml, 24 h incubation at 20°C.
Lane 6: Recombinant Ms. trichosporium OB3b protein B 6 mg/mI, 0 h incubation at 20 DC.
Lane 7: Recombinant Ms. trichosporium OB3b protein B6 mg/ml, 24 h incubation at 20°C.
Lane 8: Recombinant Ms. trichosporium OB3b protein B 0.25 mg/ml 0 h incubation at 20°C
Lane 9: Recombinant Ms. trichosporium OB3b protein B 0.25 mg/m124h incubation at 20°C
(ii) Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin "inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: WTB 6 mg/mI, 0 h incubation at 20°C.
Lane 3: WTB 6 mg/ml, 24 h incubation at 20°C.
Lane 4: WTB 0.25 mg/mI, 0 h incubation at 20°C.
Lane 5: WTB 0.25 mg/ml, 24 h incubation at 20°C.
Each lane contained - 5 ug protein.
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Analysis for the presence of truncation of the proteins indicated that G13Q was more
stable to cleavage at higher concentrations. The single G 13Q band on the gel (Figure
5.2 (i), Lane 3) indicated that intact protein was present in the 24 hours, 6 mg/ml
sample, when compared with the same protein at higher dilution after 24 hours
where many bands were visible (Figure 5.2 (i), Lane 5), indicating protein truncation
to have occurred. Less of a difference in stability was observed for WTB and
recombinant Ms. trichosporium OB3b protein B incubated for the same length of
time at the 2 levels of concentration. For WTB and recombinant Ms. trichosporium
OB3b protein B, about the same degree of truncation was identified as occurring in
both samples (Figure 5.2 (ii) and Figure 5.2 (i), Lanes 6-9).
5.2.2 Analysis of protein B' formation by activity measurement
The truncation observed for the samples WTB and G13Q resulted in the production
of their protein B' equivalents, amongst other truncates. As protein B' is inactive, its
inactivity can be used to monitor the differences in the amount of protein B'
formation in each of the samples at the different concentrations over time (Figure
5.3). However, it was unknown whether the cleavage of Ms. trichosporium OB3b
protein B resulted in inactivity within the sMMO system. Analysis of this protein,
using the same strategy as that for WTB and G13Q, was undertaken to elucidate this.
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Figure 5.3: sMMO propylene oxidation assays of (i) WTB, (ii) G13Q and (iii) recombinant Ms.
trichosporlum OB3b protein B after incubation at 20°C at concentrations of 0.5 mg/ml and 6
mg/mt.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.1) were performed by adding 8 11M
aliquots of hydroxylase and reductase to 8 11Mof protein B. Enzyme activity is shown as a percentage
of the activity remaining after incubation compared to the activity at 0 h. 100% activity represents;
1956 nmollmin/mg G 13Q, 1896 nmol/min/mg WTB and 1267 nmol/min/mg recombinant Ms.
trichosporium OB3b protein B. The activities presented are the mean of 3-4 separate experiments.
Standard error was ~ 10 %.
(i)
120
100
~~
~ 80.>..u 60<C
Q)
E 40:0-
N
C
W
0
0 20 40 60 80
Time (h)
(ii)
120
100
~e.... 80
~:~
ti 60«
Q)
E
~ 40ew
20
0
0
,---------------------------.-------------,
10 20 . 30 50 706040
Time (h)
145
-+-WTB
6mg/ml
--WTB
O.Smg/ml
-+-G130
6mg/ml
-G130
O.Smg/ml
80
(iii)
~ 100
;,S!
0
~:~ 80
t)
<C
Cl> 60E
>.
N
c:
w 40
20
0
0
--+- rec OB3b B
6mg/ml
--- rec OB3b B
O.5mg/ml
10 20 30 40
Time (h)
50 60 70 80
The pattern of protein degradation observed to occur over time at different
concentrations is illustrated by the decrease in enzyme activity (Figure 5.3). The high
level of cleavage observed for G 13Q at low protein concentrations is similarly
indicated by the rapid decrease in activity, compared to the sample incubated at the
higher protein concentration level which retains activity (Figure 5.3 (ii)), and was,
identified as being intact. Little difference in cleavage levels was observed by SDS-
PAGE. for the two samples of recombinant Ms. trichosporium OB3b protein B and
correspondingly, there is no real difference in the decrease in activity over time for
them (Figure 5.3 (iii)). Nevertheless, the loss of activity is correlated with truncation,
so Ms. trichosporium OB3b protein B is seen to undergo the same process of
inactivation upon cleavage to form protein B'. WTB shows a greater decrease in
activity for the sample incubated at the lower protein concentration (Figure 5.3 (i)),
although only an ~ 40 % loss in activity is observed for the higher protein
concentration, a difference which could not be clearly distinguished by gel analysis
alone.
5.2.3 Analysis of truncate formation by ESI-MS
ESI-MS was used to study the cleavage levels which occurred after incubation at 20
QC at the different concentrations of 6 mg/ml and 0.5 mg/ml. This technique enabled
the assignment of the number and type of cleavage products within the different
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samples of each protein. Samples of proteins WTB, G13Q and recombinant Ms.
trichosporium OB3b protein B were incubated at 20°C at concentrations of 0.5
mg/ml and 6 mg/ml. The samples were then analysed by ESI-MS and data processed
using the MassLynx program (VG Biotech). The results are shown in Tables 5.1-5.3.
Table 5.1: ESI-MS analysis ofWTB samples at (i) 0.5 mg/ml and (ii) 6 mg/ml after incubation at
20°C for various time periods.
The ESI-MS of the proteins were recorded on a Quattro II tandem mass spectrometer with an
electrospray ion source and data were processed using the MassLynx program (VG Biotech) (Chapter
2, Section 2.16.1). Data in bold indicates the predominant protein peale
(i) ..
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Mc. capsulatus (Bath) protein B
sequence
0 16230.0 Intact
24 16230.0 Intact
14752.0 SI_V2and OI32_RI33
14630.0 M12_GI3
13740.0 A2°_D21and H139_A140
13620.0 G1I9_N120
13570.0 Q22_F23
(ii
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Mc. capsulatus (Bath) protein B
sequence
0 16230.0 Intact
24 16230.0 Intact
14630.0 M12_GI3
36 16230.0 Intact
14630.0 M12_GI3
13620.0
"
G1I9_N120
48 14630.0 MIZ_G1J
13740.0 A2°_D21and H139_A140
13620.0 G119_N120
Table 5.2: ESI-MS analysis of G13Q samples at (i) 0.5 mg/ml and (ii) 6 mg/ml after incubation
at 20°C for various time periods.
The ESI-MS of the proteins were recorded on a Quattro II tandem mass spectrometer with an
electrospray ion source and data were processed using the MassLynx program (VG Biotech) (Chapter
2, Section 2.16.1). Data in bold indicates the predominant protein peak.
(i)
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Mc. capsulatus (Bath) protein B
s~uence
0 16300.0 Intact
24 16300.0 Intact
14273.6 G16_K17
13420.5 F23_F24
13261.0 G119_N120
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(h.
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Mc. capsulatus (Bath) protein B
sequence
0 16300.0 Intact
24 16300.0 Intact
48 16300.0 Intact
14700.0 M12_Q13
72 16300.0 Intact
14700.0 MI2_QI3
Table 5.3: ESI-MS analysis of recombinant Ms. trichosporium OB3b protein B samples at (i) 0.5
mg/ml and (ii) 6 mg/ml after incubation at 20 QC for various time periods.
The ESI-MS of the proteins were recorded on a Quattro II tandem mass spectrometer with an
electro spray ion source and data were processed using the MassLynx program (YG Biotech) (Chapter
2, Section 2.16.1). Data in bold indicates the predominant protein peak.
(i)
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Ms. trlchosporium OB3b protein B
sequence
0 15026.8 Intact
24 15027.0 Intact
13280.0 K14_T15
11590.0 Q29_y30
(ii)
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Ms. trickosporium OB3b protein B
sequence
0 15026.8 Intact
24 15028.6 Intact
13280.0 K14_T15
48 15028.6 Intact
13280.0 K14_T15
72 15029.0 Intact
13280.0 , K14_T15
For both WTB and G13Q at 0.5 mg/ml (Figures 5.1 (i) and 5.2 (i)) many cleavages
were identified by ESI-MS, correlating with the decrease in activity observed for the
same protein in the sMMO assay. Also correlating with the assay results were the
data for the concentrated samples of WTB and G13Q (Figures 5.1 (ii) and 5.2 (ii))
for which fewer cleavages were seen, and the dominant protein present in each case
was the intact protein. However, for low protein concentrations of recombinant Ms.
trichosportum OB3b protein B, an extra cleavage product was observed (Figure 5.3
(i)) equivalent to the B" cleavage site observed in wild-type Me. eapsulatus (Bath)
protein B (Bhambra, 1996), and the cleavage site identified in Methyloeystis sp.
Strain M (Shinohara et aI., 1998). However, the amounts of the cleavages present in
the recombinant Ms. trichosporium OB3b protein B sample were very low,
correlating with the similar activity observed at time 0 hours and 24 hours for both
samples. For the WTB and G13Q protein samples at the higher protein
concentration, after 24 hours incubation, the main cleavages occurring were N-
terminal in nature, whereas for the low protein concentration samples, N- and C-
terminal cleavages were observed. This indicates that cleavage at the higher protein
concentration was more N-terminally orientated than that at lower concentration.
This observation was in agreement with the identification that at higher protein
concentrations the protein was more stable and presumably less unfolded than at low
dilutions, where upon increased exposure to the solvent environment appears to
promote degradation at the C-terminus.
5.3 Effect of additives on the stability of protein B
Salts can exert effects on proteins that are dependent on both the concentration and
nature of the salt. NaCI and MgCh can reduce the solubility of hydrophobic groups
on the protein molecule by increasing the ionic strength of the solution. These salts
can also enhance water clusters around the protein, resulting in a loss in the total free
energy of the system, as the entropy of water decreases. These two effects together
can stabilise proteins by causing the process of the 'salting-out' of hydrophobic
residues leading to the molecule becoming more compact (Creighton, 1989). In the
case of protein B this may reduce the flexibility of the N-terminal region of the
protein, so limiting the cleavage reaction.
Glycerol has long been known to be capable of stabilising enzymes in solution
(Gekko and Timasheff, 1981). The molecule has a high content of hydroxyl groups
and is, therefore, capable of forming multiple hydrogen bonds and can act like water.
Thus glycerol can cause 'preferential hydration', a thermodynamic phenomenon
(Schachmann and Lauffer; 1949) which causes a microscopic phase separation
between the protein and the solvent, resulting in a stabilising effect.
Enzymes have been known to be inactivated by reaction with heavy metals, such as
mercury and lead. However, in this case the transition metal, copper, was considered
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as possibly exerting an effect on protein B, as it is vitally important in Me.
eapsulatus (Bath) and Ms. triehosporium OB3b cells in determining whether sMMO
or pMMO is expressed (Stanley et al., 1993). Therefore, in an attempt to re-create
the cellular environment with the intention of enhancing the stability of protein B,
studies into whether copper would have a stabilising effect on protein B were
conducted.
To monitor the effect of different reagents on the' truncation of protein B, SDS-
PAGE was used. The single mutant of protein B, G 13Q, was studied as this protein
has already been shown to be more stable than wild type protein B (Lloyd et al.,
1997; Chapter 3) and, therefore, it was considered useful to investigate the
possibility of enhancing its stability further. Also, since the G13Q protein behaves
the same as the wild-type protein B, as far as cleavage is concerned, any conclusions
drawn about this mutant would apply to the wild-type protein. Thus, samples of
G13Q (~ 1 mg/ml) were incubated with either 10 mM NaCl, 10 mM MgCh, 15 %
glycerol or 80 ~M CUS04 for 24 hours and samples taken at time 0 and 24 hours
were compared (Figure 5.4). The control samples contained no reagent.
Figure 5.4: SDS-PAGE ofG13Q incubated for 24 b in different testsolutions,
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: G 13Q 1mg/ml, 0 h incubation at 20°C.
Lane 3: G 13Q 1mg/ml, 24 h incubation at 20°C.
Lane 4: G 13Q 1 mg/ml, 0 h incubation at 20°C with NaCI (10 mM).
Lane 5: G 13Q 1 mg/ml, 24 h incubation at 20°C with NaCI (10 mM).
Lane 6: G 13Q 1mg/ml, 0 h incubation at 20°C with MgCl2 (10 mM).
Lane 7: G13Q 1mg/ml, 24 h incubation at 20°C with MgCh (10 mM).
Lane 8: G 13Q 1mg/ml, 24 h incubation at 20°C with CUS04 solution (80 f.1M).
Lane 9: G 13Q 1mg/ml, 24 h incubation at 20°C with glycerol (15 %).
Each lane contained - 5 ug protein.
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In all cases cleavage to form the truncates of G13Q occurred. On closer examination
it appeared that possibly slightly more intact G13Q was retained when the protein
was incubated with MgCb (Figure 5.4, Lane 6) compared to the control samples and
other test solutions. However, the use of visual inspection was too subjective to be a
reliable measure of stabilisation. Therefore, sMMO activity was used to elucidate
which solutions stabilised G13Q against truncation. Propylene oxidation assays were.
carried out for 1 mg/ml protein samples in the test solutions containing either 10 mM
NaCI, 10 mM MgCb, 80 !J.M CUS04 or 15 % glycerol after 0 and 24 hours
incubation at 20 QC(Figure 5.5).
Figure 5.5: sMMO propylene oxidation assays of G13Q after incubation in different test
solutions for 0 hand 24 h at 20°C.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.2) were performed by adding 8 !!M
amounts of hydroxylase and reductase to 8 !!M of protein G 13Q contained within the different test
solutions. Enzyme activity is shown as a percentage of the activity remaining after incubation
compared to the activity at 0 h for G l3Q with no additives. 100 % activity represents; 1956
nmol/minlmg G 13Q. The activities presented are the mean of 3-4 separate experiments. Standard
error bars are shown.
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The sMMO assays (Figure 5.5) indicated that MgCb had a stabilising effect on
G13Q as it retained ~ 15 % more activity than the other solutions tested and the
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control sample, which were all virtually inactive after the 24 hour incubation period.
Also the assays indicated that the activity of the sMMO complex itself could be
improved by the addition ofNaCI and MgCh to the system at a concentration of 1.3
mM (equivalent to the addition of81lM G13Q from 1 mg/ml in 10 mM salt), as seen
by the improved activities for the time 0 hour incubations for these two test
solutions. Further assays were, therefore, conducted to determine whether activity
could be improved by the addition of higher concentrations of the two salts to the
sMMO assay system. Propylene oxidation assays were conducted in the presence of
various concentrations ofNaCI and MgCh (Figure 5.6).
Figure 5.6: sMMO propylene oxidation assays conducted in the presence of NaCI and MgCh at
various concentrations. .
sMMO propylene oxidation assays (Chapter 2, Section 2.12.12) were performed by adding 8 f..lM
amounts of hydroxylase and reductase to 8 f..lMof protein G 13Q and various concentrations of salts.
Enzyme activity is shown as a percentage of the activity compared to the activity for G13Q containing
no additives. 100 % activity represents; 1956 nmol/minlmg G 13Q. The activities presented are the
mean of 3-4 separate experiments. Standard error bars are shown.
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The assays indicated that NaCI and MgCh added at certain levels increased the
activity of the sMMO complex (Figure 5.6) and so suggest that the salts were
improving the interactions of the components and thus enhancing activity.
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5.3.1 Effect of metals on protein B
It was noted, from SDS-PAGE analysis (Figure 5.4), that incubating G13Q in the
presence of copper had the effect of causing the formation of a protein band at 30
kDa. It was proposed that this could correspond to dimer formation, although it was
unusual that the dimer should not have been broken into its constituent monomers
when boiled in the presence of reducing agents and denaturants (f3-mercaptoethanol
and SDS). It was proposed that copper-induced dimer formation may provide a
means of stabilising protein B, as reduced truncate formation was identified for the
samples incubated in copper, compared to the copper-free control sample (Figure
5.4). Although incubation for 24 hours with copper resulted in the proteins
inactivation within the sMMO assay, it was important to elucidate the effect copper
was having on G13Q to prevent truncate formation and cause dimerisation.
Therefore, studies proceeded to determine the effect of copper on G13Q as well as
WTB and protein B', and to compare it to the effect observed of other metals on the
proteins. Thus, the effect of copper, cadmium, magnesium and zinc on GI3Q, WTB
and protein B' were tested by native-PAGE analysis. Protein (0.12 mg/ml) was
incubated with solutions of each of the metals (20 IlM - 80 IlM copper and 20 IlM of
the other metal salts) at 20°C for ~ 4 hours (Figure 5.7).
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Figure 5.7: Native-PAGE analysis of (i) G13Q, (ii) WTB and (iii) protein B' in the presence of
different metals
(i) Lane 1: Molecular weight markers (jack bean urease, 272 kDa (trimer) and 545 kDa
(hexamer); bovine albumin, 66 kDa (monomer) and 132 kDa (diroer); egg albumin, 45 kDa; bovine
carbonic anhydrase, 29 kDa; bovine milk Cl-lactalbumin, 14.2 kOa).
Lane 2: G 13Q.
Lane 3: G 13Q + 20llM Cu.
Lane 4: G 13Q + 25 IlM Cu.
Lane 5: G 13Q + 30 IlM Cu.
Lane 6: G 13Q + 40 IlM Cu.
Lane 7: G 13Q + 80 IlM Cu.
Lane 8: G 13Q + 20 IlM Cd.
Lane 9: G 13Q + 20 IlM Zn.
Lane 10: G 13Q + 20 IlM Mg.
Each lane contained - 5 ug protein.
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(ii-iii) Lane 1: Molecular weight markers (jack bean urease, 272 kDa (trimer) and 545 kDa
(hexamer); bovine albumin, 66 kDa (monomer) and 132 kDa (dimer); egg albumin, 45 kDa; bovine
carbonic anhydrase, 29 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: WTB/B'
Lane 3: WTB/B' + 20 I-lMCu
Lane 4: WTB/B' + 25 I-lMCu
Lane 5: WTBIB' + 40 I-lMCu
Lane 6: WTB/B' + 80 I-lMCu
Lane 7: WTB/B' + 20 I-lMCd
Lane 8: WTBIB' + 20 I-lMZn
Lane 9: WTBIB' + 20 I-lMMg
Each lane contained ~ 5 ug protein.
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Native-PAGE analysis demonstrated that copper had an effect on the proteins unlike
that of any of the other metals tested (Figure 5.7). The proteins incubated in
solutions of increasing copper concentrations were observed to run differently, and
could indicate dimer formation. Alternatively, it could be a charge effect causing the
proteins to run at a value indicative of a higher molecular weight than the values
expected. Also with increased copper concentration a reduction in truncate formation
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was identified. This was observed by the reduction in or the lack of bands on the gels
corresponding to truncates for the protein samples incubated with copper, compared
to the control samples and samples incubated with cadmium, zinc and magnesium. In
an attempt to further understand the 'copper effect' it was important to determine
whether the proteins were capable of binding copper.
5.3.2 Does protein B bind copper?
Although initial analysis of the protein sequence did not reveal any obvious copper-
binding site, in the absence of any structural data for the protein at the time of this
work, the coordination of copper binding residues was unknown and so the
possibility could not automatically be ruled out. After all, for some reason the
presumptive dimers were formed and lack of truncation observed for protein B in the
presence of copper, and there must be a reason to explain the sudden change in the
character of the protein. G13Q was used for further analysis to determine if copper
bound, as the protein had been shown to be more stable than WTB (Lloyd et al.,
1997).
5.3.2.1 Copper affinity column studies
The approach was taken to determine whether G13Q would bind to copper by using
a HiTrap® affinity column (Amersham Pharmacia Biotech, Bucks., UK). The
chelating sepharose media within the column was charged with copper. Therefore,
the column would retain selectively only proteins that exposed complex forming
amino acids, such as histidine, on their surface.
A salt gradient of ammonium chloride was used to elute the bound protein from the
column. Thus, a linear gradient of the salt was used to determine the strength of
binding of the protein to the column. The addition of the metal chelating agent,
EDTA, to the column removed the bound copper for column regeneration.
G13Q in start buffer containing 9.02 M Na2HP04, 1M NaCI, pH 7.2 was loaded onto
the copper charged HiTrap® column and washed with 1 column volume of the same
buffer. A linear gradient from 0-100 % elution buffer containing 0.02 M Na2HP04, 1
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M NH4Cl, pH 7.2 was applied over 3 column volumes. Copper elution from the
column was achieved by washing the column with 1-2 column volumes of 0.02 M
Na2HP04, 1 M NaCl, 0.05M EDTA, pH 7.2 (Chapter 2, Section 2.7). The elution
profile is illustrated in Figure 5.8.
Figure 5.8: Elution profile ofG13Q run on a HiTrap® copper affinity column.
The protein elution profile (D) is displayed together with the corresponding elution buffer gradient
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The elution profile (Figure 5.8) indicates that G13Q bound efficiently to the affinity
column. A small amount of the protein eluted at - 50 % ammonium chloride elution
buffer (peak 1), but the rest of the protein remained bound to the column and was
only eluted when the copper itself was stripped from the column using the EDTA
wash buffer (peak 2). SDS and native-PAGE analysis of the fractions indicated both
peaks contained protein G13Q (Figure 5.9). It is important to note that copper
absorbed at 280 nm also and so contributed towards the absorbance of the second
peak.
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Figure 5.9: (i) SDS and (ii) Native-PAGE analysis of copper affinity column elution fractions
Lane 1: Molecular weight markers (SDS: bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-S-Pcdehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk u-lactalbumin, 14.2 kDa. Native:
jack bean urease, 272 kDa (trimer) and 545 kDa (hexamer); bovine albumin, 66 kDa (monomer) and
132 kDa (dimer); egg albumin, 45 kDa; bovine carbonic anhydrase, 29 kDa; bovine milk a-
lactalbumin, 14.2 kDa).
Lane 2: G 13Q sample used for analysis.
Lane 3: G 13Q after buffer exchange into start buffer.
Lane 4: G 13Q First elution peak 1 in 50 % elution buffer.
Lane 5: G13Q Blank track. •
Lane 6: G 13Q Second elution peak 2 in EDT A buffer solution.
Each lane contained ~ 5 ug protein.
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The G 13Q protein, which eluted with the copper stripped from the column during the
EDTA wash, remained as a dimer after SDS and native-PAGE analysis (Figure 5.9
(i) and (ii), Lane 6). The fraction eluted from the column by ~ 50 % ammonium
chloride elution buffer (peak 1), and thus presumably more weakly bound to the
column, was only observed as a dimer by native-PAGE analysis, and was visualised
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as the constituent monomers by SDS-PAGE analysis (Figure 5.9 (i) and (ii), Lane 4).
These data suggest that some of the copper could have remained bound to protein B
causing dimerisation in the case of the EDTA eluted fractions, thus retaining dimer
structure when analysed under denaturing conditions by gel electrophoresis.
It was considered that protein B' may behave differently to G13Q with regard to
copper binding, and that copper binding may be different between the two proteins,
possibly implicating a reason for the existence of protein B'. However, analysis of
protein B' by the same method of copper affinity chromatography on the HiTrap®
column gave the same results as those obtained for G13Q. This supported the notion
that the two proteins were indeed very similar, as they reacted in the same way when
treated with copper.
5.3.2.2 Fluorescence quenching studies
Fluorescence spectroscopy provides a sensitive means of characterising protein
conformation. The polarity of the environment of the tryptophan and tyrosine
residues of a protein and their specific interactions chiefly determines the nature of
the fluorescence spectrum obtained. The change in fluorescence intensity by the
addition of certain reagents provides a means to measure the accessibility of these
amino acids in the protein structure.
Fluorescence. quenching provides a method of probing the accessibility of tryptophan
residues to small molecules. This technique was used to analyse the effect of copper
on proteins G13Q, WTB and protein B'. Samples of each protein (0.12 mg/ml) were
incubated with increasing concentrations of copper between 20 - 80 IlM.
Fluorescence data for each were recorded (Figure 5.10).
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Figure 5.10: The effect of copper on the fluorescence spectra of (i) G13Q, (ii) WTB and (iii)
protein B'.
Protein (0.12 mg/ml ) was incubated with copper at various concentrations for ~ 1Omin at 20 QC.The
solutions were placed in a 3ml quartz cuvette with a 10 mM pathlength for fluorescence analysis. The
emission spectra were recorded at room temperature with excitation at 280nm on a Perkin-Elmer LS-
50 fluorimeter (Chapter 2, Section 2.17).
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As a quenching effect was observed (Figure 5.10), other metals were studied to
elucidate whether the effect was specific to copper. Cadmium, magnesium and zinc
metals were analysed by the same method. Samples of each protein (0.12 mg/ml)
were incubated with 20 f.!M concentrations of cadmium, magnesium and zinc.
Fluorescence data for each were recorded (Figure 5.11). The chloride salts of each
metal were used in each case.
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Figure 5.11: The effect of various metals on the fluorescence spectra of (i) G 13Q, (ii) WTB and
(iii) protein B'.
Protein (0.12 mg/ml) was incubated with various metals at 20 f..lMconcentrations for ~ 10 min at 20
"C. The solutions were placed in a 3 ml quartz cuvette with a 10 mM pathlength for fluorescence
analysis. The emission spectra were recorded at room temperature with excitation at 280 nm on a
Perkin-Elmer LS-50 fluorimeter (Chapter 2, Section 2.17).
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These data indicate that copper alone causes the quenching effect observed for
proteins GI3Q, WTB and protein B' (Figure 5.11). Also the copper quenching effect
appears to be saturable, as monitored by the decrease in fluorescence intensity at the
consistent Amax value of 337 nrn. Thus, at increased concentrations of copper above
40 J..l.M,the fluorescence quench reaches a plateau (Figure 5.12).
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Figure 5.12: Copper quenching of tryptophan fluorescence at 337nm for proteins G13Q, WTB
and protein B'.
Fluorescence emission intensities at 337 run were recorded after increasing concentrations of copper
chloride were added to samples of G 13Q, WTB and protein B' (0.12 mg/ml). Data have been
modified such that the fluorescence intensities at zero copper concentration are at the same value in
each case.
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Overall, copper was shown to bind to G13Q, WTB and protein B' and there was
seen to be little difference in the ability of eac~ of the proteins tested to bind to the
COpper. The quenching effect observed indicates that the binding of copper either
causes a conformational change or that tryptophan residues are very near to the
copper-binding site. There is no apparent change in the Amax values upon copper
quenching. This shows that water has not been excluded upon complex formation
between the protein and copper, as any decrease in polarity would be observed as
causing a shift to shorter wavelengths.
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5.3.2.3 Is the secondary structure of protein B affected by copper binding?
Since quenching of fluorescence had been observed upon addition of copper to
G13Q, WTB and protein B', it was possible that there may be a conformational
change taking place upon the binding of copper. Secondary structural analysis was
conducted to determine whether any change could be observed as a result of copper
addition. Far UV CD was used to analyse the secondary structures of proteins G13Q
and WTB to which were added increasing concentrations of copper. The results are
shown in Figure 5.13.
Figure 5.13: Far UV CD spectra ..of (i) G13Q and (ii) WTB in both the metal-free and copper-
complexed state.
The CD spectra were recorded on a Jasco 1715 spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each protein sample (0.12 rog/ml) in 50
mM phosphate buffer pH 7, with addition of varying concentrations of copper chloride, in a 1 mm
pathlength quartz cuvette.
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The spectra for G13Q and WTB suggest a very slight loss of ~ character, as observed
by the slight reduction in the peaks at 215 run, indicating more a-helical character to
be present upon addition of higher concentrations of copper (Figure 5.13). Apart.
from this very minor change, there is no apparent major change in the structures of
the proteins upon copper addition.
Thus, the copper-affinity column studies confirmed the ability of G13Q and protein
B' to bind copper. The fluorescence quenching observed was also indicative of the
binding of copper to WTB, G13Q and protein B', and also that copper was causing a
change in overall structure, as would be expected for dimer formation. The CD data
Suggested only a slight change in secondary structure to occur upon copper binding.
Therefore, the constituent monomers of the copper induced dimers must not be
significantly changed in secondary structure terms by the dimerisation event.
Reduced truncate formation was also identified for increased copper levels, as the
dimers of WTB, G13Q and protein B' were formed, suggesting that in some way the
dimer form stabilised the proteins against N-terminal cleavage.
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5.4 Conclusion
Biochemical methods have been used to determine how protein G13Q has been
stabilised towards the cleavage reaction. Protein concentrations have been found to
be important in improving the protein's stability. This observation was found not to
be so marked for WTB and was not observed for recombinant Ms. trichosporium
OB3b protein B, for which protein concentration appeared to play little part in
affecting the protein's stability. However, low protein concentrations induced C- and
N-terminal cleavages for both WTB and G13Q after 24 hours incubation, whereas at
high protein concentrations "only N-terminal cleavages were observed. By
comparison, only N-terminal cleavages were identified for recombinant Ms.
trichosporium OB3b protein B, irrespective of concentration. These data suggest that
protein concentration is affecting the proteins in different ways indicating that the
structures of each are slightly different, which makes them respond in slightly
different ways to the environmental effects experienced.
The addition of MgCh has also been shown to stabilise G1~Q by maintaining the
activity of the protein at low concentration after extended incubation time. This
result further supports the proposal that the protein per se, may be involved in
autocatalytic cleavage (Chapter 4). The Mg2+ ion is large with a positive charge and
so would be attracted to the protein's nucleophilic residue(s), thus preventing or
reducing the cleavage reaction. The additions of salts (NaCl or MgCh) to the sMMO
assay were shown to significantly increase the activity observed. This suggests that
the presence of salts in the assay mix could have improved the component
interactions thus leading to greater levels of activity. This result is in agreement with
the recent findings of Brandstetter et al. (1999), where it was identified that
hydroxylase binding to protein B was increased with the increasing ionic strength of
the solution, and suggests that the sMMO component interactions are dominated by
hydrophobic contacts.
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Although unable to provide a stabilising effect, copper was clearly shown to bind to
G13Q, WTB and protein B' and resulted in dimer formation. Also, it was evident
that the copper did not destabilise the protein, as it did not cause a rapid truncation
effect upon its addition to the proteins. No major secondary structural change
accompanied copper binding, so it is possible that the quenching of fluorescence,
observed for the proteins upon addition of copper, was due to copper binding close
to tryptophan residues, or to the induction of a tertiary structural change in the
protein, possibly one of dimer formation. Copper inactivated protein B within the
sMMO system. Furthermore, copper has already been shown to effect the sMMO
assay system by inhibition of the reductase (Green et al., 1985). In the present case,
copper was identified as a progressive inhibitor showing its effect only after 24 hours
incubation. Therefore, it was concluded that the copper level, being ~ 12.5 % of the
concentration used in the Green et al. (1985) studies, was insufficient to bring about
reductase inhibition within the sMMO assay. In this study copper inactivated protein
B, possibly as a result of binding to the protein and causing it to form dimers. This
could be of importance within the cell, when, upon the presence of increased copper
levels resulting in pMMO expression, the inactivation of protein B by binding
copper rapidly shuts down sMMO activity to prevent the wasteful oxidation of
NADH. Recently the stimulatory protein DmpM of phenol hydroxylase, which
shows strong sequence similarity to protein B, has been shown to exist in an active
monomer form as well as an inactive dimer form (Cadieux and Poulowski, 1999).
The inactive dimer form has been proposed to exist for the same reason of
preventing unnecessary oxidation of NADH under certain conditions. In an attempt
to monitor for dimer formation within sMMO-expressing Me. capsulatus (Bath) cells
undergoing the copper switch in response to increased copper levels, native-PAGE
and Western blot analysis, probing with antibodies to Me. capsulatus (Bath) protein
BIB', were used. Unfortunately the studies failed to accurately determine whether an
identifiable copper induced protein B dimer was present. These preliminary studies,
nevertheless, provide a rational framework within which further studies can be
planned and implemented.
Overall, these studies, although primarily attempting to stabilise protein B, have
giVen insights into the structure and characteristics of the protein. Also, a strategy for
Improving the stability of G13Q has been developed involving the addition of MgCh
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and maintaining the protein at high protein concentration levels. This is of vital
importance for future studies using protein G13Q, in preference to WTB, as the
protein has already been made more resistant to cleavage by the GI3 to glutamine
mutation. Thus, improving the stability of this protein further, by the modifications
proposed here, provides a protein which is suitable for use in place of wild-type
protein B for most experiments, particularly those which occur over extended time
periods, such as crystallography. The fact the MgC}z not only stabilises protein
G13Q but also improves the activity of the sMMO complex, possibly by improving
component interactions, also provides a starting point for attempting to crystallise
the whole sMMO complex.
It would also be of interest to determine if implementation of these modifications to
the purification procedures of native, wild-type protein B would improve the yield of
intact protein. Only then would it become clear whether or not the inactivation of the
protein could be truly overcome by biochemical means.
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Chapter 6
Effect of M12A:G 13Q Double Mutation on the Stability and
Structure of Me. capsulatus (Bath) Protein B
6.1 Introduction
The Me. eapsulatus (Bath) single mutant of protein B,' G 13Q, degrades to form a
truncate protein B' equivalent known as G13Q B'. The site of cleavage has been
identified as MetI2-GlnI3, numbered with respect to the wild-type Me. eapsulatus
(Bath) protein B sequence an.? equivalent to the cleavage site of the wild-type
protein (Chapter 4). It was important, therefore, to try and prevent cleavage at this
site by mutating the residues at the amino acid 12-13 position. This would also give
further information on the effect of any changes in the structure of protein B, caused
by the double mutation, with respect to its level of stability.
Alanine is a small, unreactive amino acid and for this reason was chosen to replace
the Metl2 residue at the cleavage site. The glutamine residue at position 13 of the
G13Q mutant protein B was retained, as this had already beenshown to be beneficial
in reducing the rate of protein B' formation (Lloyd et al., 1997). The intention was to
establish whether this double mutation could overcome protein B' formation. The
work in this chapter details the production and characterisation of the M 12A;G 13Q
protein B double mutant.
6.2 Construction of the double mutant MI2A:G 13Q of protein B
from Me. capsulatus (Bath)
To allow the direct comparison of the double mutant MI2A:G13Q to the single
mutant G13Q and recombinant wild-type protein B itself (WTB), the same system
Was used for its cloning and expression. G 13Q and WTB were both available as
GST-fusion proteins by expression of the vectors pGEX-G13Q and pGEX-WTB
respectively (Lloyd et al., 1997: Lloyd 1997). Thus, attempts were made to introduce
170
the M12A:G 13Q mutation into pGEX- WTB using the Unique Site Elimination Kit
(Amersham Pharmacia Biotech, Bucks., UK). Unfortunately this system failed to
produce the mutations. Therefore, the strategy of introducing the mutations by PCR
was adopted.
6.2.1 peR amplification and construction of vectors
The vector used for the construction of the double mutant protein with a GST tag
was pGEX-2T, which contains a 26 kDa GST gene (Sj26) of Shistosoma japonicum
under the control of an IPTG inducible tac promoter (Amersham Pharmacia Biotech,
Bucks., UK). Figure 6.1 details the construction of the GST-fused MI2A:G13Q
vector and Table 6.1 shows the primers used. The fragment of DNA, from PCR
amplification, which encoded the MI2A:GI3Q protein B double mutant, was ligated
into the pGEX vector and introduced into E. coli InvaF' by transformation.
Transformants were isolated and sequenced to reveal those which contained the
double mutant clones. Once identified the pGEX-MI2A:G 13Q vector was
transformed into protease deficient E. coli AD202 cells (Nakano et al., 1994) for
expression to be conducted.
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6.2.2 Expression ofpGEX-M12A:G13Q
Protein expression was achieved by induction of the transformed E. coli AD202 cells
at an ODS40 ofO.5 by addition of ImM IPTG at 37°C (Figure 6.2).
Figure 6.2: Growth curve of E. coli AD202 expressing M12A:G13Q mutant protein B from Me.
capsulatus (Bath).
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After addition of the IPTG, the cells continued to grow exponentially. Western blots
of Whole celllysates, probing with anti-serum to Me. eapsulatus (Bath) protein BIB'
Were undertaken on samples at 0, 2, 4 and 6 hours after IPTG induction. Proteins
with an approximate molecular mass of 42 kDa were identified which cross-reacted
with the Me. eapsulatus (Bath) protein BIB' antibody, thus confirming that this
protein probably represented GST-MI2A:GI3Q, consisting of the GST protein tag
of "" 26 kDa attached to the protein B double mutant of - 16 kDa, giving the
Observed molecular mass. Figure 6.3 indicates the accumulation of this protein.
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Figure 6.3: Western blotting of whole cell Iysates of E. coli AD202 transformed with pGEX-
M12A:G13Q.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lanes 2-5: Whole celllysates of E. coli AD202[pGEX-MI2A:G13Q] 0 h, 2 h, 4 hand 6 h
respectively after IPTG induction blotted with antisera to Me. capsu/atus (Bath) protein BIB'.
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To determine whether GST-M12A:G13Q was expressed as a soluble protein, soluble
extract was prepared and analysed by SDS-PAGE, which indicated over expression
of the protein by a large band at ~ 42 kDa. Also, propylene oxidation assays were
conducted (Chapter 2, Section 2.12.2) and confirmed that protein B activity was
present in the soluble fraction upon reconstitution of the sMMO system by addition
of 8 ~M aliquots of hydroxylase and reductase. Thus, further optimisation of
induction conditions was unnecessary, and the double mutant was identified as being
active.
6.2.3 Purification of M12A:G 13Q
The GST tag of the M12A:G13Q protein enabled rapid affinity purification to be
Possible. Purification was conducted using the procedure optimised for the
Purification of GST- Ms. trichosporium OB3b protein B, GST-WTB and GST-
G13Q, as detailed in Chapter 3, Section 3.4 and Chapter 2, Section 2.4. Using this
method, the MI2A:G13Q protein was obtained at a purity of ~ 95 %. Figure 6.4
illUstrates the final purification step of MI2A:G13Q from E. coli AD202 [pGEX-
MI2A:G 13Q].
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Figure 6.4: SDS-PAGE of the purification of M12A:G13Q protein B from E. coli AD202
[pGEX-M12A:G13Q).
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: Blank.
Lanes 3-5: Samples of peaks from S75 purification step.
Lane 6: Purified M 12A:G 13Q after concentration.
Each lane contained ~ 5 ug protein
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ESI-MS analysis confirmed the M12A:G 13Q protein to be pure and the sequence to
be correct, as a molecular mass of 16,240.0 Da was determined compared to the
expected molecular mass of 16240.14 Da. The mass spectrometry data also indicated
that no degradation had occurred during purification (Figure 6.5). These results
indicated that the protein was of sufficient purity for further analysis to be
undertaken.
Figure 6.5: ESI-MS of pure M12A:G13Q.
The ESI-MS of the sample was recorded on a Quattro II tandem mass-spectrometer with an
e1ectrospray ion source and the data was processed using the MassLynx program (VG Biotech)
(Chapter 2, Section 2.16.1).
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Work by Lloyd et al. (1997) had shown that the activity of the G13Q mutant was
comparable to the activity of WTB. Therefore, propylene oxidation assays (Chapter
2, Section 2.12.2) were conducted and determined the activity of MI2A:G 13Q to be
1995 ± 215 nmol/minlmg, compared to the activity of G13Q which was 1956 ± 117
nmol/minlmg
The activity ofMI2A:G13Q was, therefore, comparable to that of the G13Q mutant.
The mutation ofMI2 to alanine had not affected the activity of protein B. The double
mutant was also assayed for activity prior to the removal of the GST moiety. The
GST-MI2A:G13Q protein was also found to be active, which was in agreement with
the work of Lloyd et al. (1997); which had indicated GST-WTB and GST-GI3Q to
also be active.
6.3 Characterisation ofM12A:G13Q
Since the activity of the double mutant was identified as being comparable to that of
G13Q, it was necessary to determine the effect of the specific mutations incorporated
into protein B, on its stability, affinity for the hydroxylase and secondary structure.
6.3.1 Effect of mutation MI2A:G13Q on the stability of protein B
It was important to determine if the double mutation would prevent protein B
truncation from occurring. SDS-PAGE analysis of samples of MI2A:G13Q at 1
mg/ml, incubated at 20°C for 0 - 48 hours identified that the double mutant protein
underwent cleavage to form truncates (Figure 6.6).
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Figure 6.6: SDS-PAGE ofM12A:G13Q incubated at 20°C for 48 h.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lanes 2-8: MI2A:G 13Q 0 h, 4 h, 8 h, 12 h, 24 h, 36 h, and 48 h respectively after incubation
at20°C.
Each lane contained - 5 f.1gprotein
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The stability of protein G13Q was shown to be affected by protein concentration, an
effect which was not so prominent in the WTB sample (Chapter 5). Therefore, it was
necessary to identify whether the double mutant would be similar to G13Q or WTB
in its observed truncation at different concentrations. SDS-PAGE analysis was
conducted on two samples of M12A:G13Q, one at 0.5 mg,(ml and the other at 6
mg/ml after incubation at 20°C for 0 and 24 hours. The results clearly indicated that
in both samples truncation had occurred (Figure 6.7).
Protein B becomes inactivated by truncation to protein B' (Bhambra 1996).
Therefore, inactivation within the sMMO assay-was also monitored to determine the
stability of the protein, as any decrease in activity could be attributed to protein B'
formation. The stability of the protein following incubation at 20°C was monitored.
Also, as protein concentration was shown to have an effect on protein stability in the
case of G13Q (Chapter 5), the stability of M12A:G13Q at two different
concentrations, one high and one low, was studied to elucidate whether this protein
Was affected by concentration in a similar manner to that observed for G13Q. The
activity assay method was therefore used to compare the stability of protein
M12A:G13Q at the two different concentrations and to proteins WTB and G13Q
under the same conditions (Figures 6.8 and 6.9).
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Figure 6.7: SDS-PAGE of two samples of M12A:G13Q at different concentrations incubated at
20°C for 24 h.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceratdehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lanes 2 and 3: M12A:G 13Q (6 mg/ml) at 0 hand 24 h respectively after incubation at 20°C.
Lanes 4 and 5: M12A:G 13Q (0.5 mg/ml) at Oh and 24h respectively after incubation at 20°C.
Each lane contained ~ 5 J.lgprotein
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Figure 6.8: sMMO propylene oxide stability assays of M12A:G13Q at two different
concentrations of 0.5 mg/ml and 6 mg/ml, incubated at 20°C.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.2) were performed by adding 8 J.lM
aliquots of hydroxylase and reductase to 8 J.lMof the protein B double mutant M12A:GI3Q. Enzyme
activity is shown as a percentage of the activity remaining after incubation compared to the activity at
o h. 100 % activity represents 2015 nmol/min/mg. The activities presented are the mean of 3-4
separate experiments. Standard error was ~ I0 %.
120
100
-C 80
f
;Q
o 60-c
Q)
E
~ 40
UJ
20
0
·0 10 20 30 40 50 60 70 80
Time (h)
-+-M12A:G13Q
at-6mg/ml
--M12A:G13Q
at -O.Smg/ml
179
Figure 6.9: Comparison of sMMO propylene oxide stability assays of (i) proteins WTB, G13Q
and M12A:G13Q at --0.5 mg/ml and (ii) proteins WTB, G13Q and MJ2A:G13Q at --6 mg/ml
incubated at 20 QC.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.2) were performed by adding 8 11M
aliquots of hydroxylase and reductase to 8 11Mof protein B. Enzyme activity is shown as a percentage
of the activity remaining after incubation compared to the activity at 0 h. 100 % activity represents;
1956 nmol/min/mg G13Q, 1896 nmol/min/mg WTB and 2015 nmollminlmg M12A:GI3Q. The data
shown are the mean of 3-4 sMMO assays for each reaction. Standard error was ~ 10 %.
Data for WTB and G 13Q have been previously shown in Chapter 5 and have been incorporated here
for comparative purposes only.
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The activity of the double mutant of protein B from Me. eapsulatus (Bath) was seen
to decrease over time, as observed for both WTB and the single mutant G 13Q
(Figures 6.8 and 6.9). However, more in keeping with the results obtained for WTB
and recombinant Ms. triehosporium OB3b protein B, MI2A:G13Q did not differ
greatly in the loss of activity or truncation over time, when comparing samples
incubated at high and low protein concentrations. Thus, the stabilising effect of
higher protein concentrations, observed for G13Q, was not apparent in the samples
ofMI2A:GI3Q.
After 24 hours incubation at the higher concentration of ~ 6 mg/ml at 20°C (Figure
6.9 (ii)), MI2A:G13Q was observed as being approximately 15 % less stable then
G13Q, but approximately 55 % more stable than WTB. After a further 24 hours
incubation MI2A:GI3Q was identified as being approximately 40 % less active than
G13Q and only 15 % more active than WTB. However, after 24 hours incubation at
the lower concentration of ~ 0.5 mg/ml at 20°C (Figure 6.9 (i)), MI2A:GI3Q was
observed as being approximately 60 % more stable then G 13Q, and approximately
15 % more stable than WTB. After a further 24 hours incubation MI2A:G13Q was
identified as being approximately 30 % more active than both G13Q and WTB.
Although not greatly affected in stability terms by protein concentration,
MI2A:GI3Q is observed to be more stable than the single mutant G13Q at low
concentrations of ~ 0.5 mg/ml, but less stable at high concentrations of ~ 6 mg/ml.
6.4 ESI-MS analysis ofM12A:G13Q
Since MI2A:GI3Q double mutant was seen to form an inactive truncate after
incubation at 20°C, ESI-MS analysis was used to determine the site(s) of cleavage
within the protein. A comparison of the effect of concentration on the rate of
cleavage was also made. Table 6.2 details the results obtained.
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Table 6.2: ESI-MS analysis of MI2A:GI3Q samples at (i) 0.5 mglml, and (ii) 6 mg/ml after
incubation at 20°C for various time periods
The ESI-MS of the proteins was recorded on a Quattro II tandem mass-spectrometer equipped with an
electrospray ion source. Data were processed using the MassLynx program (VG Biotech) (Chapter 2,
Section 2.16.1).Data in bold indicates dominant protein peak in each sample.
(i)
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Mc. caJlsulatus (8ath) protein 8
s~uence
0 16240 Intact
24 16240 Intact
15560 N3_S4
15360 N5_A6
15133 y7_DH
36 16240 Intact
15361 N5_A6
15129 y7_DH
14572 Q13_L14
48 16240 Intact
15563 N3_S4
14701 A12_Q13
14572 Q13_L14
13275 F24_A25
(ii)
Time (h) Observed molecular Cleavage site numbered with respect to the
mass (Da) wild-type Mc. capsulatus (8ath) protein 8
sequence
0 16240 Intact
2 16240 Intact
6 16240 Intact
12 16240 Intact
24 16240 Intact
15560 N3_S4
15130 y7_DH
36 16240 Intact
15560 N3_S4
15130 y7_DH
48 16240 Intact
15560 N3_S4
15360 N5_A6
15130 y7_DH
14700 A12_Q13
14570 Q13_L14
13270 F24_A25
72 14700 A"-Q'~
13400 A12_Q13+C-terminal cleavage
13272 F24_A25
The cleavage patterns are similar for the cleavage sites identified after incubation at
20°C at the different concentrations (Table 6.2). At both the low protein
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concentration of ~ 0.5 mg/ml and the higher protein concentration of ~ 6 mg/ml
cleavage was not observed within the first 36 hours at the A12_Q13site, equivalent to
the M12_G13cleavage site of wild type Me. eapsulatus (Bath) protein B, the M12_G13
cleavage site of WTB and the M12_Q13 cleavage site of G13Q (Chapter 5).
Nevertheless, cleavage at A12_QI3is observed in both cases after extended incubation
at 20°C for 48 hours. Interestingly, in both cases the activity decrease observed after
- 24 hours incubation only corresponded to truncation of the N-terminus from Si up
to and including Y7• Overall, the patterns of degradation are similar for both the
concentrations studied, in agreement with the activity and SDS-PAGE results
obtained, which also suggest that MI2A:G 13Q does not differ significantly m
activity loss or truncation over time at the two different concentrations.
6.S Affinity ofM12A:G13Q for the hydroxylase
Surface plasmon resonance techniques have also been used to show that Me.
eapsulatus (Bath) protein B binds to the hydroxylase and that protein B' binds to a
much lesser extent (Bhambra, 1996; Kazlauskaite et al., 1996). Protein B inhibits the
activity of the hydroxylase, when functioning via the peroxide shunt system,
indicating that the protein interacts significantly with the hydroxylase (Jiang et al.,
1993). Therefore, the inhibition of the peroxide shunt reaction was used as an
indicator of protein B binding to the hydroxylase, the greater the inhibition, the
greater the binding.
_,
MI2A:GI3Q, WTB and G13Q were compared with regard to inhibition levels of the
peroxide shunt reaction, when added at concentrations of 25 f.lMand 50 f.lM(Figure
6.10).
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Figure 6.10: The effect of the double and single mutants of Me. capsulatus (Bath) protein Band
WTB on the oxidation of propylene in the hydroxyiaseIH202 system.
The hydroxylase was at a concentration of 24 f.!Mand H202 at 100 mM. Reactions were incubated for
10 min before injecting 500 f.!l of the gas phase of the reaction onto a calibrated Porapak Q GC
column for product quantification (Chapter 2, 2.12.3). Enzyme activity is shown as a percentage of
the activity of the hydroxylase activated via the peroxide shunt reaction, which represents 550.3 nmol
propylene oxide produced (9.2nmollmin/mg). The values presented are the mean of 3-4 separate
experiments. Standard error bars are shown.
The data for WTB bas been previously displayed in Chapter 4 and bas been incorporated here for
comparative purposes.
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WTB inhibits the peroxide shunt reaction most strongly, whereas, G13Q and
MI2A:G 13Q showed weaker inhibition levels, which were very similar (Figure
6.10).
6.6 Theoretical modelling of the N-terminal region of M12A:G13Q,
as compared to G13Q and wild-type Me. capsulatus (Bath) protein B
The recent availability of the NMR structure of protein B from Me. capsulatus
(Bath) (Walters et al., 1999) permitted homology modelling to be initiated as a
means of studying the effect of the mutations on the structure of the protein. It was
hoped that this would give an insight into the functional differences observed
between the proteins. The first 33 amino acids of the N-terminal region of the G13Q
and MI2A:G13Q mutants were identified as having 97 % and 94 % identity with the
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equivalent ammo acid residues of protein B from Me. eapsulatus (Bath). The
orientation of the N-terminal of protein B with respect to the protein core is unknown
and, as a result, the N-terminal regions were modelled alone. Models were produced
using the Swissmodel programme available on the ExPASY server (Peitsch, 1995).
Figure 6.11 shows models obtained for the polypeptide chains of G13Q and
MI2A:G13Q, compared to the structure of the equivalent region of wild type protein
B as determined by NMR structural analysis.
Figure 6.11: The polypeptide chains of the models of the N-terminal regions (residues 1-33) of
(I) G13Q and (ii) M12A:G13Q and (iii) the structure of the N-terminal region of protein B from
Mc. capsulatus (Bath) (Walters et al, 1999).
Structures modelled as detailed in Chapter 2, Section 2.23 and displayed using Rasmol 2.7.1 (RasWin
Molecular Graphics, H. Bernstein). Magenta indicates the structure to be a. helical in nature, pale blue
indicates the structure to be 13 turns and white indicates random character. Amino acids labelled are
numbered with respect to the wild-type Me. eapsulatus (Bath) protein B sequence.
(i)
Q22 JS1.. ~).
~
D8 fj'-::='
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The models (Figure 6.11) indicated that there was a change in secondary structure at
the y7_D8 site. Residues SI to y7 were random in character and D8 to DI8 exhibited
l3-turn structure. Similarly, in each case, l3-turn character was present for residues
E27 and N28, whilst the neighbouring structure was random in nature. a13Q
differed from wild-type protein B and MI2A:a13Q in that its N-terminal region
indicated a-helical character between residues A20and Q22.This was lacking for the
other two proteins which exhibited instead a mixture of random character (A20)and
l3-turn structure (D2I to F23).Therefore, the double mutation of al3 to glutamine and
MI2 to alanine did not apparently affect the secondary structure of the N-terminal
region of the protein when compared to that for wild-type Me. capsulatus (Bath)
protein B, whereas, the single mutation of aI3 to glutamine was predicted to cause a
slight change in the secondary structure of the region. Interestingly, a13Q has been
identified as the more stable protein under certain conditions, so the a-helical
character identified may orientate the protein such that at high protein
concentrations, protein interactions are enabled which cause stabilisation. In order to
assess the validity of these models, work proceeded to gain experimental secondary
structural information on the proteins.
6.7 Determination of the secondary structure ofM12A:G13Q
In order to determine whether the MI2 to alanine and o" to glutamine mutations
incorporated into protein B from Me. capsulatus (Bath) had an effect on the structure
of the protein, secondary structure determination techniques, including near UV and
far UV CD and fluorescence were conducted on the purified protein. Comparisons
were made with the single protein B mutant, a13Q, and WTB itself.
Circular dichroism spectroscopy is very sensitive to the secondary structure of
proteins, and far UV CD can be interpreted to give information on the secondary
. structural types present within a sample, whereas near UV CD spectroscopy provides
evidence of the tertiary structure and dynamics of proteins.
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Fluorescence spectroscopy similarly provides a sensitive means of characterising
proteins and their conformation. The tryptophan, tyrosine and phenylalanine
residues, which are the same sequentially in each of the proteins studied here,
determine the spectra obtained. The polarity of the environments of these residues
can then be identified and thus the proteins can be analysed to elucidate whether this
is the same or different in each case. Since the proteins only differ with regard to the
amino acids mutated within the N-terminal region, and the core regions are the same,
any change in fluorescence or secondary structure can only be interpreted as being a
result of the mutations and the orientation of the N-terminal region relative to the
core of the protein.
Figure 6.12 illustrates the far and near UV CD spectra for each of the proteins WTB,
G13Q and M12A:G13Q.
Figure 6.12: (i) Far UV CD and (ii) Near VV CD spectra of M12A:G13Q compared with those
for WTB and G13Q.
The CD spectra were recorded on a Jasco 1715 spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each protein (i) at 0.12 mg/m1 and (ii) at
0.4 mg/ml in 50 mM phosphate buffer, pH 7, in a (i) l mm and (ii) !O mm pathlength quartz cuvette.
The data for WTS and G 13Q has been displayed previously in Chapter 4 and is incorporated here for
comparative purposes.
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The near DV CD data for WTB, G13Q and M12A:G13Q (Figure 6.12 (ii)) appear
much the same, indicating there to be little difference in the packing and dynamics of
the three proteins. However, the far DV CD data (Figure 6.12 (i)) indicate WTB and
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M12A:G13Q to be very similar in their secondary structural characteristics, whereas
the data for of G13Q suggests there to be more a-helix content compared to the other
two proteins, as indicated by the more pronounced minima at 208 nm and 222 nm.
This is in strong agreement with the modelling data (Section 6.6) which indicated the
N-terminal region of G13Q to contain a-helical character, which was not proposed
to be the case for WTB and M12A:G 13Q. This could correlate with the differences
in stability observed for each.
M12A:G 13Q had been shown to undergo cleavage and an activity decrease after
incubation at 20°C for 24 hours. Analysis of the secondary structure of the protein
over this time period was conducted to determine whether any structural change
occurred (Figures 6.13, 6.14 and 6.15).
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Figure 6.13: Fluorescence spectra of M12A:G13Q after incubation at 20 QC for 0 hand 24 h.
The fluorescence spectra were recorded on a Perkin-Elmer LF-50 fluorimeter at room temperature
with excitation at 280 nm (Chapter 2, Section 2.17). The spectra shown are sum/averages of 8 scans
of each protein (0.5 mglml in 50 mM phosphate buffer, pH 7) in a 3 ml quartz cuvette with a 10 mm
pathlength.
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Figure 6.14: Far UV CD spectra ofMI2A:G13Q after incubation at 20 QC for 0 hand 24 h.
The CD spectra were recorded on a Jasco J715 spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each protein (0.4 mglml in 50 mM
phosphate buffer, pH 7) in a I em path length quartz cuvette.
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Figure 6.15: Near DV CD spectra of M12A:G13Q after incubation at 20°C for 0 hand 24 h.
The CD spectra were recorded on a Jasco 1715 spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each protein (0.12 mg/ml in 50 mM
phosphate buffer, pH 7) in a 1 mm pathlength quartz cuvette.
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In each instance the secondary structure remains ~pproximately the same, as no
difference is observed for the CD and fluorescence data (Figures 6.13, 6.14 and
6.15). Therefore, the loss in activity observed after 24 hours cannot be attributed to a
change in secondary structure.
6.8 Conclusion
The achievement of cloning and expression of the MI2A:G 13Q double mutant has
facilitated studies into its effect on the stability and structure of protein B. The
protein was determined as having sMMO activity equivalent to that observed for
WTB and G13Q under the same conditions and to bind to the hydroxylase in the
absence of the reductase. The cloning strategy adopted, like that used in the cloning
and purification of G13Q and WTB (Lloyd et al., 1997; Chapter 3), enabled the
rapid purification of the overexpressed protein to be possible. Thus, protein was
purified in its intact form. Nevertheless, over time, truncation was observed to occur,
firstly at the N3 _S4 position and then progressively from this region towards the C-
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terminus, including the A12_Q13site, equivalent to the site cleaved in the native Me.
eapsulatus (Bath) protein B, WTB and GI3Q.
Modelling studies suggested M 12A:G 13Q to be similar to WTB. CD supported these
theoretical data indicating that G13Q had slightly more a-helical character than the
other two proteins. In agreement with previous data on WTB, MI2A:G13Q also
undergoes little secondary structural changes upon cleavage.
Overall, the double mutation of protein B succeeded in making a mutant protein B
which was more stable than G13Q at low protein dilutions. This is an important
observation as the two proteins only differ by one amino acid. Interestingly, a
stabilising effect was observed for the G 13Q single mutant at high protein
concentrations, which was not the case for the double mutant M12A:G13Q.
Modelling and secondary structural studies have identified slightly more a-helical
character to be present in G13Q, whereas MI2A:G13Q is more random in nature and
may explain this difference in stability. The stabilising of the secondary structure of
G13Q may be positively influenced by increased protein concentrations decreasing
exposure of the protein to the solvent environment. Reducing the protein
concentration would, therefore, have a negative effect on structural forces and
interactions resulting in the loss of secondary structure, possibly exposing the protein
to cleavage and inactivation. By contrast, the less ordered nature of M12A:G 13Q is
less affected by protein concentration in terms of stability. Initially G13Q and
MI2A:G 13Q exhibited the same level of specific activity, yet differed greatly in
their activities after incubation over time at the two different concentrations. It is
possible that this can be explained in terms of the inactivatory cleavage mechanism
occurring by means of attack by a specifically nucleophilic amino side chain acid
group on the exposed N-terminal region (Chapter 4). This proposal is supported by
the fact that at high protein concentrations the a-helical nature of the N-terminus of
G13Q is stabilised. This means that the region susceptible to attack is not exposed to
the specifically reactive nucleophilic side chain group on the core of the protein.
However, upon dilution, the a-helical character of the N-terminal region may
become weakened or partially unfolded due to exposure to the adverse
environmental conditions, which weaken or break the forces of interaction involved.
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Thus, at low protein concentrations, the N-terminal region could become susceptible
to nucleophilic attack leading to cleavage. However, for M12A:G 13Q the random
nature of the N-terminal region could mean it is exposed and, therefore, susceptible
to the cleavage reaction at both high and low protein concentrations, as illustrated by
the similar activities and cleavages of the protein over time at the two protein
concentrations.
The mutations studied here have given insights into the character of Me. capsulatus
(Bath) protein B, enabling structure to be related to stability. It is interesting that
cleavage at the y7_D8 site of M12A:G13Q resulted in an activity decrease, which
was identified by the presence of low activity truncates of M12A:GI3Q lacking N-
terminal amino acids SI to v'. This highlights the importance of these first few N-
terminal amino acids in relation to activity. It also poses the question of how many
of them are actually essential for protein B activity within the sMMO complex. This
is addressed in Chapter 7.
192
Chapter 7
Expression, purification and characterisation of truncates
of recombinant protein B from Me. capsulatus (Bath)
7.1 Introduction
.
In addition to work by Bhambra (1996) and Lloyd et al. (1997) which identified an
inactive form of Me. eapsulatus (Bath) protein B lacking in the first 12 amino acids
from the N-terminus, a truncation mutant of protein B deficient in the first 25 amino
acids from the N-terminus was also shown to lack catalytic activity within the
sMMO assay (Brandstetter et al., 1999).
Recent studies favour the formation of the inactive protein B' truncate via an
autocatalytic mechanism of cleavage (Chapter 4; Lloyd et al., 1997; Bhambra,
1996). However, most proteins which undergo an autocatalytic cleavage reaction
produce proteins with an activatory function. Examples of self-catalysed protein
modifications, including protein splicing, autoprocessing and autocleavage reactions,
have been discovered in all three kingdoms of life, eukaryotes, prokaryotes and
archaea and represent exceptions to the idea that the final protein product is always
co-linear with the nucleotide sequence of the gene (Shao and Kent, 1997; Perler et
al., 1997). Therefore, it must not be ruled out that the cleavage of protein B to
protein B', although inactivating th~ sMMO complex, may have some other
activatory role yet to be elucidated.
Nevertheless, it is interesting that the activity of the sMMO complex should be lost
upon the loss of only 12 amino acids from the N-terminus of protein B. It is,
therefore, necessary to determine exactly how many of these 12 amino acids are
essential for sMMO activity, and whether these amino acids per se are responsible
for the degradation of protein B. In order to address these issues, N-terminally
truncated proteins of Me. eapsulatus (Bath) protein B were constructed, expressed,
purified and analysed.
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Truncates were constructed with the 013Q mutation and a C-terminal affinity tag to
facilitate ease of purification and resistance to cleavage. Since the 013Q protein
behaves the same as the wild-type protein B as far as cleavage is concerned, any
conclusions on this mutant would apply to the wild-type protein.
The truncates were numbered with reference to their first amino acid and its position
within the wild-type Me. eapsulatus (Bath) protein B sequence. Figure 7.1 below
illustrates the numbering of the first fewN-terminal amino acids of013Q protein B.
Figure 7.1: Schematic illustration of the numbering of the N-terminal of Mc. capsulatus (Bath)
protein B single mutant G13Q.
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Truncates were produced at the S4,N5, A6, y7, D8, A9, 010, and QI3 positions as well
as the intact G13Q protein with the same C-terminal tag. Figure 7.2 schematically
represents the truncate proteins produced.
Figure 7.2: Schematic representation of the Mc. capsulatU$ (Bath) G13Q protein B truncates
produced.
Truncate
Protein
Gl3Q-tag
S4-tag
NS-tag
A6-tag
Y7-tag
OS-tag
A9-tag
GIO-tag
QI3B'-tag
Schematic representation of truncate protein sequence
SI y2 N3 S4 N5 A6 v' 08 A9 GIO III MI2 QI3 LI4 KI5 C-terminal-tag
S4 N5 A6 v' 08 A9 GIO III MI2 QI3 LI4 KI5 C-terminal-tag
N5 A6 y7 08 A9 GIO III MI2 QI3 LI4 Kl5 C-terminal-tag
A6 v' 08 A9 GIO III MI2 QI3 LI4 Kl5 .. , .C-terminal-tag
v' 08 A9 GIO III MI2 QI3 Ll4 KI5 C-terminal-tag
08 A9 010 III MI2 QI3 Ll4 KI5 C-terminal-tag
A9 G10 III MI2 QI3 LI4 KI5 C-terminal-tag
GIO III MI2 Ql3 Ll4 KI5 C-terminal-tag
QI3 LI4 Kl5 .... .C-termmal-tag
7.2 peR amplification and construction of vectors
Protein B from Me. eapsulatus (Bath) has been expressed in an active form in E. coli
cells transformed with a pT7-5B plasmid containing the gene encoding protein B,
under the control of a T7-RNA polymerase promoter expression system (West et al.,
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1992). Similarly, the wild-type and G13Q mutant proteins have been expressed as
GST fusion proteins under the control of an IPTG inducible tac promoter (Lloyd et
al., 1997).
It was necessary to construct the protein B truncates with no extra amino acids at the
N-terminus, which could result from the cloning strategy adopted, in order that the
presence of certain amino acids at this position of the protein could be deduced.
Thus, the method used was that of the Impact FM (Intein Mediated Purification with
an Affinity Chitin-binding Tag) system by New England Biolabs®. This system
produces proteins with no extra amino acids present at the N-terminus, and thus was
the method of choice when compared to producing the truncates with N-terminal
affinity tags, as is the case with the GST fusion system (Amersham Pharmacia
Biotech, Bucks., UK).
Unfortunately the Impact FM system failed to produce clones so another, more
reliable, cloning method was necessary to produce the truncates. The pET system
(Novagen Inc., Madison, WI, USA) was chosen. For protein expression to be
achieved the vectors have to be in E. coli cells which contain the T7 RNA
polymerase gene under the control of the lac promoter, such as BL21 (DE3).
Therefore, when cells are induced with IPTG, the repression of the lac operator by
the lac repressor of the host cell's genome is relieved, enabling T7 RNA polymerase
production. Also the binding of the lac repressor to the lad gene of the pET vector is
relieved by induction. The T7 RNA polymerase can, therefore, bind to the T7
promoter of the pET vector and transcription of the insert can occur (Figure 7.3).
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Figure 7.3: Schematic representation of the control elements of the pET system (adapted from
Novagen pET manual).
Details are given in the text.
E. coli BL21(DE3) cell
T7RNA
T7 RNA Polymerase
Polymerase "
gene
lac operator
~
~ lac repressor
lost ~
Truncated
chromosome
pET-3a 6-His-tag
IPTG relieves repression of lac operator
The primers for PCR amplification of the inserts were designed such that a six
histidine tag (6-His-tag) was encoded at the C-terminus of the protein to allow
purification of the protein on a nickel chelating column. A schematic representation
of the cloning procedure is detailed in Figure 7.4.
PCR reactions were performed using the pGEX-GI3Q plasmid (Lloyd et al., 1997;
Chapter 2, Section 2.27.1) as the te,mplate to amplify mmoBG13Q truncated genes.
Details of the primers used can be found in Table 7.1 and the annealing temperature
used in each case was 50 DC. The truncate genes were digested with BamHI and
Ndel restriction enzymes and then ligated with pET-3a that had been digested with
the same restriction enzymes. After ligation and transformation into E. coli DH5a,
colonies were screened by restriction analysis and the inserts were DNA sequenced
to confirm the identity of the PCR insert. Plasmids containing the desired truncate
genes were transformed into E. coli BL21(DE3) cells for protein expression.
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7.3 Expression of truncated proteins
Protein expression was achieved by induction of the transformed E. coli BL21(DE3)
cells at an OD540 ofO.5 by addition of 1 mM IPTO at 37°C (Figure 7.5).
Figure 7.5: Growth curve of E. coli BL21(DE3) expressing the Q13-His-tag truncate of protein
B from Me. capsulatus (Bath).
The growth curve is typical of that obtained for each of the 6-His-tagged protein B truncates.
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Whole cell lysates were taken at 0, 3 and 5 hours after IPTO induction and analysed
using SDS-PAOE and Western blotting by probing with antisera to protein B.
Proteins, each with an approximate molecular mass of 16,000 Da, were identified
which cross-reacted with the Me. capsulatus (Bath) protein BIB' antibodies. This
confirmed that the proteins probably represented the 6-His-tagged truncated proteins
in each case. Figure 7.6 indicates the accumulation of the Q13 protein B truncate,
which was typical of the results obtained for the other truncated proteins.
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Figure 7.6: (i) SDS-PAGE and (ii) Western blotting of truncated protein B expression in E. coli
BL21 (DE3).
(i) Lane I: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk u-lactalbumin, 14.2 kDa).
Lanes 2-4: whole cell lysates of E. coli BL21(DE3) [pET-3a-Q13-His-tag] 0, 3 and 5 h
respectively after IPTG induction.
(ii) Lanes 5-7: Western blot of lanes 2-4, probed with anitsera against protein BIB' from Me.
capsulatus (Bath).
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SDS-PAGE analysis of soluble extracts for each of the truncate protein clones
indicated that each of the soluble fractions contained the truncate protein. In order to
determine if G13Q protein B with a C-terminal 6-His-tag was active, and to
determine at which truncation point the activity of protein B was lost, propylene
oxidation assays of the soluble extracts of each of the protein B truncates were
performed in the presence of 8 J..tM of each of the hydroxylase and reductase. As a
control, the soluble extract of untransformed BL21(DE3) cells was also assayed.
Results are shown in Table 7.2.
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Table 7.2: Soluble extract assays of the truncated proteins of protein B
Assays containing 8 ~M aliquots of pure hydroxylase and reductase from Me. capsulatus (Bath) and 5
mg soluble extract in MOPS buffer, pH 7 (Chapter 2, Section 2.12.2). The results are the conclusions
of three separate experiments for each reaction. Activity is represented by ,/ and inactivity by x
Soluble Extract Activity
G13Q-His-tC!& ./
S4-His-tag ./
N5-His-tag ./
A6-His-tag . ./
Y7-His-tag ./
D8-His-tag x
A9-His-ta_g x
G 1O-His-tag x
Ql3-His-tag x
BL21(DE3) cells x
From the results of the soluble extract assays, the loss of activity occurs between
residues y7 and D8. It was also confirmed that G13Q protein B with a C-terminal 6-
His-tag did not inhibit sMMO activity. The Q13 truncate, equivalent to protein B',
was seen to be inactive, as expected. However, it was necessary to purify the
proteins to obtain specific activity values for each of the individual truncated
proteins and for further analysis.
7.4 Purification of the truncated proteins
Purification was achieved using the HisTrapTM kit (Amersham Pharmacia Biotech,
Bucks., UK), which involved affinity chromatography using nickel chelating
columns (Chapter 2, Section 2.6).
The proteins were eluted from the Ni-chelating columns using 500 mM imidazole. It
was noted that imidazole inactivated sMMO itself, but it did not damage protein B,
since sMMO activity was restored upon removal of the imidazole. Nevertheless, it
was not possible to assay the activities of the truncated proteins in their semi-purified
state. Also, imidazole was observed to cause precipitation of the truncated proteins
when subjected to a freeze-thaw cycle. Thus, imidazole was removed immediately
after the truncated proteins were eluted from the nickel-chelating columns by gel
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filtration purification on a Superdex 75 column. This not only desalted the protein
from the imidazole but also purified it from some contaminating higher molecular
mass proteins. The purification procedure outlined above gave protein estimated to
be ~ 95 % pure by SDS-PAGE analysis (Figure 7.7). Figure 7.S shows each of the
truncate proteins after the final purification step, indicating them all to be pure, and
that little or no degradation had occurred during the purification procedure. These
results were confirmed by ESI-MS analysis of the proteins which indicated them all
to be pure, with very little or no degradation products. The ATG start codon, which
codes for a methionine, is often post translationally removed, as was the case for
wild-type protein B from Me. capsulatus (Bath) and the truncate proteins G13Q-His-
tag, S4-His-tag, Ae-His-tag, A9-His-tag, and GlO-His-tag . However, for N5-His-
tag, Y7-His-tag, Dx-His-tag and Q13-His-tag, the first methionine amino acid was
retained, as detailed in Table 7.3. Overall, the indications were that these proteins
were of sufficient purity for further analysis.
Figure 7.7: SDS-PAGE of the purification of Q13 protein B truncate from E. coli BL21(DE3)
[pET -3a-Q13-His-tag).
The results are typical of those obtained for the purification of each of the truncate proteins.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk e-lactalbumin, 14.2 kDa).
Lane 2: Soluble Extract of from E. coli BL21(DE3) [pET-3a-Q13-His-tag), - 50 ug.
Lane 3: Flow through fraction from Ni chelating column, - 25 ug.
Lane 4: Wash fraction from Ni chelating column, - 15 ug.
Lane 5: Elution fraction from Ni chelating column, - 25 ug.
Lane 6: S75 fraction of truncated protein B protein, - 15 ug,
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Figure 7.8: SDS-PAGE of purified 6-His-tagged protein B truncates from the various protein B
truncate clones.
Lane 1: Molecular weight markers (bovine albumin, 66 kDa; egg albumin, 45 kDa;
glyceraldehyde-3-P-dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa; soybean trypsin inhibitor, 20 kDa; bovine milk a-lactalbumin, 14.2 kDa).
Lane 2: G13Q-His-tag from E. coli BL21(DE3) [pET-3a-G13Q-His-tag].
Lane 3: S4-His-tag from E. coli BL21(DE3) [pET-3a-S4-His-tag].
Lane 4: N5-His-tag from E. coli BL21(DE3) [pET-3a-N5-His-tag].
Lane 5: A6-His-tag from E. coli BL21(DE3) [pET-3a-A6-His-tag].
Lane 6: Y7-His-tag from E. coli BL21 (DE3) [pET-3a- Y'Z-His-tag].
Lane 7: D8-His-tag from E. coli BL21 (DE3) [pET-3a-D8-His-tag].
Lane 8: A9-His-tag from E. coli BL21 (DE3) [pET-3a-A9-His-tag].
Lane 9: GIO-His-tag from E. coli BL21 (DE3)'[pET-3a-G 10-His-tag].
Lane 10: QI3-His-tag from E. coli BL21 (DE3) [pET-3a-Q13-His-tag].
Each lane contained - 5 ug purified protein
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Table 7.3: ESI-MS analysis of the purified Me. capsulatus (Bath) protein B truncates.
The ESI-MS of the samples were recorded on a Quattro II tandem mass-spectrometer with an
electrospray ion source and the data was processed using the MassLynx program (VG Biotech)
(Chapter 2, Section 2.16.1).
Protein Calculated Observed Difference between Reason for mass
molecular molecular calculated and observed differences
mass (Da) mass (Da) masses (Da) observed
GI3Q-His-tag 16877.87 16745.0 132.87 Lacking N-terminal
Methionine
S4-His-tag 16577.56 16445.0 132.56 Lacking N-terminal
Methionine
N5-His-tag 16490.48 16490.0 - Containing N-
terminal Methionine
Ae-His-tag 16376.38 16245.0 131.38 Lacking N-terminal
Methionine
Y7-His-tag 16305.30 16305.0 - Containing N-
terminal Methionine
D8-His-tag 16142.12 16140.0 - Containing N-
terminal Methionine
A9-His-tag 16027.03 15895.0 - 132.0 Lacking N-terminal
Methionine
G lu-His-tag 15955.95 15825.0 - 130.95 Lacking N-terminal
Methionine
QI3-His-tag 15654.54 15654.2 - Containing N-
terminal Methionine
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7.5 Characterisation of the truncated proteins
The specific activities of the protein B truncates were determined so that they could
be compared directly to the wild-type protein B, and G13Q (Lloyd et al., 1997). It
was also important to compare the structural features of the truncated proteins to
determine whether any insight into the mechanism of cleavage of protein B could be
gained.
7.5.1 Activities of the protein B truncates
The activities of the protein B truncates were determined usmg the propylene
oxidation assay. The results are presented in Figure 7.9.
Figure 7.9: Activities of the protein B truncates.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.2) were performed by adding 8 11M
aliquots of hydroxylase and reductase to 8 11Mof the protein B truncate. Enzyme activity is shown as
a percentage of the activity of G 13Q which represents 1956 nm/min/mg protein. The activities
presented are the mean of 3-4 separate experiments Standard error bars are shown.
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The assay data for the pure protein B truncates confirmed the results obtained for the
soluble extract assays of the protein B truncates (Table 7.2). The loss of the first 7
amino acids from the N-terminus of protein B leads to inactivation. As was expected,
the C-terminal 6-His-tag had no effect on the activity of G13Q-His-tag, as its activity
was approximately the same as that observed for the original G13Q mutant. Also,
activity was retained at this level up to amino-acid S4, after which inactivation of
protein B is seen to be gradual, as the activity level significantly decreased with the
removal of each subsequent amino acid from the N-terminus .
.,
7.5.2 Comparison of the cleavage sites that occur within the truncated proteins
It was unknown what effect truncating protein B would have on its ability to undergo
the cleavage reaction, which possibly occurs via an autocatalytic mechanism
(Chapter 4). In order to determine whether the protein B truncates cleaved, and if so,
identify the cleavage site(s), ESI-MS was used.
The cleavage pattern of G13Q at high concentrations (~ 6 mg/ml) has been
determined using ESI-MS for samples incubated at 20°C for varying time lengths
(Chapter 5). This approach was used here to identify the cleavage(s) that occurred
within the various protein B truncates (Table 7.4). Therefore, it was possible to
determine if the pattern of cleavage proteins produced was the same as that identified
for G13Q and if truncating protein B,had any effect on the rate of degradation. This
in tum would identify important aspects of the N-terminal region of protein B
relating to reasons for the cleavages observed.
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Table 7.4: ESI-MS of the cleavage products of the protein B truncate proteins.
Truncated proteins (~6 mg/ml) were incubated at 20°C and sampled and analysed by ESI-MS at time
o h, 24 h, 3 days, and 6 days. A Quattro II tandem mass-spectrometer was used with an electrospray
ion source and data were processed using the MassLynx program (VG Biotech) (Chapter 2, Section
2.16.1) Cleavages highlighted in bold represent the major peak(s) within the sample.
G13Q-His-tag
Incubation Observed Cleavage site numbered with respect
time at 200 C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 16745.0 Intact
24 h 16743.02 Intact
15521.6 M12_QI3
15279.5 L14_K15
14097.7 F24_A25.' others C-terminal
3 days 16744.76 Intact
others C-terminal
6 days others C-terminal
S4-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 16445.0 Intact
24 h 16444.2 Intact
15520.5 M12_Q13
15279.5 , LI4_KIS
14851 D18_F19
14025.0 A25_D26
3 days 15523.3 Mll_QIJ
15281.86 L14_K15
14635.05 A20_D21
6days 15281.77 U'I_KD
14634.56 A20_D21
14026.32 A2S_D26
others C-terminal
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N5-His-tag
Incubation Observed Cleavage site numbered with respect
time at20 °C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 16490.0 Intact
24h 16487.0 Intact
15519.3 M12_Q13
3 days 16489.87 Intact
15522.5 M12_Q13
15393 QI3_LI4
6 days 16489.3 .' Intact
15523.0 MI2_QI3
15393.6 QI3_LI4
14633.79 A20_D21
others C-terminal
A6-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 16245.0 Intact
24h 16245.3 Intact
15521.59 M12_Q13
15395.6 Q13_L14
3 days 16244.79 Intact
15523.05 MI2_QI3
15394.9 QI3_LI4
15153.65 K15_G16
6days 16244.6 Intact
15523.05 , M12_Q13
15394.9 QI3_LI4
15153.65 K15_G16
Y7-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. capsulatus
mass (Da)' _{_Bath_}protein B sequence
Oh 16305.0 Intact
24 h 16304.4 Intact
15522.2 MI2_QI3
3 days 16306.42 Intact
15524.05 MI2_GI3
15154.51 KI7_DI8
6days 16305.6 Intact
15524.0 MI2_QI3
15153.79 KI7_DI8
14706.57 FI9_A2O
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D8-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 16140.0 Intact
24h 16140.3 Intact
15649.7 III_MI2
15522.7 MI2_QJ3
15280 L14_K15
15152.9 K15_G16
14246.1 F24_F25.
others C-terminal
3 days 15524 MIZ_QI3
15154.96 K15_G16
others C-terminal
6days 15525.0 MI2_Q'J
others C-terminal
A9-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 15895.0 Intact
24 h 15824 Intact
15523.3 MI2_QJ3
15395 QJ3_LI4
3 days 15520.2 Mll_Ql:l
14965 K17_D18
others C-terminal
6 days 15522.8 . M1Z_QI3
others C-terminal
GIO-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. capsulatus
mass (Da) (Bath) protein B sequence
Oh 15825 ., Intact
24h 15825 Intact
15395 QJ3_LI4
3 days 15825 Intact
15523.54 M12_QJ3
15395.3 QJ3_LI4
6days 15825 Intact
15523.99 MI2_Q13
15153.68 K15_G16
others C-terminal
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G13QB'-His-tag
Incubation Observed Cleavage site numbered with respect
time at 20°C molecular to the wild-type Me. eapsulatus
mass (Da) (Bath) protein B sequence
Oh 15654.2 Intact
24h 15654.2 Intact
14968.8 K17_D18
3 days 15654.54 Intact
14968.64 K17_018
6 days 15654.67 Intact
14968.26 K17_018
The data indicate that an increase in stability is observed as the level of truncation
increases from the intact protein to truncate Y7, so over the range of the first 7 N-
terminal amino acids a decrease is observed in the number and amount of cleavage
proteins. However, the stability decreases sharply upon loss of the y7 amino acid to
give truncate D8. Stability then increases again for the truncated proteins from
residues A9 to Q13. These observations are schematically represented in Figure 7.10,
which graphically displays the level of intact protein remaining over time for each of
the truncates with respect to their level of truncation.
Figure 7.10: Graphical representation of the change in the stability of protein B which occurs
upon N-terminal truncation of the protein.
Schematic representation of the data from mass spectrometry analysis of truncate protein samples (~ 6
mg/ml) incubated at 20°C over time. The graph illustrates' the relationship between the level of
protein B truncation and the point in time, after incubation, at which intact protein was observed.
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A dramatic change in the level of stability of the protein B truncates was observed
between truncates Y7 and D8, the site at which activity within the sMMO complex
assay was also lost. Therefore, this could imply that the factor responsible for
increasing the stability of the Y7 truncate is lost upon removal of this amino acid,
and it could be the loss of this factor which is responsible for the inactivity of the D8
truncate. Analysis of the structure of the proteins was, therefore, undertaken in an
attempt to determine whether the significant factor observed could be related to the
structure of protein B.
7.5.3 Comparison of the molecular dimensions of the truncated proteins by size
exclusion chromatography
As previously mentioned (Section 7.4), SDS-PAGE analysis had indicated the
molecular masses of the truncated proteins to be correct, a result which was
confirmed by ESI-MS analysis. Therefore, a comparison of the molecular
dimensions of the protein B truncates was undertaken using size exclusion
chromatography. It is due to the fact that proteins vary considerably in shape from,
for example, spherical to ellipsoidal, that gel filtration gives information on the
molecular size but not generally molecular mass. As the molecular masses of the
truncated proteins were known accurately, any deviation from these values could be
seen as reflecting a difference in molecular shape between the proteins. It had
previously been shown that the activity of protein B had been lost within the sMMO
assay by the loss of the first 7 amino acids from the N-terminus of the protein. It
was, therefore, considered importan,t to determine whether any change in the
molecular dimensions of the protein could be observed. The truncated proteins were,
thus, subjected to size exclusion chromatography on the Superdex 75 FPLC column
(Amersham Pharmacia Biotech, Burks., UK) and the elution volume for each was
recorded and the molecular size inferred from the calibration curve (Figure 7.11)
(Chapter 2, Section 2.9).
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Figure 7.11: Size exclusion chromatography of protein B truncates.
Molecular size values displayed were inferred from the calibration curve.
S % error bars are displayed.
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The molecular sizes inferred from the data suggest the truncated proteins to range
from 30-43 kDa (Figure 7.11). These data are in agreement with the size obtained for
wild-type Me. eapsulatus (Bath) protein B (Chapter 4) of 35 kDa. The range of sizes
observed indicates that the truncation of protein }3 causes slight changes in the
molecular dimensions, such that the proteins elute slightly differently from the intact,
wild-type protein B, but not significantly, as they are all roughly within the 5 % error
range. Recent work by Brandstetter et al. (1999) suggested that the N-terminus of
protein B was responsible for its anomalous migration in size exclusion
chromatography. The truncation mutant they studied, which lacked the first 25
amino acids from the N-terminus, was shown to run as expected for its molecular
mass on a gel filtration column, whereas the wild-type protein eluted at a higher
retention volume. Here it has been shown that the truncation of the N-terminus of
protein B up to residue 13 does not have a great enough effect on the N-terminus to
enable elution at a retention volume closer to that expected for the molecular mass of
protein B itself. Thus, the first 13 N-terminal amino acids are effecting the migration
. of the truncate proteins to give a molecular size equivalent to that of the wild-type
protein.
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7.5.4 Theoretical secondary structure determination of the N-terminus region of
the protein B truncates
It was possible that a change in secondary structure of the N-tenninal region of
protein B was responsible for the change in stability at the y7_D8 site. Consequently,
a theoretical approach was used to elucidate the effect of truncating protein B on the
secondary structure of the protein within this region.
The secondary structure of the proteins was predicted using the Jpred'' program (Cuff
and Barton 1999), available on the internet at http://jura.ebi.ac.uk:8888/. The
program works by combining a number of modem, high quality prediction methods
including PHD, DSC... PREDATOR, NNSSP, Mulpred, and Zpred to form a
consensus (Jpred). A 72.9% accuracy is expected for the consensus method. The
consensus secondary structure predictions for each of the truncate proteins is shown
in Figure 7.12.
Figure 7.12: Secondary structure predictions of each of the truncated proteins of protein B from
Me. eapsu!atus (Bath) using the Jpred" program.
The first 34 N-terminal amino acids are shown with their corresponding secondary structure
predictions. H indicates a-helix nature and E, extended conformation.
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The NMR structure of protein B from Me. capsulatus (Bath) was published very
recently, after this work had been conducted. Nevertheless, the secondary structure
data determined provided a possible insight into the effect of truncating protein B on
the secondary structural features of the N-tenninal region of the protein.
The secondary structure data predicts a sudden decrease in the content of a.-helix for
. truncates Y7 and D8 compared to truncates A6, N5, S4 and the intact protein, with
extended conformations being predicted for truncates A9 and G10. These factors
may be involved in the reason for the inactivity of the truncated proteins upon
truncation from residue D8 onwards. However, truncates Y7 and D8 were predicted
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to have the same secondary structure within the N-terminal region and, therefore, the
reason for the sudden loss in activity upon removal of the y7 amino acid is not due to
a secondary structure change being induced. Even if the secondary structure
predictions are not as accurate as expected, they still provide a means to compare the
effect of truncation upon the possible structure of the proteins computationally.
Experimental secondary structure determination was undertaken to gain further
insights into the reason for the loss of activity upon truncation of the protein.
7.5.5 Secondary structure determination of the truncated proteins
It was an important observation that the site at which activity was lost was the same
as that at which the level of stability of the protein truncates decreased. Similarly, a
decrease in the proportion of alpha helix content of the N-terminal region of the
protein occurred within this region. CD studies of truncates Y7 and D8 were carried
out to determine whether a difference in secondary structure could be observed
(Figure 7.13).
Figure 7.13: Far UV CD spectra of the Y7 and D8 truncated proteins of protein B from Me.
eapsulatus (Bath).
The CD spectra were recorded on a Jasco 1715 spectropolarimeter at room temperature (Chapter 2,
Section 2.18). The spectra shown are averages of 10 scans of each truncate protein (0.25 mg/ml) in 50
mM phosphate buffer, pH 7, in a I mm pathlength quartz cuvette.
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The spectra both have minima at 208 nm and 222 nm and a maximum at 192 nm,
indicative of a moderate proportion of alpha helix present in both proteins. The
spectra are similar to those obtained for protein B itself and suggest that there is not a
great structural difference between the two truncated proteins. They also indicate the
truncates to have the same secondary structure as protein B itself, so the loss in
activity at the y7_D8 site cannot be accounted for by a loss of secondary structure of
the inactive D8 truncate protein.
7.6 Conclusion
The development of a system for the expression of the protein B truncates,
incorporating a C-terminal 6-His-tag, and for their rapid and simple affinity
purification, has proved to be a most efficient method for obtaining highly pure
samples of the proteins. The cloning method had the added advantage of
incorporating no extra amino acids at the N-terminus, thus allowing the accurate
study of reactions occurring within this region of the protein. Therefore, the
availability of pure samples of the protein B truncates proved vital in facilitating the
study of protein B to B' formation. The use of this system for the expression and
purification of protein B truncates is, therefore, of importance for the continuation of
research into this subject which has remained a mystery for nearly a decade, since
the. first observation of the truncation of protein B in 1990 by Pilkington and co-
workers.
Activity studies of the truncated proteins of protein B of Me. eapsulatus (Bath) have
provided the first conclusive evidence that the first seven amino acids of protein B
(SI, V2, N3, A4, N5, A6, and y7) are essential for its activity in the complete sMMO
system. Also highlighted was the fact that with the loss of each amino acid from the
N-terminus, the activity level became reduced. This indicated the importance of each
individual amino acid, as well as these first seven collectively for enabling activity to
be possible. Truncation at positions on the C-terminal side of these have been
identified as being inactive. Overall, this illustrated the immense importance of so
few amino acids with respect to involvement in conveying protein B activity.
214
Upon the loss of the y7 amino acid to form the inactive D8 truncate protein, the
stability of the protein was observed to decrease dramatically. It had been presumed
possible that with increasing levels of truncation of protein B, stability to cleavage
would improve, as the proposed mobility of the N-terminal region would be reduced
as it became shorter. The observation of the sudden change in stability at the site at
which activity was lost also suggested that the Y7 amino acid was vital for the
stability and activity of protein B. Nevertheless, no significant change in overall or
secondary structure was observed between the significant truncates, Y7 and D8.
The crucially important seventh amino acid, tyrosine, contains an -OH group as part
of its side chain moiety. It is possible that the hydroxyl group forms an
intermolecular hydrogen-bond with an amino acid side chain group on the surface of
the core region of the protein, maintaining the N-terminal region in a specific
orientation, essential for activity. Upon the loss of v', this essential conformation
would be lost, preventing protein B from being active within the sMMO complex. It
would also increase its instability, as it would result in the exposure of the remaining
N-terminal region, thus allowing it to contact other groups which could bring about
autocatalytic degradation (possibly via the autocatalytic mechanism proposed in
Chapter 4). The weakening and resultant loss of this proposed important hydrogen
bond might well occur routinely upon purification of protein B and so enable the
cleavage reactions observed to be possible.
This work also opens up a number of further possibilities to be tested. These would
include determining the binding affinities of each of the truncates to the other sMMO
components and identifying in what respect the inactive truncates prevent sMMO
activity from occurring. For example, it could be elucidated if any change in the
redox potentials of the hydroxylase occurs upon the addition of the truncates.
Overall, the development of this system for the expression and purification of the
protein B truncates will prove invaluable in enabling further studies into the roles of
protein B and its truncates within the sMMO system, and possibly within Me.
capsulatus (Bath) cells, to be finally understood.
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Chapter 8
Component Interactions of sMMO
8.1 Introduction
In recent years there has been much progress towards understanding the mode of
.'action of sMMO. In particular the crystallisation of the hydroxylase component
(Rosenzweig et al., 1993) allowed detailed examination of the residues involved in
substrate binding and oxygen activation. Insights into local conformational changes
and perturbations, that occur upon di-iron centre reduction or protein B binding, have
been investigated, using techniques such as electron paramagnetic resonance (EPR),
electrochemistry, circular dichroism (CD), magnetic circular dichroism (MCD),
extended X-ray absorption fine structure (EXAFS) and fluorescence spectroscopy
(Woodland et al., 1986; Fox et al., 1991; Froland et al., 1992; Paulsen et al., 1994;
Rosenzweig and Lippard, 1994; Kazlauskaite et al., 1996; Coates-Pulver et al.,
1997; Davydov et al., 1997). Knowledge of the physical interactions of the
individual sMMO components, however, is limited, as the lack of a crystal structure
of the sMMO complex means that it remains' uncertain as to the precise
stoichiometry and arrangements of the components within the complex. The crystal
structure of the hydroxylase identified it as a dimer consisting of two trimers of the
a, ~, and y subunits. From this data it was proposed that two equivalents of each of
the reductase and protein B would~e required to bind to each trimer of the
hydroxylase dimer (Rosenzweig et al., 1993). Evidence, such as surface plasmon
resonance measurements, also indicated that the components bound in a 1:2:2
hydroxylase:protein B:reductase molar ratio (Lloyd et al., 1997). Tentative
assignments as to the binding sites of protein B and the reductase on the hydroxylase
have been provided by cross-linking studies of sMMO from Ms. trichosporium
OB3b (Fox et al., 1991). Thus, as no studies have been conducted which give direct
information on the relative disposition of the components within the complex or
global conformational changes that may occur, this aspect of investigation has been
undertaken in this study.
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The techniques of single particle analysis by electron microscopy (SPA), atomic
force microscopy (AFM) and small angle X-ray scattering (SAXS) have been used
as powerful techniques for probing conformational changes and gaining information
on the relative disposition of the components within the complex. This Chapter
details the findings of this work.
8.2 Single particle analysis by electron microscopy
Electron microscopy (EM) is used to visualise how subunits interact in high-order,
functional complexes, and image conformational changes which occur to control the
assembly and activation of many protein complexes. The resolution of electron
micrographs is limited when contrasted with that for X-ray crystallography. Proteins
tend to give noisy images, even when micrographs are recorded using the most
advanced instruments. However, the use of digital image processing largely
overcomes this drawback.
Analysis of sMMO using this technique was undertaken in collaboration with Drs
Bob Ford and Mark Rosenberg (Department of Biomolecular Sciences, UMIST,
UK). Electron micrographs of (i) the hydroxylase, and (ii) the sMMO complex were
recorded using a Philips CM100 electron microscope (Chapter 2, Section 2.20), so
that comparisons could be made between the conformation of the hydroxylase alone
and when in complex with the other sMMO components. Typical micrographs for
the hydroxylase and sMMO complex are shown in Figure 8.1.
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Figure 8.1: Typical electron micrographs of negatively stained (i) hydroxylase and (ii) sMMO
complex.
The proteins (i) hydroxylase (0.05 mg/ml) and (ii) sMMO complex (1 :2:2) ratio of
hydroxylase:protein B:reductase (0.1 mg/ml) were immobilised on carbon-coated EM grids and
negatively stained with 4 % uranyl acetate. Electron micrographs were recorded at x 83-104 k
magnification and scanned at a resolution of 5.4 AJpixel. Arrows point to particles of the hydroxylase
protein in (i) and the sMMO complex in (ii).
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Single particle analysis was carried out on the micrographs using SPIDER (Frank et
al., 1996). Particles were selected using Ximdisp (Chapter 2, Section 2.20),
examples of which are shown for the hydroxylase and the sMMO complex in Figure
8.2.
Figure 8.2: Samples of the particles selected for SPA work from (i) the micrograph of the
hydroxylase and (ii) the micrograph of the sMMO ~omplex.
The sizes of the particles are indicated.
130A
160A
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Particles were subjected to an alignment procedure involving the use of an iterative
process of cross-correction and auto-correction to rotationally align the molecules in
their characteristic orientations. These were finally classified into groups, in order to
produce average, refined images, as illustrated by the dendograms in Figure 8.3.
Figure 8.3: Dendogram representation of groups of particle averages of (i) the hydroxylase
protein and (ii) the sMMO complex.
Selected particles (lOO of the hydroxylase and 736 of the complex) were subjected to reference free
translation and rotational alignment. Aligned particles were clustered into groups, based on a
hierarchical method, so that averages of similar particles could be calculated (Chapter 2, Section
2.20). Groups of particle averages are visually displayed with their numerical value.
(i)
!
1.000.970.940.910.88 I
0.8531~-----------4~0 15 6 8
(ii)
~
1.00
.86
.71
.57
.42
O.28
79
c----.,-I82 194
I
114 194
The particle analysis studies identified two distinct species present within the
hydroxylase sample, corresponding to particle averages 31 and 40 in Figure 8.3(i) .
.These were identified as corresponding to the protein in two different orientations by
analysis of their dimensions and indications of their structures. The two orientations
are illustrated in Figure 8.4 where they are displayed next to the crystal structure in
the same orientation.
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Figure 8.4: Electron contour maps of the hydroxylase particle averages (i) 31 (Side View) and
(ii) 40 (Front View) with the crystal structure (Rosenzweig et aL, 1993) in the same orientation.
Size values are indicated.
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The hydroxylase was visualised as having approximately the same dimensions as
those determined for the crystal structure of the protein (Rosenzweig et aI., 1993). It
was, therefore, observed as retaining its bi-Iobed dimer form at the low
concentrations used here. The resolution of the SPA data is approximately 30 A
compared to the atomic resolution of2.2 A for the crystal structure data.
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The particle analysis studies for the complex identified various groups of particles,
differing from one another in orientation and resolution (Figure 8.3 (ii)). However, in
each case the particles were identified as being of increased length (155 A),
compared to the particles of hydroxylase alone (Figure 8.4), and enlarged at one end
to form an approximate 'pear' shape. The two largest particle average groups, both
corresponding to particle averages of 194 (Figure 8.3 (ii)), were of increased
resolution compared to the other groups and clearly illustrated this point (Figure
8.5).
Figure 8.5: Electron contour maps of the sMMO complex displayed with the crystal structure of
the hydroxylase (Rosenzweig et al., 1993) in the orientation in which it is thought to be present
within the complex.
Particle averages of the two largest particle average groups are displayed. Size values are indicated.
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In both cases analysis of the complex dimensions and indications of structure
suggest that the hydroxylase is present in the side view orientation (Figure 8.5). The
images indicate there to be an increase in size only for one trimer of the hydroxylase
dimer and consequently the 2-fold symmetry is not preserved. This would imply that
only one trimer of the hydroxylase molecule is involved in binding to protein B
and/or the reductase under the conditions of the experiment, whilst the second trimer
remains unchanged. Resolution assessment of the complex data indicated it to be ~
50A.
Formation of the sMMO complex by addition of the hydroxylase, reductase and
protein B at molar ratios of 1:5:5 was undertaken in an attempt to improve complex
formation and determine whether or not the 1:2:2 complex could be observed. This
study, however, failed in producing large quantities of complexed protein, as
ascertained by viewing the EM grid. Large amounts of smaller proteins, probably
protein B and the reductase, were observed supporting the idea that complex
formation had not been complete.
The data aquired therefore indicate that the complex does not exist in a 1:2:2 ratio of
hydroxylase:reductase:protein B, as predicted for the binding of one molecule of
each of protein B and the reductase to each trimer of the hydroxylase dimer
(Rosenzweig et al., 1993). Propylene oxidation activity assays were conducted to
determine whether any increase in activity was observed for the complex formed at
the 1:2:2 ratio, compared to that observed for the complex formed at a 1: 1: 1 ratio of
hydroxylase:reductase:protein B. The results are shown in Figure 8.6.
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Figure 8.6: Activity assays for the sMMO complex formed at different ratios of
hydroxylase:protein B:reductase.
sMMO propylene oxidation assays (Chapter 2, Section 2.12.1) were performed for the I: 1:I ratio of
hydroxylase:protein B:reductase by mixing 8 f.lM aliquots of the hydroxylase, protein 8 and
reductase. For the 1:2:2 ratio of hydroxylase:protein B:reductase, 16 f.lM aliquots of protein 8 and the
reductase were added to 8f.lM of the hydroxylase. Enzyme activity is shown as a percentage of the
activity of the 1:I :1 reaction which represents 1956 nmol/min/mg. The data shown are the mean of 3-
4 sMMO assays for each reaction. Standard error bars are shown.
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No significant difference was observed for the activity of the complex assayed under
the two different conditions. This indicated that the reductase and protein B were not
rate limiting when the complex .was assayed at the 1:1:1 molar ratio of
hydroxylase:protein B:reductase, since an increase in the ratio of these proteins gave
no increase in activity. This evidence supported the SPA observations that only one
half of the hydroxylase dimer was participating in binding (as activity was observed
at its optimum level under these conditions). However, in the absence of studies to
identify the level of iron present or the presence of damaged sites in the hydroxylase
protein used in these experiments, it is unclear whether these observations are as a
consequence of iron depleted or damaged hydroxylase lowering its activity and level
of binding to the other sMMO components.
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8.3 Atomic force microscopy
Atomic force microscopy or scanning force microscopy, as it is often referred to, is a
powerful tool for the investigation of biological structures. Invented in 1986, it
yields three-dimensional low-resolution structural information (Binnig et al., 1986).
As mentioned in Chapter 4, the technique is based on the movement of a sharp tip at
the free end of a soft cantilever which scans over a sample keeping the tip at almost
touching distance from the sample surface. The tip and cantilever movement is
coupled to an optical readout system for monitoring the bending of the cantilever
induced by the surface topography and thus digitally reproduces the topography of
the sample surface (Schaper and Jovin, 1996). The technique was used to compare
the structures of the hydroxylase protein alone, to that of the sMMO complex to
determine whether any conformational change in the hydroxylase could be observed
upon addition of the other components, protein B and the reductase. Fluid AFM
analysis was conducted in an attempt to retain the proteins in their native
conformations.
In collaboration with Mr. Bernie Sattin (Department of Chemistry, University of
Toronto, Canada), samples of hydroxylase and the sMMO complex, prepared in a
1:2:2 ratio of proteins hydroxylase:protein B:reductase were analysed using this
technique (Chapter 2, Section 2.26). The fluid AFM images obtained for the
hydroxylase and the sMMO complex are shown in Figure 8.7.
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Figure 8.7: Tapping mode AFM images of (i) the hydroxylase and (ii) the sMMO complex.
Labelled are samples of the hydroxylase, sMMO complex and aggregates of the proteins.
(i)
"M
(ii)
"M
The images indicate that under the conditions of the experiments, the sMMO
proteins had a tendency to aggregate (Figure 8.7). However, this did not significantly
interfere with the process of data collection for the various particles observed.
Analysis showed the hydroxylase sample to be fairly homogeneous and the proteins
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to have immobilised in almost the same orientation on the mica surface in each case,
as seen by the uniformity of the sample surface (Figure 8.7 (ij), In the case of the
sMMO complex sample, some hydroxylase was seen to be unbound, whilst other
particles appeared larger in size, correlating with complex formation (8.7(ii». The
volumes of the particles imaged in both cases were determined and the distribution
of the observed volumes for the samples are shown in Figure 8.8.
Figure 8.8: Distribution of the observed volumes of (i), hydroxylase and (ii) sMMO samples.
Observed volumes data analysed using Origin™ 4.10 software (Microcal Software Inc., USA).
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The graphs indicate that the hydroxylase has been observed by this technique as
having a volume of ~ 250 nrrr' (Figure 8.8 (i)). This particle size constitutes the
largest proportion of particles in the sMMO complex sample (Figure 8.8 (ii)), further
verifying that complex formation was incomplete, and much uncomplexed
hydroxylase remained in solution. The second peak observed for the sMMO sample
(Figure 8.8 (ii)) at a volume of ~ 650 nnr' is presumed to correspond to aggregates of
the hydroxylase and the other proteins, as it would be too large to be the complex
itself, being over double the size of the constituent hydroxylase protein. The varying
. particle volumes, in between and larger than this, are presumed to similarly
correspond to aggregates of varying quantities of the proteins which constitute the
complex itself.
The imaging of the reductase and protein B separately, in order to determine the
sizes of the molecules under the conditions of fluid AFM analysis were also
conducted, so that the composition of the complex could be identified, had it been
formed clearly. However, it was only possible to conduct AFM imaging after the
samples had been dried, and thus the various volumes obtained for the particles
observed could not be compared to those obtained under fluid imaging. Similarly,
difficulties were encountered when attempting to visualise the hydroxylase:protein
B':reductase complex under fluid, which would have been an interesting comparison
to the active sMMO complex, and determined whether indeed the complex did form.
Overall, the technique proved to be problematic, as much protein aggregation meant
that difficulties were encountered throughout.
8.4 Small angle X-ray scattering (SAXS)
The technique of SAXS, as mentioned in Chapter 4, is a valuable tool for studying
the structural basis for biomolecular function, revealing details of functionally
important conformational flexibility and interactions by the study of the
conformations of biomolecules in solution as well as within functional complexes.
SAXS is applicable to molecules and molecular assemblies ranging in sizes from 10-
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1,000 A (Trewhella et al., 1998). SAXS is thus ideally suited to the analysis of the
sMMO proteins individually and in complex.
X-rays can be produced with wavelengths ranging from - 0.1-100 A and can
therefore probe the most important dimensions of biomolecular structures (1-1000s
A). Upon encountering a particle in solution a small proportion of the X-rays will be
deflected or 'scattered'. The structure of the particle dictates the angular dependence
of the scattering. Solution scattering is thefefore referred to as 'small-angle'
scattering. The scattering data from a particle details structural information on the
overall size and shape of the molecule. Scattering data is dependent on geometric
shape and is therefore very highly sensitive to domain orientations, and thus
conformational changes and/or flexibility, as well as molecular associations in
solution (Trewhella et al., 1998).
The technique was used to study the stoichiometry and arrangements of the sMMO
components within the complex in solution, and determine whether any shape
changes occurred upon complex formation. SAXS studies were carried out in
collaboration with Drs J. Trewhella and S. Gallagher (Los Alamos National
Laboratory, New Mexico, USA) (Chapter 2, Section-z.Zo).
Solution scattering profiles of the sMMO complex and the isolated components were
measured and are shown in Figure 8.9 together with the model I(Q) profiles
calculated using uniform ellipsoids for the reductase and protein B, and the crystal
structure coordinates for the hydroxylase (Rosenzweig et al., 1993). For the sMMO
complex itself, the model profile was calculated using the model shown in Figure
8.l5.
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Figure 8.9: I(Q) versus Q data for sMMO and its individual components.
Experimental data are depicted by the symbols; protein B (.), reductase (+), hydroxylase (A),
sMMO (1:10:10 mixture = 1:2:2 complex) (.6). The scattering profiles are offset by multiplication
factor in order to separate them on the vertical axis for easy viewing (0.2, 4, 16, 258, and 4096,
respectively), The errors indicated are based on counting statistics only. The solid lines represent the
model I(Q) profiles calculated using uniform ellipsoids for the reductase, protein Band B', and the
crystal structure coordinates for the hydroxylase. For the sMMO complex the solid line represents the
model profile calculated using the model shown in Figure 8.15.
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The scattering data were collected for the protein components of sMMO over a range
of concentrations from 2 - 15 mg/ml, in 25 mM MOPS pH 7, 13 QC. For each
component there was no concentration dependence of scattering data, indicating that
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interparticle interference effects were negligible and, hence, no correction was
required. As previously detailed in Chapter 4, the technique determined protein B to
be monomeric in nature. Scattering data were measured from mixtures of the sMMO
components with 1:1:1, 1:2:2, 1:5:5, 1:10:10 and 1:20:20 ratios of the
hydroxylase:protein B:reductase. Analysis of the 10 values indicated for the 1:10: 10
mixture was consistent with the formation of the 1:2:2 complex with 8 free
equivalents of the reductase and protein B. 1:2:2 complex formation was also
observed for the 1:20:20 ratios of hydroxylase.protein B:reductase, with 18 free
equivalents of protein B and reductase.
Pair distance, P(r) or vector length distribution function, is a useful function in the
interpretation of SAXS data. It is obtained by inverse Fourier transformation of the
intensity I(Q) versus Q. P(r) is the frequency of vectors lengths connecting small-
volume elements within the scattering particle weighted by their scattering densities
and goes to zero at a value corresponding to the maximum dimension of the particle,
dmax• Rg is calculated as the second moment of P(r). P(r) is sensitive to the symmetry
of the scattering particle, and to the relationships between domains or repeating
structures (Trewhella et al., 1998). The P(r) functions calculated for the scattering
profiles are shown in Figure 8.10. The best fit ellipsoid models for the reductase and
protein B have approximate dimensions of 72, 44, 32 A and 50, 34, 30 A
respectively. These models give reduced "l values of 1.03 and 1.01 respectively
indicating a near perfect fit which would have "I: = 1.0.The model P(r) function was
calculated using the crystal structure coordinates (Rosenzweig et al., 1995) which
gives a fit ofx.2 = 0.99.
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Figure 8.10: p(r) functions for sMMO and its individual components.
The experimentally derived functions for (a) protein B C.), reductase C+), and (b) hydroxylase CA),
sMMO (1:10:10 mixture = 1:2:2 complex) C.6.). The solid lines are the PCr) functions calculated for
the models indicated in Figure 8.9. The PCr) profiles are scaled such that their areas are proportional
to the molecular weight of the component or complex for convenient comparison of shape changes.
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The reductase and protein B components give unimodal P(r) profiles indicative of
compact globular proteins (Figure 8.10 (a)) whereas for the hydroxylase the P(r)
profile is bimodal with a shoulder at 70 A (Figure 8.10 (b)). The shoulder indicates
the bi-lobal nature of the hydroxylase which results from the way in which the two
a~'Y trimers associate to form the dimer (Figure 8.11).
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Figure 8.11: Hydroxylase crystal structure.
(a) Surface representation showing the bilobal nature of the dimerised trimers (George et al., 1996).
The active sites are indicated (.). The structure has been rotated to show the two canyon-like features
(1 and 2), which previously had been proposed as possible binding sites of protein B and the
reductase (Rosenzweig et al., 1993). (b) Top view of the structure in panel (a) showing the positions
of the two canyons.
a
b
. The measured volumes for each of the isolated components, calculated usmg
Equations 2.2 and 2.3 (Chapter 2, Section 2.25), are in good agreement with the
expected values based on monodispersed proteins of mass 250, 38.6 and 15.8 kDa
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for the hydroxylase, reductase and protein B, respectively and assuming a specific
volume ofO.74 cm3/g (Harpaz et al., 1994) (Table 8.1).
Table 8.1: Molecular Volumes for each sMMO component
Component Measured volume (A-') Expected volume (Al)
Protein B 19200 ±3100 19400
Reductase 43200 ±2000 47300
Hydroxylase 275000 ±1800 305800
Figure 8.12 illustrates the formation of the 1:2:2 complex. It shows a plot of the
observed 10 values for the mixtures of sMMO components added to form the
complex against the molar ratio of reductase and protein B to hydroxylase in the
solution. Also shown are the expected 10 dependencies assuming different
stoichiometries of hydroxylase:reductase:protein B.
Figure 8.l2:Titration of hydroxylase with protein B and reductase.
The 10 values measured for the mixtures of hydroxylase:reductase:protein B plotted as a function of
the protein B and reductase to hydroxylase mole ratio. The solid line indicates the expected 10 values
assuming two equivalents of protein B and reductase bind to one hydroxylase. The dashed lines
correspond to alterative stoichiometries for binding as indicated.
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The comparisons showed that the observed data fit the 1:2:2 complex being formed
with 10 equivalents of protein B and reductase compared to hydroxylase and that at
molar ratios of 1:5:5 and less, only the 1:1:1 complex or hydroxylase alone were
observed.
The Per) profile (Figure 8.10 (b)) illustrates that upon formation of the 1:2:2
complex an increase in dmax was observed from 125 to 150 A, and the shoulder at 70
A is lost. This illustrates that the overall structure is more elongated and has lost the
bilobal character of the hydroxylase alone. The Rg value for the scattering particle
increases from 42 to 46 A and the molecular volume increases by 26 %, as is
expected for the formation of the 1:2:2 complex. Interestingly, these changes are not
observed for a mixture of hydroxylase: reductase: protein B' added at a 1:10:10 ratio,
as the Per) profiles are identical (Figure 8.13) and thus illustrate that complex
formation has not occurred, and protein B' does not bind to the hydroxylase.
Similarly, parallel scattering experiments in which the hydroxylase was titrated with
the reductase or protein B, up to 10 equivalents of each, showed no evidence for
their binding to the hydroxylase either. Also, addition of hydrogen peroxide up to
concentrations of 100 mM, which activates the hydroxylase to function via the
peroxide shunt mechanism, did not give rise to any conformational change.
Figure 8.13: p(r) functions for the hydroxylase, sMMO complex and sMMO complex formed
with protein B' instead of protein B (1:10:10 mixture of hydroxylase:protein B':reductase).
For ease of viewing, P(r) profiles are not scaled as in Figure 8.10.
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The single ellipsoid fit to the scattering data for the 1:2:2 complex of
hydroxylase:reductase:protein B gives dimensions of 150, 71, 66 A with a 'X: value
of 1.04 whereas the best fit ellipsoid for the isolated hydroxylase calculated from the
crystal structure data has dimensions of 125, 95, 65 A compared to the best-fit
ellipsoid calculated from the scattering data 127, 98, and 65 A ("1.,2 = 1.01). Upon
complex formation there is an accompanying increase in dmax and a narrowing in a
second dimension by 24 A or 25 %, so illustrating that the hydroxylase cannot be
accommodated within the molecular envelope of the complex without a
conformational change. Since both protein B and reductase are necessary for this
observation, it appear!l that both proteins are required for binding to induce the
conformational change.
Modelling studies were subsequently undertaken in order to identify the nature of the
conformational change. It was proposed that the required conformational change
could occur by means of the rearrangement of the two trimers that associate to form
the hydroxylase dimer. The two trimers contact each other with relatively small areas
of interaction at each end of their long axes between the two f3 subunits. At one end
of this interaction there is a planar interface of approximately 200 A2, which could
provide a potential pivot point in the structure, about which the hydroxylase can
rotate to give a structure with an increased dmax, while maintaining a significant area
of contact between the trimers. This, similarly, brings about the narrowing of the
structure in the second dimension. Rotation of the hydroxylase systematically in 100
"
steps about the pivot point, so as to increasingly extend the long axis of the
hydroxylase dimer interface, was modelled. Best fit ellipsoid models of protein B
and the reductase were placed close to the active sites, such that they sat within the
overall ellipsoid dimensions for the complex. Model Per) functions were determined
and compared to the experimental Per) function. It was elucidated that one
hydroxylase trimer would have to rotate approximately 1800 with respect to the
second one in order to fit the scattering data as illustrated in Figure 8.14. The bound
protein B and reductase components fit within the unfilled portion of the ellipsoid for
the complex as shown in Figure 8.15 This allows them to bind closely to the active
sites of the hydroxylase and gives a compact structure.
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Figure 8.14: Proposed model for the extended hydroxylase structure.
Ellipsoid models for the isolated hydroxylase dimer (left) and the sMMO complex (right) are shown
as yellow dots that fill the ellipsoid volumes. A ribbon representation of the hydroxylase crystal
structure is superimposed on the ellipsoids, with the individual trimers that associate to form the
dimer coloured blue and red. For the complex (right), the hydroxylase dimer is shown in the extended
conformation.
Figure 8.15: Model of the interaction between the three components of sMMO.
The hydroxylase structure is shown in ribbon form (dark blue and red), protein B (light blue) and the
reductase (yellow) are represented by ellipsoids filled with small spheres.
The rotation preserves the 2-fold symmetry expected for the dimer. The quality of
the model fit to the data is "l = 1.13, indicating excellent agreement. Likewise the
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structural parameters for the model and experimental data both have a dmax of 150 A,
the Rg values are both 46 A and the volumes agree within 10 %.
Models, in which protein B and the reductase were positioned so that they filled the
canyon positions indicated in Figure 8.11, could not account for the increases in Rg
and dmax obtained upon complex formation. The best X2 obtained for such models
compared to the scattering data was 16, indicating a very poor fit. Alternative models
positioning protein B and the reductase on thesurface of the hydroxylase in highly
extended conformations could give an increase in dmax, but did not give the correct
Rg values or shape functions and at best only gave a fit of X2 = 6, similarly indicating
poor fits. This evidence further supports the idea that the conformational change
observed must occur via the rotation of the hydroxylase trimers.
These results support the previous studies which have suggested that the
stoichiometry of the sMMO complex is 1:2:2 hydroxylase:reductase:protein B
(Froland et al., 1992; Rosenzweig et al., 1993; Lloyd et aI., 1997). However, under
the conditions here, 10 equivalents of each of the reductase and protein B are
required to see full complex formation. The results of the activity assays containing
hydroxylase:reductase:protein B in a 1:10: 10 ratio were not significantly different to
those obtained for the proteins added at ratios of 1:1:1 or 1:2:2 (Figure 8.6).
However, previous studies have observed maximal sMMO activity for mixtures
containing 2 equivalents of protein B and reductase to hydroxylase (Froland et al.,
1992). Therefore, it appears that the addition of NADH and/or substrate may
increase the affinity of the reductase and protein B to the hydroxylase, thus driving
the equilibrium towards complex formation.
8.5 Conclusion
, The work presented in the Chapter used various techniques to yield new structural
information on the component interactions of the multicomponent sMMO enzyme.
The SAXS data have been modelled to show that upon formation of the enzyme
complex, the hydroxylase undergoes a dramatic conformational change, such that
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one dimension is narrowed by 24 A, whilst the longest dimension increases from 120
A to 150 A. Both the reductase and protein B were used to induce the conformational
change. However, sMMO retains its 2-fold symmetry expected for a dimer and
identifies the complex as consisting of the hydroxylase:reductase:protein B at a ratio
of 1:2:2.
The 1:2:2 stoichiometry of the components within the sMMO complex has been
implied from various studies. For example, tlte dimeric form of the hydroxylase,
identified from its crystal structure, suggested that 2 equivalents of the reductase and
protein B would be required to bind to a single hydroxylase dimer (Rosenzwieg et
al., 1993). The identification of the possible binding sites of protein B and the
reductase to the hydroxylase from analysis of cross-linking data (Fox et al., 1991),
crystal structure data for the hydroxylase in the presence of a short peptide of the
reductase component (Rosenzweig et al., 1997), and NMR data on the interactions of
protein B with the hydroxylase (Walters et al., 1999), have further supported this
suggestion. Also the titration of the hydroxylase with reductase and protein B gave
an optimum activity ratio of 1:2:2 hydroxylase:reductase:protein B (Froland et aI.,
1992). Perturbation of the partially and fully reduced EPR signal of the hydroxylase
upon addition of 2 mol protein B / mol hydroxylase and the results of isothermal
titration calorimetry and stopped flow fluorescence spectroscopy also indicated that
the reductase and protein B bind to the hydroxylase with a 2: 1 stoichiometry (Fox et
al., 1991; Gassner and Lippard, 1999). However, the SAXS studies indicated that
under the conditions of the experiments 10 equivalents each of the reductase and
protein B were required to see full' complex formation. This suggests that the
addition of NADH and/or substrate may increase the affinity of the reductase and
protein B to the hydroxylase, driving the equilibrium towards complex formation.
The addition of hydrogen peroxide, which activates the hydroxylase to function via
the peroxide shunt mechanism, failed to induce any conformational change. For this
reason it was thought that protein B primarily facilitated the conformational change
in the hydroxylase in order to allow close interaction between the reductase and the
hydroxylase. Previous works have also proposed that the formation of a
hydroxylase-protein B complex was responsible for inducing either a global or local
shape change in the hydroxylase (Rosenzweig and Lippard, 1994; George et aI.,
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1996; Kazlauskaite et al., 1996; Davydov et al., 1997; Coates-Pulver et al., 1997;
Rosenzweig et al., 1997). In the absence of protein B and reductase, the hydroxylase
exists in a conformation which hinders access to the active site, as the X-ray crystal
structure shows there to be no direct passage for substrate to the active site
(Rosenzweig et al., 1993). This further highlights the need for a conformational
change in the hydroxylase to occur for substrates to reach the active site for catalysis.
Similarly, the conformational change modelled from the SAXS data would most
certainly affect the environment of the di-iron eentre, thus explaining the alteration
in its EPR spectrum and redox potentials upon binding of protein B (Fox et al., 1991;
Paulsen et al., 1994; Rosenzweig and Lippard 1994; Kaslauskaite et al., 1996). CD
and MCD have been used previously to observe an induced conformational change,
only in the presence of protein B, affecting the active site pocket and di-iron cluster
(Davydov et al., 1997; Coates-Pulver et al., 1997) and EXAFS has shown protein B
to induce a conformational change near the substrate binding site and di-iron centre
(Rosenzweig and Lippard, 1994).
The interactions between the components in the model are also in agreement with
previous findings. The primary interactions suggested are between the reductase and
the a. and 13 subunits of the hydroxylase, in agreement with the crystal structure of
the hydroxylase in the presence of a short peptide of the reductase and cross-linking
data, and between protein B and the a. subunit of the hydroxylase, in agreement with
the cross-linking data (Fox et al., 1991; Rosenzweig et al., 1997). The model also
suggests a role for the 'Y subunit in contributing to the overall stability of the complex
by providing additional interactions with protein B.
The SAXS data is in good agreement with the previous studies mentioned. However,
the AFM and SPA results did not give the same findings. The use of the technique of
AFM proved problematic in obtaining good quality images as the proteins had a
tendency to aggregate under the conditions of the experiment. Therefore, it was not
possible to collect sufficient accurate data for analysis work.
The technique of SPA clearly visualised the hydroxylase alone as a bi-lobed dimer
comparable in size to the dimensions obtained for the crystal structure of the protein
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(Rosenzweig et al., 1993). The complex formed upon addition of the
hydroxylase:reductase:protein B at a ratio of 1:2:2 was identified as having lost its
dimer symmetry, being more 'pear' shaped in character with an increase in the
longest dimension from 130 A to 155 A, in good agreement with the SAXS data.
However, unlike the SAXS data no narrowing was observed. Instead, an increase in
the overall size of one hydroxylase trimer was observed, while the second trimer
remained the same in dimension as that observed for one trimer of the hydroxylase in
the hydroxylase only sample. It was presumed that the increase in size corresponded
to the binding of 1 protein B and 1 reductase molecule to the hydroxylase trimer.
However, it could not be ruled out that the size increase could be the result of some
other combination of these sMMO components binding to the hydroxylase trimer.
Interestingly, the SAXS data observed the 1:1:1 complex of the
hydroxylase:reductase:protein B when the components were added in a 1:5:5 ratio.
Unfortunately, the SPA data for the complex formed at a 1:5:5 ratio of
hydroxylase:reductase:protein B proved difficult to analyse because of the large
proportion of unbound smaller proteins (protein B and reductase) interfering with the
identification of the complexed particles. Nevertheless, the SPA data agrees with the
SAXS results here, as they imply that the formation of the complex by addition of
the components at lower ratios does not result in the formation of the 1:2:2 complex.
The slight discrepancies in the actual results could be due to the differences in the
techniques.
It has also been observed from previous studies that up to 60 % of the binding sites
on the hydroxylase are either damaged or temporarily unavailable, so preventing full
complex formation from occurring (Gassner and Lippard, 1999). Also iron depleted
hydroxylase is routinely purified which contains ~ 2 - 3 mol of iron per mole of
hydroxylase instead of the theoretical value of 4. Therefore, it is possible that
binding of the other components to only one trimer of the hydroxylase reflected the
iron-depleted nature of the second trimer to which the reductase and protein B may
not have been able to bind (Liu et al., 1995).
As protein B binds tightly to the hydroxylase in the oxidised state (Hox), and with the
hydroxylase having 4 - 5 orders of magnitude higher affinity for protein B in this
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form compared to that for hydroxylase in the reduced state (Hred)(Liu et al., 1997), it
would be expected to observe binding under the conditions of these experiments.
This would result in the formation of the activated complex (Liu et al., 1995).
Since the reductase can transfer electrons to the hydroxylase in the 'absence of
protein B, it must be capable of binding to the hydroxylase for the reason of
transferring electrons to the active site to reduce the active site iron from Fe(III) to
Fe(II) in the absence of protein B (Lund et al., 1985). However, recent studies have
revealed that 0.1 reductase to 1 hydroxylase ratio afforded the same shift in redox
potentials as the 1:1 reductase.hydroxylase ratio (Waller and Lipscomb, 1996). It
was also noted that the ratio of reductase:hydroxylase in cells of Ms. triehosporium
OB3b was 1:10, suggesting that this observation was of physiological relevance
(Waller and Lipscomb, 1996). This phenomenon was also observed for Me.
eapsulatus (Bath) cells and it was thought that during nonnal in vivo catalysis the
reductase was present at 10% of the hydroxylase concentration (Liu et al., 1997).
Findings by Gassner and Lippard, (1999) have indicated that the reductase can
transfer electrons to several hydroxylase molecules in the time it takes for the
hydroxylase to complete a single turnover. This could be the reason for the low
levels of reductase present, as one molecule can activate many hydroxylase
molecules. This was further supported by their findings that the sMMO system
operates most efficiently when the concentration of reductase is one fifth that of the
hydroxylase with the concentration of protein B being greater than or equal to that of
the hydroxylase. Under these conditions methane hydroxylation and NADH
consumption occur with an ~ 1:1 stoichiometry. However, further modification of
the protein ratios can increase the rate of substrate hydroxylation. Therefore, the
reductase can bind and dissociate rapidly from a large population of Hox,as present
in this experiment. It is therefore possible that this is partly the reason why the SPA
data only visualises protein binding, on average, to 1 trimer of the hydroxylase
dimer.
Under normal assay conditions, upon reduction of a hydroxylase-protein B complex
by the reductase, a tightly assembled complex containing Hred:proteinB:reductase
would be formed, which enables reaction with molecular oxygen during catalysis
(Gassner and Lippard, 1999). However, in the absence of NADH the tight complex
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would be prevented from forming. Prior to formation of the reduced hydroxylase,
protein B and reductase complex, it is proposed that either protein B or reductase
associates with the hydroxylase to form a rapidly equilibrating pre-complex, which
slowly isomerises by means of a structural change to give a thermodynamically
stabilised equilibrium complex (Gassner and Lippard, 1999). It is also entirely
possible that it is one of these 'pre-complexes' that has been visualised by SPA,
created under the conditions of adding 1:2:2 ratios of hydroxylase: reductase: protein
B and so supports the idea of pre-complex formation occurring during the sMMO
reaction. The SAXS data, on the other hand, have identified full complex formation.
It is possible that the excess quantities of reductase and protein B present, compared
to the hydroxylase, pushed the equilibrium towards complex formation in the
absence of the other reaction chemicals.
The collection of the SPA and SAXS data were also conducted at different
temperatures, SPA at 4 °C and SAXS at 13°C. Studies have also identified
temperature dependent conformational changes to occur between the hydroxylase
and protein B and that the sites of interactions of the proteins differ, which could be
linked to the greatly increased rate of catalysis by the hydroxylase at the optimum
temperature of 45°C compared to that at the lower temperatures, at which the SPA
and SAXS experiments were conducted (Gassner and Lippard, 1999; Walters et al.,
1999). The lack of any significant differences in the activities of the complex when
compared at ratios of hydroxylase:reductase:protein B of 1:1:1, 1:2:2 and 1:10: 10
could indeed reflect this idea. Therefore, the complexes formed under assay
conditions are not equivalent to those identified by the techniques of SPA and
SAXS, particularly as the activity assays are conducted in the presence of substrates
and NADH, which are absent under the conditions used to visualise the complexes.
Similarly the difference between the 'complexes' observed by SPA and SAXS could
reflect their formation occurring at different temperatures.
. The techniques used in this Chapter have identified methods and conditions suitable
for the study of the sMMO complex. Further studies of the complex by SPA would
need to involve antibody labelling to clearly identify the proteins involved in
forming the complex. Also, it would be important to try to 'capture' the complex in
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its active form in the presence of NADH and substrate. One possibility would be to
use acetylene, the suicide substrate inhibitor of sMMO in an attempt to immobilise
the complex in its active state for visualisation by eitherlboth SPA and/or SAXS.
Anaerobic conditions would also prevent turnover of the enzyme and could be used
in 'capturing' the nature of the reactive complex. Nevertheless, the results detailed
here have provided vital insights into the conformation of the sMMO system and yet
the need to obtain crystals of the complex remains apparent as the only means of
validating the observations made so far.
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Chapter 9
General Discussion
Throughout this work a range of molecular biology, biochemical and structural
approaches has been taken to study the regulatory protein, protein B, and component
interactions of sMMO. One of the major developments, that facilitated the studies
.'
described in this work, was the improvement of the purification protocols for wild-
type and recombinant protein B from Me. eapsulatus (Bath) and Ms. triehosporium
OB3b and the single mutant of Me. eapsulatus (Bath) protein B, G13Q, and the
hydroxylase and reductase 'Components of sMMO from Me. eapsulatus (Bath). Many
of the characterisational studies of both protein B and the sMMO complex involved
the use of techniques requiring significant quantities of highly pure protein. Also, the
construction, expression and purification of the M12A:GI3Q double mutant and the
truncates of Me. eapsulatus (Bath) protein B were vital in furthering the
understanding of the protein B cleavage reaction.
Since the first observation of the truncation of protein B by Pilkington et al. (1990),
the mechanism and reason(s) for the occurrence haveremained elusive. Work by
Bhambra (1996) and Lloyd et al. (1997) established that the loss of only the first 12
N-terminal amino acids resulted in the formation of the inactive truncate of protein B
known as protein B'. The results from the study of the recombinant N-terminal
truncates of Me. eapsulatus (Bath) protein B identified that only the first 7 amino
acids were actually essential for activity, and that a decrease in specific activity was
observed as each amino acid from 1 to 7 was lost. The stability of the truncates with
respect to the cleavage reaction also changed significantly between the truncate
containing the 7th amino acid, tyrosine, which was observed to be stable, and the
truncate lacking the 7th amino acid, which was identified as being unstable.
Therefore, a dramatic change occurred whereby both activity and stability were lost
upon removal of the Y7 amino acid of protein B.
Tyrosine is an amino acid with hydrogen-bonding capabilities. It contains a -OH
group, which at pH 7 can serve as a hydrogen-donor. Hydrogen-bonds are present
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between main-chain -NH and -co groups forming a. helices and P sheets, but side
chains of certain amino acids, such as tyrosine, can also participate in hydrogen-
bonding, which is an especially strong type of dipole-dipole interaction. All but two
of the first 7 amino acids of protein B have hydrogen-bonding capabilities with Si,
N3, S\ and NS serving as both hydrogen-bond donors and acceptors. Residue D8 can
serve as a hydrogen-acceptor, whereas the remaining amino acids of the N-terminus
up to the Metl2_Glyl3 cleavage site do not have hydrogen-bonding potential. Inter-
and intra-molecular interactions, such as hydrogen-bonding between side chains, can
contribute to the higher structure of a protein, with the protein naturally assuming its
most stable higher structure.
The loss of activity of the truncates and a decrease in their stability with respect to
the cleavage reaction, as they become N-terminally truncated, must indicate a loss of
some stabilising effect. Stabilising interactions, which include electrostatic and van
der Waals forces, hydrogen-bonds and salt bridges between amino acid side chain
groups and disulphide bonds (S-S), may therefore be present. These may possibly
maintain the structure of the N-terminal region, either in a specific structure or
orientation relative to the protein core, and are conceivably essential for activity.
Since the amino acids necessary for the S-S cross-links and salt bridges are not
present within the first 12 N-terminal amino acids of protein B, this suggests
electrostatic and van der Waals forces and hydrogen-bonding to be important. The
loss of hydrogen bonding capabilities of the N-terminal amino acids of protein B,
roughly correlates with the loss of activity and stability of the protein. However, both
y7 and D8 amino acids have hydrogen-b~nding potentials, and yet truncate Y7 is
observed as being stable and active, whereas this is not the case for truncate D8.
Hydrogen-bonds are not all of the same strength, which implies that y7 may form a
stronger bond, such as
I
-O-H---N-
I
-- = Hydrogen-bond of 7 kcal/mol
whereas D8 may form a weak bond, such as
-N-H---O- --=Hydrogen-bond of 2 kcal/mol
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which can be broken more easily. Hence, it could be interpreted that maintenance of
the structure and orientation of the N-terminal region of protein B may be aided in
truncate Y7 by the presence of hydrogen-bonds between the Y7 and D8 amino acids
and the core of the protein, whereas in the case of the D8 truncate, this effect may be
lost. However, since the secondary structure and overall molecular size of truncates
Y7 and D8 are virtually the same, it could further imply that the activity of protein B
may be more related to the orientation of the N-terminal region relative to the core of
the protein than the structure of the N-terminal region alone. This is a proposal
which is also supported by the increased hydrogen-bonding potential in the Y7
truncate compared to that of the D8 truncate. With increasing truncation of protein
B, such essential interactions required to orientate and stabilise the N-terminal
region, relative to the protein core, could be lost, resulting in its increased flexibility,
which would mean that the protein could become destabilised and susceptible to
cleavage and inactivation.
The recent NMR structure of Mc. capsulatus (Bath) protein B (Walters et al., 1999)
failed to define the orientation of the N-terminus (residues 1-34) relative to the core,
as shown in Figure 9.1, and provided evidence that at 25 °C the N-terminal residues
D22_A26 interacted with the hydroxylase, although it was also found that this may not
be the case at 45 °C. The remaining interactions were concentrated within the core
region of the protein. These results are in agreement with the observation that the
inactive truncate protein B', which lacks only the first 12 N-terminal amino acids
and thus retains residues D22_A26, can inhibit the hydroxylase functioning via the
"
peroxide shunt mechanism. Therefore, it must be capable of interaction with the
hydroxylase in the same manner as observed for intact protein B itself. However,
inhibition was identified as being less than that for protein B, suggesting interactions
to be weaker and thus 'affected' by the loss of the 12 N-terminal amino acids. This is
also in agreement with studies by Kazlauskaite et al. (1996) and Lloyd et al. (1997),
in which the binding of protein B' to the hydroxylase was determined, by surface
plasmon resonance (SPR), to be weaker than that identified for protein B. It could be
possible that maintenance of the structure and/or the orientation of the N-terminal
residues D22 -A 26 are mediated by the first 12 amino acids of protein B. Therefore, in
their absence, the position of residues D22 -A 26 relative to the core of the protein is
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lost, weakening the protein's interaction with the hydroxylase. Due to time
limitations, it was not possible to test the levels of inhibition of the truncates of
protein B within the peroxide shunt system in order to identify their strength of
binding to the hydroxylase. It would, therefore, be of importance to determine this or
alternatively use SPR studies to identify specific binding constants for the
interactions of the truncates with the hydroxylase.
,
Figure 9.1: Orientation of the N~and Cstermiual regions ofMe. capsulatus (Bath) protein B as
determined by NMR analysis (Waiters et al, 1999).
Shown are all 14 structures identified for the protein from the NMR data, displayed using Rasmol
2.7.1 (RasWin Molecular Graphs, H. Bernstein).
C-terminal regions of each
of the protein B structures
from the NMR ~ ~
.>Core of protein B
Nsterminal regions of each
of the protein B structures
from the NMR data
Proteins B and B' have been shown to have the same secondary structure, although
the molecular shapes have been observed as being slightly different. SAXS identified
protein B' as being longer and thinner than protein B. This result supports the
proposal that the first 12 amino acids could be maintaining a 'shape' aspect of
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protein B, which is lost upon their removal. For example, upon loss of interactions
within the first few N-terminal amino acids, the remains of the N-terminal region
could become exposed and more flexible. The modelled ellipsoids for the scattering
data could, therefore, represent this change. Protein B has also been identified as
being capable of self-association under certain conditions, whereas protein B' exists
as a monomer. This could also be explained as being due to a molecular shape
change occurring upon the loss of the first 12 amino acids from the N-terminus.
Protein B maintains a structure which allows interactions to be possible, but is
reduced upon cleavage to form protein B'. Ultimately, confirmation of these
possibilities awaits the elucidation of crystal structures of proteins B and B', which
would give details of the orientation of the termini relative to the core and allow a
detailed comparison of the two proteins to be possible. However, difficulties were
encountered when attempting to obtain crystals of protein BIB', possibly due to the
'flexible' nature of the N-terminal region of the protein. Thus perhaps a better
approach may be to crystallise protein BIB' when in complex with the hydroxylase.
This would not only serve in attempting to improve the stability of protein BIB' for
crystallisation to be possible but would give vital information on aspects of protein B
and B' binding to the hydroxylase.
The availability of a system for the optimised expression and purification of the
protein B truncates, however, provides a means to identify further how the truncation
of protein B prevents sMMO activity, and may enhance the understanding of the
sMMO reaction mechanism. For example, future work could involve elucidating the
effects of the protein B truncates on the redox potentials of the hydroxylase, their
effects on the conformation of the active site of the hydroxylase and their effects on
the formation of the reaction intermediates, compounds P and Q. Such findings
would help establish fully the means by which protein B carries out its critical role
within the sMMO system.
It was established by Bhambra (1996) and Lloyd et al. (1997) that cleavage of
protein B was not protease mediated. Mutation of the Gly13 residue at the cleavage
site to a glutamine improved the stability of the protein to the cleavage reaction,
although further mutations of GlylO,Gly13and Gly16resulted in a decrease in activity
of the protein within the sMMO system (Lloyd et al., 1997; Brandstetter et al.,
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1999). Further verification that cleavage occurred in the absence of proteases was
obtained using chromatofocusing chromatography. The results demonstrated that a
highly purified sample of protein B from chromatofocusing chromatography
degraded to protein B', which could then be repeatedly resolved and repurified.
Since each sample of repurified protein B underwent cleavage to protein B', it is
most likely that the truncates are generated autocatalytically. Further studies
identified protein B to contain a specifically nucleophilic residue, which provides a
means of inducing the cleavage reaction observed. Wild-type and recombinant Me.
eapsulatus (Bath) protein B, and G13Q have been identified as being similar in
terms of secondary structure and cleaved at the same position within the N-terminal
region. Combined, these data could be interpreted to suggest that the specifically
nucleophilic group is probably a side chain moiety of one of the outer core amino
acids which can contact the N-terminal region mediating cleavage, as dictated by the
structure of the protein. It is possible that purified protein B experiences destabilising
conditions in vitro and thus the proposed interactions responsible for maintaining the
orientation of the N-terminus are lost. The resultant increased flexibility of the N-
terminus, as is observed from the NMR structure of protein B (Walters et al., 1999),
could allow the nucleophilic group to access certain N-terminal sites leading to
cleavages at these specific positions. This proposal .is also supported by the
observation that for G13Q at higher concentrations, which helps maintain the
delicate balance of non-covalent forces, the protein is stabilised against the cleavage
reaction. The concentration effect was also present for WTB although it was less
pronounced, possibly reflecting very slight differences in their N-terminal structures
.,
due to the difference in the amino acid at position 13 with respect to the wild-type
protein B sequence.
Attempts to identity conditions which stabilise protein B identified magnesium as
reducing the rate of inactivation due to cleavage. Magnesium is a large ion with a
positive charge and would therefore be attracted to any nucleophilic, electron
donating groups, such as the proposed side chain moiety of the outer core amino acid
which is suggested to be responsible for the cleavage reaction. Thus, it is possible
that the binding of Mg2+to the nucleophilic group would prevent its attack on the N-
terminal amino acids, and so stabilise protein B against cleavage. This finding also
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supports the suggestion that nucleophilic attack IS responsible for the cleavage
reactions of protein B.
Mutational analysis of wild-type Me. eapsulatus (Bath) protein B involving the
changing of the Metl2_Glyl3cleavage site to AlaI2_GlnI3,forming the double mutant
MI2A:G13Q, did not affect the structure or activity of protein B. However, the
single mutant, G13Q, was identified as possessing slightly more a-helical character
.'in the N-terminal region. In terms of stability and binding to the hydroxylase,
MI2A:G13Q was observed to differ slightly from WTB and G13Q. It was more
stable than G13Q at lower protein concentrations, possibly because the slight a-
helical character present fer G13Q was lost upon dilution due to solvent exposure
effects, whereas MI2A:G13Q was less affected due to being less structured. In
support of these proposals were the observations of the cleavage sites of
MI2A:G13Q and G13Q. For MI2A:G13Q the cleavage patterns are similar for
samples incubated at high and low protein concentrations, whereas for G13Q
cleavage patterns are different. The site equivalent to the Metl2-Glyl3cleavage site
of Me. eapsulatus (Bath) protein B is identified as the main cleavage product for
G13Q incubated at high protein concentrations. In comparison, when G13Q is
incubated at low protein concentrations, various N- and C-terminal cleavages are
identified. This reflects the possibility that for G13Q at high protein concentrations
the secondary structure and orientation of the N-terminus are stabilised for longer,
whereas at lower protein concentrations they are lost, giving the different cleavages
in response to the difference in nature of accessible sites. For M12A:G13Q the
results support the observation of the protein being less structured than G13Q
because the effect of dilution just enhances the number of cleavage sites, possibly
due to an increase in flexibility, as any stabilising interactions of the N-terminus
become weakened or lost. Nevertheless, the slight increase in a-helical character of
the N-terminal region ofG13Q appeared only to stabilise the region against cleavage
and not to affect sMMO activity. Interestingly, G13Q did not inhibit the
hydroxylase, when functioning via the peroxide shunt mechanism, as much as
M12A:G13Q or WTB. This further identifies a slight structural difference between
the N-terminal regions of the proteins, where the mutations lie, which affects binding
to the hydroxylase but not activity. Since protein B in conjunction with the reductase
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has been identified as causing the hydroxylase to undergo a conformational change
enabling activity, it is possible that the three proteins mediate this to the same degree
but binding to the hydroxylase in the absence of the reductase differs.
Proteins B and B' have been identified as binding copper, which results in dimer
formation. The side chain of histidine is an excellent metal ligand and two histidine
residues are present, one within each of the unstructured and exposed N- and C-
"terminal regions of protein B, as identified from its NMR structure (Walters et al.,
1999). Therefore, it is possible that copper binds to the His32 and Hisl39 residues of
the N- and C-termini respectively. Their orientations relative to the core of protein B
are undefined and so both histidine residues may be able to complex with copper in
solution. This could be aided by the solution environment in which the flexibility of
the termini may be enhanced. Also, in order to form dimers, it is possible that copper
bound to protein B binds to a second protein B molecule via the two equivalent
histidine residues of the second protein, thus giving the usual tetrahedral co-
ordination observed for metal-bound proteins. A combination of the observations
that proteins B and B' are affected by copper in the same way, and yet differ with
regard to their first 12 N-terminal amino acids, and that analysis of the NMR
structure of Me. eapsulatus (Bath) protein B indicated no other metal-complex
forming residues to be exposed, supports the idea that the N- and C-terminal
histidines are involved in complexing with copper, leading to dimer formation in the
manner suggested. The ultimate reason for a copper-induced dimerisation effect on
proteins B and B' remains unknown. Sinc~ copper is important in inducing pMMO
expression in Me. eapsulatus (Bath) cells, it would be important to determine
whether this observation had any functional significance either within the sMMO
system or the cell itself.
Wild-type and recombinant Ms. triehosporium OB3b protein B have been identified
as undergoing an inactivatory cleavage reaction like that observed for protein B of
Me; eapsulatus (Bath). However, the main cleavage sites differ between the wild-
type (Thrls_GlyI6) and recombinant protein (LysI4_Thrls) by one amino acid. This
difference suggests that in this case the extra amino acids present at the N-terminus
of the recombinant protein, as a result of the cloning method used, have affected the
protein slightly. Studies also identified Ms. triehosporium OB3b protein B to be
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more stable than Me. capsulatus (Bath) protein B and the mutants G13Q and
MI2A:G 13Q. They also identified Ms. trichosporium OB3b protein B to be only
marginally less active than these proteins when assayed within the Me. capsulatus
(Bath) sMMO system. Within the N-terminal region Ms. trichosporium OB3b
protein B differs from Me. capsulatus (Bath) protein B by a few amino acids. The
core structure of the protein itself, as recently determined by NMR (Chang et al.,
1999), identifies the protein to be structurally different to Me. capsulatus (Bath)
protein B, an observation already made by secondary structural analysis. These
differences must enhance the stability of the protein to the cleavage reaction. Based
on these observations, mutational studies can be devised to try to develop a more
stable Me. capsulatus (Bath) protein B for sMMO activation studies. Future work
could involve construction and expression of various mixtures of the N- and C-
terminal and core regions of the two homologous proteins. This would also further
the understanding of the reasons for the instability of Me. capsulatus (Bath) protein
B and the stability of the homologousMs. trichosporium OB3b protein B.
Protein B' has been identified in sMMO-expressing Me. capsulatus (Bath) cells but
not those of Ms. trichosporium OB3b. This further supports the observation that Ms.
trichosporium OB3b protein B is more stable with respect to cleavage than Me.
capsulatus (Bath) protein B and, therefore, any protein B cleavages that did occur
may have been present only at very low levels, insufficient for detection.
Nevertheless, the identification of protein B' within the Me. capsulatus (Bath) cells
would imply that it posses a function within the cell, although it has been
demonstrated that this is not one of switching the substrate specificity of sMMO. It is
entirely possible that its formation in vivo and in vitro is purely a reflection of a
destabilising solvent environment. Nevertheless, its presence and identification have
provided the basis of much of the work in this thesis, which has furthered the
understanding of various aspects of the structure and function of protein B. Reasons
for the occurrence of the cleavage reaction and the inactivity of protein B' have been
proposed, as have methods to minimise cleavage, and identification of the amino
acids necessary for protein B activity have been determined. A schematic
representation of the main features of protein B elucidated from the results obtained
in this study is shown in Figure 9.2.
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A further understanding of the functioning of Me. capsulatus (Bath) protein B within
the sMMO system has also been gained from this study. SAXS data have been
modelled to show that protein B and the reductase induce a dramatic conformational
change in the hydroxylase such that one trimer of the hydroxylase dimer is rotated by
1800 relative to the other, thus preserving the 2-fold symmetry expected for a dimer.
The results identified the complex as consisting of the hydroxylase:reductase:protein
B in a ratio of 1:2:2, which is in agreement with previous studies investigating the
stoichiometry of the complex (Rosenzweig et al., 1993; Froland et al., 1992; Fox et
al., 1991; Gassner and Lippard, 1999). Hydrogen peroxide, which can activate the
hydroxylase to function via the peroxide shunt mechanism, failed to induce any
-conformational change in the protein. Consistent with these results was the proposal
that protein B primarily facilitated the conformational change in the hydroxylase in
order to allow close interaction between the reductase and the hydroxylase for
electron transfer to occur efficiently. However, component interaction studies of the
sMMO system using the technique of SPA by EM yielded contrasting results, as the
complex was identified as having lost its dimer symmetry with binding of the other
sMMO components occurring on only 1 trimer of the hydroxylase dimer.
The differences between the 'complexes' observed by the two techniques could
reflect the difference in nature of the two processes. Nevertheless, the studies
identified methods and conditions suitable for the study of the sMMO system and
provided a means of investigating the component interactions of the complex in the
absence of crystal structure data. Due to thelimitations of time, it was not possible to
obtain further insights into the conformation of the sMMO system whilst in its active
state in the presence of, for example, NADH and/or substrates. Use of the suicide
substrate inhibitor, acetylene, to immobilise the complex in its active state, or
anaerobic conditions to prevent enzyme turnover and thus capture the reactive
complex, may provide a means of visualising activated sMMO using the techniques
of SAXS and/or SPA.
Ultimately the major challenge that will be faced is that of crystallising the sMMO
complex, ideally with and without substrate bound. Only then will the true
component interactions of the sMMO system in its active form be elucidated. It
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would also assist in enabling the understanding of exactly how a small cofactor-less
protein, such as protein B, can have such a dramatic effect on the regulation of the
activity of the sMMO complex.
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ABSTRACT: We present here X-ray scattering data that yield new structural information on the
multicomponent enzyme methane monooxygenase and its components: a hydroxylase dimer, and two
copies each of a reductase and regulatory protein B. Upon formation of the enzyme complex, the
hydroxylase undergoes a dramatic conformational change that is observed in the scattering data as a
fundamental change in shape of the scattering particle such that one dimension is narrowed (by 25% or
24 A) while the longest dimension increases (by 20% or 25 A). These changes also are reflected in a 13%
increase in radius of gyration upon cemplex formation. Both the reductase and protein B are required for
inducing the conformational change. We have modeled the scattering data for the complex by systematically
modifying the crystal structure of the hydroxylase and using ellipsoids to represent the reductase and
protein B components. Our model indicates that protein B plays a role in optimizing the interaction between
the active centers of the reductase and hydroxylase components, thus, facilitating electron transfer between
them. In addition, the model suggests reasons why the hydroxylase exists as a dimer and that a possible
role for the outlying y-subunit may be to stabilize the complex through its interaction with the other
components. We further show that proteolysis of protein B to form the inactive B' results in a conformational
change and B' does not bind to the hydroxylase. The truncation thus could represent a regulatory mechanism
for controlling the enzyme activity.
Soluble methane monooxygenase (sMMO) from metha-
notrophs, such as Methylococcus capsulatus (Bath) or
Methylosinus trichosporium OB3b, catalyzes the biologically
and environmentally important conversion of methane to
Illethanol (1, 2). Methane has been implicated as contributing
to the greenhouse effect, interacting with atmospheric oxygen
to .YIeld CO2 and water vapor (3). sMMO can reduce the
a~ount of methane released to the atmosphere through
Illlcrobial oxidation. Further, an understanding of the sMMO
Illechanism of action may help in the design of robust
Catalysts that can effect the direct oxidation of methane to
Ill
h
ethanol at ambient temperature and pressure-a reaction
t at has so far eluded the chemical industry.
h The sMMO enzyme has three functional components: the
t~droX~lase, which is a non-heme diiron-containing protein
at eXIsts as a dimer of a,By-subunits [(a,BY)2, 250 kDa)
and Contains the site of oxidation where dioxygen and
~ethane bind; the reductase (38.6 kDa), which contains a
~Fe-s) cluster and an FAD center and transfers electrons
r 0111 NAD(P)H to the hydroxylase; and the small (15.8 kDa)
egulatory protein B, which has a variety of roles including
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by~ und~rcontractto theUniversityof Californiaandwas supported
Scie EprOjectKPIIOIOIO (J.T.)and theBiotechnologyandBiological
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II nlVerSJtyof Warwick.
tOI'\.Preosentaddress: SolidStateDivision,Oak RidgeNationalLabora-
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enhancing electron transfer between the other components,
altering the redox potential of the diiron site, changing
substrate specificity of the hydroxylase, among others (2,
4-6). The regulatory protein B can exist in two forms, one
active and an inactive variant (B') that has lost between 12
and 30 residues from the N-terminus (5, 7, 8). The evidence
for the stoichiometry of the three components in the active
sMMO complex (1 hydroxylase dimer:2 reductase:2 protein
B) will be discussed below in the context of published data
as well as our scattering experiments.
In recent years, there have been great strides toward an
understanding of the mode of action ofsMMO. In particular,
crystallization of the hydroxylase component (9, 10) has
allowed a detailed examination of the residues involved in
the binding of substrates (II) and activation of oxygen
required in the oxidation processes (IO). The field has also
benefited from extensive investigation of the mechanism of
methane oxidation using kinetic approaches (I2, 13). Other
techniques, such as EPR, electrochemistry, CD, MCD,
EXAFS, and fluorescence spectroscopy (5, 14-20), have
provided insights into local conformational changes and
perturbations which occur upon reduction of the diiron center
or binding of the regulatory protein B. To date, however,
our knowledge of the physical interactions of the individual
components of sMMO has come from interpreting binding
studies which give no direct information on global confor-
mational changes that may occur. Small-angle scattering is
a powerful technique for probing global conformational
changes in proteins arising from the addition of substrates,
inhibitors, regulators, and other cofactors (21, 22). In
10.10211bi982991n CCC: $18.00 © 1999 American Chemical Society
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addition, information on the relative disposition of compo-
nents within a complex can be obtained. We have therefore
used small-angle X-ray scattering to determine the solution
conformations of each of the isolated sMMO components
and to investigate the effects of binding of the reductase and
protein B components on the conformation of the hydroxyl-
ase dimer in a single oxidation state. This new structural
information helps to explain previous observations about
sMMO and also provides new insights into the component
interactions, regulatory mechanisms, methane oxidation, and
the role of the various protein components in this process.
MATERIALS AND METHODS
Protein Preparation. The hydroxylase and reductase, as
well as the B' form of protein B, were purified from M.
capsulatus as previously described (7). The protein Bused
in our experiments was a mutant form with a CHn residue
substituted for Gly 13 in the wild-type sequence, thus making
the protein more resistant to inactivation by truncation at
this position. This recombinant protein B was expressed in
Escherichia coli and purified as described previously (7).
The purified proteins were stored at -70 °C and thawed
immediately prior to the scattering experiments. Protein
concentrations were initially determined colorimetrically by
the method of Bradford (23) using bovine serum albumin
as a standard and commercially available reagents (Bio-Rad).
More accurate protein concentrations were obtained by
analysis of the 10 values from the small-angle scattering data
(see below). The sMMO complex was prepared by simple
mixing of the components, and its activity was followed by
the production of propene oxide in the liquid phase by gas
chromatography (24) with 25 mM MOPS, pH 7.0, and a
preincubation time of 30 s.
X-ray Scattering Data Acquisition and Analysis. X-ray data
were collected using either the small-angle X-ray scattering
station at Los Alamos described previously (25) or our newer
instrument which has a two-dimensional detector and a
rotating anode source with double focusing mirrors to give
a point-source geometry. The data from each instrument gave
identical structural parameters for the same protein samples,
although the brighter source and two-dimensional detector
of the newer instrument give dramatically improved counting
statistics. Samples were maintained at 16 °C during data
acquisition. Typical data collection times were 10 min to 2
h, depending on protein concentration and molecular mass.
All scattering experiments were repeated at least two times
using samples from independent preparations.
Scattering data were reduced and analyzed as previosuly
described (25). Parameters used in the interpretation of the
scattering data included radius of gyration, Rg, forward (or
zero-angle) scattering intensity, 10, and the pairwise length
distribution function, p(r). P(r) is the probable frequency of
vector lengths connecting small-volume elements within the
scattering particle. P(r), therefore, goes to zero at the
maximum linear dimension of the particle, dmax• For a dilute
solution of monodisperse, identical particles the scattering
intensity, I(Q), and P(r) are related by a Fourier transforma-
tion:
P{r) = r2/2,c j/{Q)(i{sin{Qr)/Qr) dQ (I)
where Q = (4.7l sinO)/A. is the amplitude of the scattering
Biochemistry. Vol. 38. No. 21. 1999 6753
vector, 0 is half the scattering angle, and A. the wavelength
of the scattered radiation (1.54 A). P(r) is calculated from
the experimental scattering profile using an indirect Fourier
transform method (26). Rg and 10 are calculated as the second
and zeroth moments of P(r), respectively.
10. when normalized to molar concentration, is proportional
to the square of the molecular weight for particles with the
same mean scattering densities. By using a standard protein
of known molecular weight (lysozyme in this study), one
can determine th~ molecular weight of another monodisperse
protein sample by taking ratios of the 10 values. An 10 analysis
can thus be use to check the monodispersity in samples of
known protein concentration or to determine accurate protein
concentrations for solutions known to be monodisperse (27).
In addition, 10 is highly sensitive to complex formation (27).
For a three component system with component molecular
weights Ma, Mb, and Mc, 10 is proportional to (Ma + Mb +
Me)2 for the 1:1:1 complex but to the much smaller Ma2 +
Mb2 + Me2 if the components do not form a complex. For a
mixture of partially complexed components,lo is proportional
to the concentration-weighted average of the 10 values for
the complexed and uncomplexed components.
Molecular volumes were calculated from the scattering
data using the equation:
(2)
where Qi is the scattering invariant (28):
Qi =Tif dQ/{Q) (3)
Because the scattering data are measured only over a finite
Q-range, the scattering invariant, and hence molecular
volume, calculations are subject to systematic error. These
errors vary for different experiments and in our case are of
the order of 10% based on comparison of the expected
volumes with those calculated from the scattering data.
Modeling the Scattering Data. In the absence of high-
resolution crystal structure data, the scattering from globular
proteins can be effectively modeled using uniform-density
ellipsoid shapes (29, 30). Protein B and the reductase were
each modeled as uniform density ellipsoids, and model
scattering profiles were calculated using a Monte Carlo
simulation program [SASMODEL (30)). SASMODEL gen-
erates models using one or more ellipsoid shapes with
dimensions constrained within a range given by the user.
Large numbers of models are generated by an algorithm that
assigns random values (within the defined constraints) to the
lengths of each semi-axis. For each model generated, a P(r)
function is calculated using a rapid Monte Carlo integration
method (25) in which the ellipsoids are filled with random
points and all possible vector lengths between the points are
summed to give P(r). Model P(r) functions based on the
hydroxylase crystal structure [Protein Data Bank (POB)
accession no. P22869], as well as for the sMMO complex,
were calculated using a program (PRPDB) that utilizes a
rapid Monte Carlo integration method similar to that used
by SASMODEL. The atomic coordinates from the crystal
structure are placed in a box with a three-dimensional grid.
An option to include a hydration layer, in which the solvent
layer at the surface of the protein is assigned a different mean
scattering density to the bulk solvent, is included. The
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thickness and contrast of the hydration layer are parameters
that can be chosen by the user. The volume elements of the
grid are assigned scattering density values based on the
number of electrons that fall within the volume element (from
either the protein or hydration layer components). Altema-
tively, a uniform density can be assigned to grid elements
occupied by the structure. The model Per) is calculated by
filling each volume element occupied by the molecular shape
with 4000 random points and summing all vector-lengths
between pairwise combinations of the saved points. PRPDB
can also use the output from SASMOOEL and calculate Per)
profiles from uniform density ellipsoid shapes as well as
composite models made up from uniform density ellipsoids
combined with crystal structure coordinates. Typically, 4000
points were used in our model Per) calculations which gave
smooth well-determined profiles. Both SASMOOEL and
PRPOB calculate model scattering profiles for .~omparison
with experiment by Fourier transformation of Per). Model
fits are evaluated using least-squares methods and saved in
POB format for ease of viewing.
RESULTS AND DISCUSSION
Analysis a/the sMMO Component Structures. To evaluate
the sMMO component structures, as well as to aid in
interpretation of the scattering profile of the sMMO complex,
we first measured the solution-scattering profiles of each of
the isolated components (Figure 1). Scattering data were
measured for a series of five protein concentrations in the
range 2-15 mg/mL, in 25 mM MOPS, pH 7.0, T= 13 QC.
For each component, there was no concentration dependence
of the scattering data, indicating that interparticle interference
effects (31) were negligible and hence required no correction.
The vector length distribution functions for each component,
calculated as the inverse Fourier transform of the scattering
profiles (26), are shown in Figure 2. The best-fit ellipsoid
models for the reductase and protein B have approximate
dimensions 72, 44, 32 A and 50, 34, 30 A, respectively.
These models give reduced X2 values of 1.03 and 1.01,
respectively, indicating a near perfect fit (which would have
X2 = 1.0) to the scattering data. For the isolated hydroxylase,
a model Per) function was calculated using the crystal
structure coordinates (l0). This fit gives X2 = 0.99 without
inclusion of a hydration layer. Thus, under the conditions
of our experiments, hydration layer effects are not detected
and the crystal and solution structures for the hydroxylase
are the same. Figures 1 and 2 show the excellent fits of the
model I(Q) and Per) functions to those derived from
experiment for each component.
The reductase and protein B components give unimodal
Per) profiles typical for compact globular proteins (Figure
2a). In contrast, the Per) function for the hydroxylase is
bimodal with a shoulder at 70 A (Figure 2b). This shoulder
is due to the bilobal shape of the hydroxylase that arises
from the way in which the two af3y trimers associate to form
the dimer (Figure 3). The values obtained for dmax, Rg, and
molecular volume for each of the isolated components are
in good agreement with the expected values based on
monodisperse proteins of mass 250,38.6, and 15.8 kOa, for
the hydroxylase, reductase, and protein B, respectively, and
assuming a specific volume of 0.74 cmvg (Table 1). The
Gallagher et al.
0.00 0.05 0.10 0.20 0.250.15
Q (1'1.1)
FIGURE I: I(Q) versus Q data for sMMO and its individual
components. Experimental data are depicted by the symbols; protein
B (.), B' (D), reductase (+), hydroxylase (...), sMMO (1:10:10
mixture = I:2:2 complex) (.0.). The scattering profiles are offset
by multiplication factors in order to separate them on the vertical
axis for easy viewing (0.2, 4, 16,258, and 4096, respectively). The
errors indicated are based on counting statistics only. The solid
lines represent the model I(Q) profiles calculated using uniform
ellipsoids for the reductase, protein Band B', and the crystal
structure coordinates for the hydroxylase. For the sMMO complex,
the solid line represents the model profile calculated using the model
shown in Figure 6.
molecular volumes were calculated from the scattering data
using eqs 2 and 3 (Materials and Methods).
Structural Differences between Protein Band B'. Figure
2a shows a comparison of the Per) functions for protein ..B
and B'. A significant increase in dmox is observed for B'
compared with B. The best-fit ellipsoid which approximated
the scattering from B' has dimensions 66, 28, and 27 A (x2
= 1.02) compared to 50, 34, and 30 A for protein B, i.e., B'
is longer and thinner than B. (As a measure of the
discrimination between these fits to the data one can compare
the scattering data for B to the best-fit ellispoid determined
for B' which gives a X2 of 12.5. Vice versa, the experimental
data for B' compared to the best-fit model for B gives a X2
of 13.0). The measured 10 values and molecular volumes
show that both protein Band B' are monodisperse in solution,
indicating that the observed changes in structural parameters
cannot be attributed to aggregation (Table I). The observed
extension of the structure upon removal of the N-terminal
segment of protein B therefore must be due to a partial
unfolding or to some sort of opening of the structure triggered
by the loss of interactions with the N-terminal residues. In
subsequent scattering experiments on mixtures of the hy-
droxylase with the reductase plus protein B or B' under
conditions whereby binding of B is observed (see below),
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FIGURE2: P(r) functions for sMMO and its individual components. The experimentally derived p(r) functions for (a) protein B (.), B'
(0), reductase (+), and (b) hydroxylase (.a.), sMMO (1:10: 10 mixture = I :2:2 complex) (zx), The solid lines are the P(r) functions calculated
for the models indicated in Figure I. The p(r) profiles are scaled such that their areas are proportional to the molecular weight of the
component or complex for convenient comparison of shape changes.
there is no evidence for binding of B', including in the 10
data that are most sensitive to complex formation.
Several authors have suggested that the in vivo proteolytic
cleavage of the 12 N-terminal residues of protein B to yield
an inactive form of the protein, designated as B', may
represent a means for controlling activity of the enzyme
complex (5,7,8). In the absence of methane, the uncoupling
of sMMO activity from NADH oxidation by inactivation of
protein B would prevent consumption of limited cellular
NADH resources. Kazlauskaite and coauthors (5), for
example, found that although protein B alters the potentials
at which the hydroxylase component is reduced, B' does not.
It has been unclear, however, how the loss of the 12
N-terminal residues of protein B (to give B/) results in
inactivation. The scattering data show that a conformational
change occurs in B upon cleavage of the N-terminal segment
and binding is inhibited.
Titration of Hydroxylase with Reductase Plus Protein B
to Determine Stoichiometry within the sMMO Complex.
Scattering data were measured from mixtures of the sMMO
components with 1:1:1, 1:2:2, 1:5:5, 1:10:10, and 1:20:20
ratios of hydroxylase:reductase:protein B. The measured 10
value is proportional to the square of the molecular weight
of the scattering particle and, for protein solutions of known
concentration, is extremely sensitive to molecular associa-
tions (see Materials and Methods). Analysis of the 10 values
indicate that 0, s10, and :s25% of the total protein Band
reductase were bound to the hydroxylase for the 1:1: I, 1:2:
2, and 1:5:5 mixtures, respectively (Table 1). This minimal
binding is consistent with the minimal changes observed in
Rg and P(r) compared to the isolated hydroxylase. The 10
values for the 1:10: 10 and 1:20:20 mixtures are consistent
with formation of the 1:2:2 complex with 8 and 18 free equiv
of the reductase and protein B, respectively. Figure 4 shows
a plot of the observed 10 values for the mixtures plotted
against the molar ratio of (reductase and protein B) to
hydroxylase in the solution. Also shown are the expected 10
dependencies assuming different stoichiometries of hydroxy-
lase:reductase:protein B. The comparisons show clearly that
the observed data fit the 1:2:2 complex being formed with
z 10 equiv of protein B and reductase compared to the
hydroxylase. The discrimination between the different sto-
ichiometries is excellent and well beyond the errors in the
data.
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FIGURE 3: Hydroxylase crystal structure. (a) Surface representation
showing the bilobal nature of the dimerized trimers (I/). The active
sites are indicated (e). The structure has been rotated to show the
two canyon-like features (1 and 2) which previously had been
proposed as possible binding sites of protein B and the reduc~ase
(9). (b) Top view of the structure in panel a showing the posttrons
of the two canyons.
The scattering results are consistent with prior evidence
for the physical interactions within the sMMO complex,
including titrations of the hydroxylase with reductase and
protein B, which give an optimum ratio for activity at 1:2:2
(hydroxylase: reductase: protein B) (15); cross-linking
studies which provided a tentative assignment of the binding
sites of protein B and reductase to the hydroxylase (20); the
crystal structure of the hydroxylase in the presence of a short
peptide of the reductase component (32); and perturbation
of the partially and fully reduced EPR signal of the
hydroxylase by addition of protein B (20). Combined, these
data suggest possible sites of interaction between the three
components and that the stoichiometry of components within
the complex is I :2:2. The stoichiometry of components
within the sMMO complex has also be implied from the
dimeric form of the hydroxylase, which suggests that two
equivalents of the reductase and protein B will be required
to bind to a single hydroxylase dimer (9).
Because interpretation of small-angle scattering data in
structural tenus requires a homogeneous solution of mono-
disperse, identical particles, our titration experiments were
done in the absence of NAD(P)H and substrates in order to
prevent turnover which would result in a mixture of different
states. Under these conditions, 10 equiv each of the reductase
and protein B are required to see full complex formation,
whereas maximal activity of sMMO from Methylosinus
thrichosporium OB3b is observed for mixtures containing 2
equiv of both the reductase and protein B per hydroxylase
(J 5). It therefore appears that the addition ofNAD(P)H and!
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or substrate may increase the affinity of the reductase and
protein B to the hydroxylase, thus driving the equilibrium
toward complex formation.
Structural Changes Observed Upon Binding of Reductase
and Protein B to the Hydroxylase. To determine the structural
parameters of the sMMO complex, we used the scattering
data from the I: 10: 10 mixture of hydroxylase:reductase:
protein B. The 8 free equiv of reductase and protein B in
this mixture make relatively small contributions to the
scattering (4% imd 10% total intensity for protein Band
reductase, respectively) due to their small size compared to
the complex. This contribution is most evident in the overall
intensity and 10 values, and will be less evident in the shape
of the scattering profile from which the particle shape
parameters are calculated. Since we know the amount of free
protein B and reductase, as well as their scattering profiles,
we can subtract their contributions proportionately according
to their known concentrations. These corrected curves gave
PCr) profiles, Rg and dmox values that are indistinguishable,
within the limits of the experimental errors, from those
calculated from the uncorrected data. Nevertheless, all of
the interpretation and modeling for the sMMO complex were
done using these corrected data.
Accompanying formation of the 1:2:2 sMMO complex,
we observe in the Per) profiles an increase in dlllax, from 125
to 150 A and the shoulder at 70 A is lost, indicating that its
overall structure is more elongated and has lost the bilobal
character of the hydroxylase alone (Figure 2b). In addition,
the Rg value for the scattering particle increases from 42 to
46 A and the molecular volume increases by 26%. This latter
increase is within the tatistical error, what is expected for
the fonuation of a I :2:2 complex (Table I).
The single ellipsoid fit to the scattering data for the
complex gives dimensions 150, 71, and 66 A with a X2 value
of 1.04. In comparison, the best-fit ellipsoid for the isolated
hydroxylase calculated from the crystal structure coordinates
has dimensions of 125, 95, and 65 A, which agree well with
those of the best-fit ellipsoid calculated from the scattering
data 127,98, and 65 A (x2 = 1.01). These ellipsoid fits
indicate that the molecular envelopes of both the hydroxylase
and the complex can be reasonably approximated with
uniform density ellipsoid models. Importantly, upon complex
formation and the accompanying increase in dlllox, there is a
narrowing in a second dimension (by 24 A, or 25%),
indicating that the hydroxylase cannot be accommodated
within the molecular envelope of the complex without a
conformational change. The point is illustrated in Figure 5
which shows the best fit ellipsoids for the hydroxylase and
the sMMO complex superimposed with the crystal structure
for the hydroxylase and the hydroxylase in the sMMO
complex derived from the scattering data (see below).
Parallel scattering experiments in which the hydroxylase
was titrated either with the reductase or protein B alone, up
to 10 equiv of each, showed no evidence for their binding
to the hydroxylase, either in tenus of the expected increases
in 10 values or conformational changes. These results show
that both the reductase and protein B are required for binding
and inducing the conformational change
Modeling the sMMO Complex. The crystal structure of
the hydroxylase shows two extended canyon-like features
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expectedvolume (A-l)
Table I: Ra, dmax, and MolecularVolumes for Each Component of sMMO and ComponentMixtures"
component/mixture Rs (A) dmax (A) measured10(arbitraryunits) measuredvolume(Al)
protein B
protein B'
reductase
hydroxylase
1:1:1
1:2:2
1:5:5
1:10:10
1:20:20
50
70
70
125
125
125
130
150
150
17.5± 0.9
19.8± 0.9
23.1 ±0.4
41.1 ± 0.04
42.1±0.7
43.3± 1.6
44.1 ± 0.6
46.4 ±0.4
46.5 ±0.5
3950 ± 150
3650 ± 160
9650 ±470
62500 ±2100
67350 ±2200
71020 ± 2350
121520 ± 3520
185000 ± 2680
264 200 ± 2450
19200 ± 3100
20300 ± 1700
43200 ± 2000
275000 ± 1800
298 100± 13 100
280 700 ± 29 200
294600 ± 19200
)46 300 ± II 800
348200 ± 10040
19400
17900
47300
305800
a Errors indicated are based on counting statistics alone. Expected volumes are calculated using eqs 2 and 3 in Materials and Methods and a
partial specific volume of 0.74 cml/mg (37). The expected volume for a I:2:2 complex of the hydroxylase:reductase:proteinB is 373 900 Al. In
absolute terms, the volumes determined from the scattering for the hydroxylase and the complex are -90% of the values expected based on
calculation from their specific volumesand molecularmass, with -4% statistical error. This agreement is excellent given the finite Q-range of the
experimental data (see Materials and Methods).
350
300 .' '1:3:3.-
1200
~ 150
_.-..-100 _"-'-"'-""-i~~o-'-'...•.-_ .....-.....
D 5 1D 15 20
Molar ratio (protein B and Redudalle) to Hydroxylase
FIGURE 4: Titration of the hydroxylase with protein B and
reductase. The 10 values measured for the mixtures of hydroxylase:
reductase:protein B plotted as a function of the protein B and
reductase to hydroxylase mole ratio. The solid line indicates the
expected 10 values assuming two equivalents of protein B and
reductase bind to one hydroxylase. The dashed lines correspond to
alternative stoichiometries for binding as indicated.
(Figure 3) which have been proposed as potential binding
sites for the reductase and protein 8 (9). Models for the
complex in which protein 8 and the reductase were
Positioned so that they filled these canyon-like features,
however, cannot account for the increases in Rg and drnax
observed upon complex formation. The best X2 obtained for
such models compared with the scattering data was 16.0, a
result that is not surprising since we know that the overall
dimensions of the hydroxylase cannot fit within the molecular
envelope calculated for the complex. It is possible to obtain
the observed increase in the dmax for the complex by
Positioning protein 8 or the reductase on the surface of the
hydroxylase in highly extended arrangements. These types
of models, however, do not give the correct Rg values or
shape functions. In general, they do not have the correct ratios
of dmax to cross-sectional area for the elongated shape of the
complex, and models of this type all gave X2 values 2:6,
indicating poor fits.
Inspection of the hydroxylase structure suggests that the
required conformational change can be achieved via a
rearrangement of the two trimers that associate to form the
hydroxylase dimer. Within each trimer, the individual
subunits have convoluted surfaces of interaction, whereas
the two trimers contact each other with relatively small areas
of interaction at each end of their long axes between the
two ,8-subunits. At one end of this interaction, there is a
planar interface of approximately 200 A2. This planar
interface provides a potential pivot point in the structure
about which the hydroxylase can rotate to give a structure
with an increased dmax, while maintaining a significant area
of contact between the trimers. Rotating about this pivot point
takes advantage of the long axes of the trimers to obtain the
increase in dmax of 25 A while at the same time narrowing
the structure in a second dimension (Figure 5). To test this
hypothesis against the scattering data, the hydroxylase was
rotated systematically in 100 steps, about the pivotpoint so
as to increasingly extend the long axis of the hydroxylase
dimer interface. At the. same time, best-fit ellipsoid models
of the reductase and protein 8 (two of each) were placed as
close to the hydroxylase active site such that they sat within
the overall ellipsoid dimensions for the complex. Model P(r)
functions were determined and compared to the experimental
P(r) function. If the extension of the hydroxylase structure
in this manner accounts predominantly for the increase in
drnax, one hydroxylase trimer would have to rotate ap-
proximately 1800 with respect to the second to fit the
scattering data (Figures 5 and 6). This rotation preserves the
2-fold symmetry expected for the dimer. It also increases
the distance between the active sites from 45 to 75 A. A
plot of log I(Q) vs Q for the experimental data from the
complex and that determined from the model (Figure 1)
shows the quality of this model fit to the data <x2 = 1.13).
Further, the model P(r) agrees well with that determined from
the experimental data (Figure 2b). There is likewise excellent
agreement for the structural parameters determined for the
model and the experimental data. Both have a dmax of 150
A, the Rg values are both 46 A and the volumes agree within
10% (346300 A3 for the experimental and 379 100 A3 for
the model).
Interpretation of the sMMO Model and Relationship to
Previous Work. The precise binding site of the reductase
and protein 8 components on the extended form of the
hydroxylase cannot be determined from the X-ray scattering
data alone. Further, we cannot rule out the possibility of there
being some small rearrangements of the subunits within the
hydroxylase trimers as the dimer opens. However, Figure 6
shows our model for the interaction between the extended
hydroxylase and the other components that gives the best
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FIGURE5: Proposed model for the extended hydroxylase structure. Ellipsoid models for the isolated hydroxylase dimer (left) and the
sMMO complex (right) are shown as yellow dots that fill the ellipsoid volumes. The upper and lower representations (a and b) are obtained
by rotating the respective structures 90° about their long axes. A ribbon representation of the hydroxylase structure is superimposed on the
ellipsoids, with the individual trimers that associate to form the dimer colored blue and red. The two orientations of the isolated hydroxylase
are shown (left) with the ribbon representations based on the unmodified crystal structure. For the complex (right), the hydoxylase dimer
is shown in an extended configuration obtained by a rotation of the long axes of each trimer about a pivot plane between the trimers,
opening them by approximately 180°. Note, the orientation of the blue trimer is held constant in the views shown in panel a to aid in the
comparison. The reorientation of the hydroxylase dimer upon forming the complex accounts for the observed increase in dmax as well as the
narrowing of the structure in a second dimension. The bound protein B and reductase (shown in Figure 6) fit within the unfilled portion of
the ellipsoid for the complex.
fit to our scattering data consistent with everything we
currently know about sMMO. In this model, protein B binds
close to the pivot point in the hydroxylase, and we propose
that it plays a role in maintaining the extended form of the
hydroxylase dimer. This arrangement would allow the
reductase component to bind close to the hydroxyl-
ase active site and could, therefore, represent the manner in
which protein B enhances electron transfer, binding of
molecular oxygen, and substrate oxidation (5). No evidence
for complex formation, or conformational changes, was
observed upon addition of either the reductase or protein B
alone to the hydroxylase, indicating that both are required
to bring about the conformational change under the equi-
librium conditions of the scattering experiments. It appears
then that protein B may facilitate the conformational change
of the hydroxylase, but that the reductase is also required
and may play a role in locking the hydroxylase in the
extended configuration. Hydrogen peroxide can provide
electrons and oxygen to the hydroxylase for the methane
oxidation reaction in the absence of the reductase and protein
Methane Monooxygenase Structure by X-ray Scattering
FIGURE6: Model of the interaction between the three components
of sMMO. The hydroxylase structure is shown in ribbon form (dark
blue and red), protein B (light blue), and the reductase (yellow)
are represented by ellipsoids filled with small spheres. The rotation
of the hydroxylase trimers about the pivot region shown in Figure
5 allows Band C to bind closely the hydroxylase giving a compact
structure with protein B and the reductase interacting with the active
sites. The ellipsoids of the reductase and protein B are effectively
rotational averages of their structures. As a result, their volumes
are somewhat larger than the actual protein structure is (51 600
and 26700 A3 for the ellipsoid models compared to 43 300 and
19200 A3 for the reductase and protein B, respectively), and they
therefore were allowed to overlap some with the hydroxylase such
that they fit within the overall molecular boundary for the complex.
B (33). Addition of hydrogen peroxide up to concentrations
of 100 mM did not give rise to any conformational change
in the hydroxylase as evidenced by the scattering data. This
result supports our proposal that the role of protein B is
primarily to facilitate the conformational change in the
hydroxylase in order to allow close interaction between the
reductase and hydroxylase. Our model for the complex also
suggests why the hydroxylase exists as a dimer since contacts
between protein B and both of the hydroxylase trimers occur.
These contacts could enhance the interactions between the
reductase and protein B with the hydroxylase.
We have compared the interactions between the compo-
nents in our model with other data collected under equilib-
rium conditions such as chemical cross-linking studies (20)
and the crystal structure of the hydroxylase in association
with a short peptide from the reductase (32). The primary
interactions suggested from these data are between the
reductase and the a- and f3-subunits(crystal and cross-linking
data) and between protein B and the a-subunit (cross-linking
studies only). Our model.supports these assignments, but also
Suggests that there are further interactions. Indeed there
appear to be interactions between the reductase and protein
B with all three subunits of the hydroxylase. The active site
is centered in the a-subunits, and the surface of interaction
between the two hydroxylase trimers is provided by the
,B-subunit. The y-subunit, however, is situated toward the
Outside of the hydroxylase dimer, and its precise role has
been to date unclear. The scattering data presented here
Suggest that the y-subunit contributes to the overall stability
of the complex by providing additional interactions with
protein B.
Our scattering data on the fully oxidized hydroxylase are
also consistent with previous electrochemical and EPR
experiments carried out under nonequilibrium conditions
during reduction of the hydroxylase. The electrochemical
measurements suggest that while protein B can alter the
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reduction potentials of the hydroxylase in the absence of
reductase, B' cannot (5). In addition, Fox and co-workers
(20) showed that the EPR spectrum of the hydroxylase is
altered by addition of protein B. If the binding of protein B
were to affect the hydroxylase in the manner proposed here,
it would most certainly affect the environment of the diiron
center thus explaining the alteration in its EPR spectrum and
redox potentials (5, 20). In addition to the effects on the
environment of the diiron center of the hydroxylase, the
proposed close association between protein B and the
hydroxylase suggests how protein B could alter the hydroxyl-
ase substrate specificity (15). Protein B is positioned such
that it can be involved in recognition of substrates entering
the hydroxylase active site. A similar proposal was suggested
for phenol hydroxylase, a closely related enzyme (34).
CONCLUSIONS
In summary, we have shown that formation of the sMMO
complex results in a conformational change in the hydroxyl-
ase that involves an extension in one dimension and a
narrowing in a second. We have proposed a model that fits
the scattering data for the complex in which the pair of
trimers that associate to form the hydroxylase dimer are
rotated with respect to each other about a pivot plane such
that the 2-fold symmetry expected for a dimer is preserved.
The best-fit model of the complex is a compact structure
containing one hydroxylase dimer and two molecules each
of the reductase and protein B, and requires close interaction
between all of the protein components. In the model, the
conformational change in the hydroxylase allows the reduc-
tase to bind close to the hydroxylase active site. Both protein
B and the reductase are required for the conformational
change. The reductase thus not only provides reducing power
for the methane oxidation process but also appears to act in
concert with protein B to induce the extended conformation
of the hydroxylase dimer. Inactivation of protein B to B' by
cleavage of 12 N-terminal residues is accompanied by a
conformational change that renders the protein unable to bind
and alter the global structure of the hydroxylase. This
inhibition of binding provides a means to regulate the activity
of the enzyme in vivo.
There are other examples of regulation of enzyme activity
via conformational changes induced by proteins binding and
modulating access to, or the configuration, of the active site.
An example is the binding of calmodulin to the autoinhibitory
region of myosin light chain kinase that results in its removal
from the surface of the catalytic core and a subsequent
closure of the catalytic cleft upon substrate binding (35, 36).
The sMMO example presented here involves a much more
dramatic movement of molecular mass, however, than the
more typical calmodulinlkinase/substrate interaction and
associated conformational transitions.
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